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ABSTRACT
Fibrillation is defined as turbulent cardiac electrical activity and results in the inability 
of the myocardium to contract. When fibrillation occurs in the ventricles, it is known 
as ventricular fibrillation (VF). The consequence of VF is sudden death unless treated 
immediately. Fibrillation can also occur in the atria and is known as atrial fibrillation 
(AF). The consequences of atrial fibrillation (AF) are less immediate; however, it leads to 
increased risk of stroke. Despite the impact of fibrillatory arrhythmias, there are many gaps 
in our mechanistic knowledge of these arrhythmias. The purpose of this dissertation is to 
study through several projects how different cardiac substrates help initiate and/or sustain 
fibrillation.
The first project examined several properties of the ventricular conduction system 
during VF. The conduction system coordinates excitation and consequently coordinates 
the contraction of the ventricles. Despite the conduction system's unique structure, its role 
in VF remains unclear. We examined the proximal conduction system and found that it 
develops a more rapid activation rate than the ventricular myocardium during prolonged 
VF, and may be driving the arrhythmia.
The second and third projects examined the effects of fibrosis on electrical conduction 
to initiate and/or sustain AF. Despite fibrosis being associated with AF, it is still unknown 
whether it is a byproduct of an underlying heart disease and does not in itself promote 
AF, or if it affects the organization of conduction during fibrillation to promote AF. In the 
second project we studied the effect of fibrosis on conduction following different types of 
triggers. We found that fibrosis causes transverse conduction slowing following premature 
stimulation, which makes AF more likely to initiate. As AF persists, single episodes of 
AF last longer before the patient transitions into normal sinus rhythm, and in some cases 
AF can become permanent. The third project examined why some patients may never 
transition from AF to normal sinus rhythm. Specifically, this project found that regions of 
dense fibrosis anchor high-frequency activation that may be driving the arrhythmia. These 
studies showed that fibrosis causes conduction changes that make AF more likely to initiate 
and to be sustained.
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A guiding principle in physiology is that structure dictates function. This principle 
can be expanded to state that the function of a system cannot be completely understood 
until the structure is known. Cardiac electrophysiology follows this same paradigm and 
leads to an understanding of how different cell and tissue types within the heart have 
different functions, an example of which is the first examination of the heart with electron 
microscopy. These early studies found structural differences between cell types in the 
heart. Specifically, it was found that there existed a working myocardium and conductive 
tissue [1]. These cell types were then examined with various electrical measurements and 
it was found that the conductive tissue can have more rapid conduction velocities than 
the myocardium, and the conductive tissue has autorhythmicity, or pacemaker function [1]. 
Under physiological conditions, cardiac conduction is due to the formation and coordinated 
propagation of electrical impulses through cardiac cells. Arrhythmias are broadly referred 
to as disorders in cardiac impulse formation and/or impulse propagation [2]. The concept 
that structure dictates function has been well characterized for normal electrophysiology 
conditions. However, much is still unknown about the relationship between these different 
cells and structures in the heart, which we define as the cardiac substrate, and mechanisms 
of arrhythmia. The purpose of this dissertation is to utilize the structure function principle 
to examine the relationship between cardiac substrate and mechanisms of how arrhythmias 
initiate and become sustained.
The goal of understanding the relationship between structure and function with mecha­
nisms of arrhythmia is not novel; however, the implementation has many unique challenges. 
Uncovering the relationship between structure and function in arrhythmia entails the 
development of novel imaging and electrical recording techniques as well as the development 
of methodology to bridge these two domains. Specifically, this dissertation has been made 
possible by recent advancements in noninvasive imaging, electrical recoding equipment, and 
signal processing techniques.
21.1 Background
Understanding the relationship between cardiac substrate and mechanisms of arrhyth­
mia is a topic of great interest and study in cardiac electrophysiology, primarily because 
arrhythmia can lead to failure of the cardiovascular system [3, 4]. The focus of this 
dissertation is fibrillation, the most severe arrhythmia, which is defined as turbulent cardiac 
electrical activity whereby propagation of electrical waves through the heart is disrupted, 
with consequent production of wavelets, high frequency rotating waves, and inability of 
the myocardium to contract [5]. When fibrillation occurs in the ventricles it is known 
as ventricular fibrillation (VF). The consequence of VF is sudden death unless treated 
immediately [6]. Fibrillation can also occur in the atria and is known as atrial fibrillation 
(AF). The consequences of atrial fibrillation (AF) are less immediate, however it also leads 
to decreased life expectancy, quality of life and increased risk of stroke [7-10]. Despite the 
huge impact of fibrillatory arrhythmias, there are many gaps in our mechanistic knowledge 
of arrhythmias, and especially fibrillation, as well as many technical challenges to studying 
them.
Fibrillation is thought to initiate and be sustained due to alterations in normal cardiac 
impulse formation and impulse conduction [2]; however, much is still unknown about the 
role of specific substrates beyond the myocardium in causing these alterations to cardiac 
impulses. Most canonical theories of fibrillation (which is discussed in detail in Chapters
3.1 and 3.2) state that abnormalities in cardiac conduction within the myocardium are 
responsible for the turbulent electrical activity that is characteristic of fibrillation. However, 
great mechanistic leaps in our understanding of arrhythmia have occurred from examining 
the cardiac substrate beyond the myocardium. The ventricular conduction system has been 
shown to initiate VF with abnormal impulse formation [11,12]. In addition, many reports 
suggest that the conduction system may be critical in sustaining prolonged VF [13-15]. 
Structures beyond the myocardium have also been shown to be critical for initiating and 
sustaining AF. Haissaguerre et al. found that the pulmonary veins in the left atrium 
are prone to ectopic activity to initiate AF [16]. Furthermore, reports have found that 
a fibrotic substrate during AF may cause decreased coupling between myocardial cells 
to increase AF stability [17]. This dissertation builds on these and other reports to 
suggest that the cardiac substrate may, at least in part, explain the observed electrical 
organizations of fibrillation. In three aims we tested the general hypothesis that specific 
detectable substrate abnormalities beyond the working myocardium are responsible for the 
initiation and organization of cardiac impulses in fibrillation. This hypothesis was tested
3using multiple methods to discriminate different cardiac substrates including electrogram 
morphology from different forms of abnormal substrates, microscopy of histology, and novel 
magnetic resonance imaging (MRI) methods. The electrophysiological properties of the 
heart were then measured and compared directly with features of the cardiac substrate.
In the first aim of this dissertation we examined whether the proximal ventricular con­
duction system may facilitate sustained VF. The ventricular conduction system coordinates 
excitation and consequently coordinates the contraction of the ventricles. Cardiac impulse 
propagation begins at the sinoatrial (SA) node in the right atrium and conducts to the 
atrioventricular (AV) node. The ventricular conduction system is then excited by the 
AV node. The ventricular conduction system electrically connects the AV node to the 
ventricular myocardium (VM) and consists of specialized conduction cells that conduct 
rapidly, but do not have contractile function. One component of this system that is located 
at the distal end of the AV node is called the Bundle of His or His Bundle, the distal end of 
which is known as the Purkinje system. The His/Purkinje system consists of a network of 
electrically coupled cells, and is the only connection from the atria to the VM. The terminal 
Purkinje is one structure beyond the myocardium that has been implicated in sustaining 
VF, however it is unclear whether the His Bundle is involved in sustaining VF as well. The 
first aim of this dissertation was to determine whether the proximal ventricular conduction 
system may be a driver of prolonged VF.
1.1.1 Specific A im s
Aim 1 of this dissertation is to characterize how the activation rate and conduction 
velocity of the proximal conduction system change during the time course of VF. The 
hypothesis of this aim was that the proximal ventricular conduction system is a driving force 
during the time course of VF, and that it is not being passively driven by the VM. Most 
studies of VF measure only signals from the VM because canonical theories of fibrillation 
suggest that the VM alone can sustain the arrhythmia, which is likely true during early VF. 
However, growing evidence suggests that the ventricular conduction system may be critical 
for sustaining prolonged VF [14]. This difference in early and prolonged VF is due to many 
cellular changes that occur during VF that alter the electrophysiology of the heart [18,19]. 
Specifically, it is thought that the distal Purkinje system develops a more rapid activation 
rate than the VM during prolonged VF. However, it is unknown whether this activity is 
exclusive to the distal regions of the ventricular conduction system or whether it occurs 
in the proximal ventricular conduction system as well. In this aim we overcame previous
4challenges to studying the ventricular conduction system, which included signals being of 
low amplitude, often being masked by larger ventricular signals, and having mostly unknown 
characteristics during VF. We overcame these challenges by applying novel signal processing 
techniques to directly measure the electrical activity from the ventricular conduction system.
Fibrillation in the ventricles has many similarities to fibrillation in the atria, but a 
primary difference between the arrhythmias is that VF is an acute arrhythmia and AF 
can be chronic. VF lasts only from seconds to minutes before it's either treated, becomes 
fatal, or very rarely self terminates. Fibrillation in the atria is not immediately fatal, 
and therefore this arrhythmia can persist for years, causing many electrical and structural 
changes to the cardiac substrate. AF has also been shown to be progressive, starting out 
as short lasting (paroxysmal) episodes, but eventually the arrhythmia becomes persistent 
or even permanent [20]. As AF progresses, it is associated with the development of a 
nonconductive tissue within the atrial substrate as a result of fibrosis. It is known that 
fibrotic tissue density increases as AF progresses and that more fibrosis is associated with 
a worse prognosis [21,22]. Despite fibrosis being associated with AF, it is still unknown 
whether fibrosis is a byproduct of an underlying heart disease, and does not in itself promote 
sustained AF, or if it affects the organization of conduction during fibrillation to promote 
sustained AF. The next two aims in this dissertation examine how fibrotic tissue relates to 
conduction changes and whether fibrosis can cause increased incidence and maintenance of 
AF.
Past studies have found that increased levels of fibrotic tissue may increase stability 
of AF, allowing individual episodes to last longer; however, the mechanism is unknown 
and controversial [23,24]. W hat is less known is whether fibrotic tissue causes conduction 
changes that increase the likelihood of AF onset. Although potentially similar, it is 
important to recognize that the mechanisms by which AF is sustained may be very different 
from the mechanisms that cause it to initiate. For example, for fibrillation to initiate, there 
must be a trigger, such as a premature atrial contraction (PAC), and the cardiac tissue must 
have a response that is different from normal sinus conduction to initiate the arrhythmia. 
A further subtlety is the differentiation between sustained and nonsustained arrhythmia 
that may be directly related to the cardiac substrate. Healthy hearts, i.e., hearts without a 
history of AF, may transiently be able to sustain AF; however, these hearts usually cannot 
sustain AF for longer than a few tens of seconds. In various rapid atrial paced animal 
models of AF it has been shown to take over one month of pacing before this arrhythmia 
sustains [25]. Furthermore, when AF first becomes sustained in these animal models, it is
5characterized by lower activation frequencies and less turbulent electrical activity than in 
hearts that have experienced AF for longer durations [26,27]. These studies suggest that 
healthy hearts may have compensatory mechanisms that do not allow the heart to maintain 
the rapid activation rate necessary to sustain the arrhythmia for longer periods of time. 
However, in hearts with a history of AF, the compensatory mechanisms may fail due to 
the presence of a fibrotic substrate, which may cause anatomical slowing or even block of 
conduction, to sustain the arrhythmia [24,26,28]. In aim 2 we examined how the structure 
of fibrosis relates to the onset of AF.
Aim 2 is to determine how local fibrotic tissue architecture and densities in chronic 
AF relate to conduction changes that facilitate reentrant activity. The hypothesis of this 
aim was that specific architectures of fibrotic myocardium cause conduction slowing and/or 
block, thus facilitating the initiation of sustained AF. Fibrotic tissue is nonconductive and 
therefore it likely slows conduction; however, certain architectures of fibrotic myocardium 
may have a more pronounced effect than others. Understanding whether certain archi­
tectures of fibrotic myocardium slow conduction is of critical importance, because slowed 
conduction is necessary for initiating fibrillation in all major mechanistic theories of this 
arrhythmia. Past reports suggest that overall fibrosis density may not be as important as 
the fibrotic structure for causing conduction disruptions [29,30]. For example, a heart with 
large patches of fibrotic tissue may be more arrhythmogenic than a heart with homogenous 
diffuse fibrotic tissue [31]. Other groups have expanded on this finding to show qualitatively 
that large fibrotic strands may cause conduction slowing [32]. This aim built and expanded 
on these past reports by quantitatively measuring the structure of fibrotic myocardium 
and comparing this structure to conduction velocity [33]. The goal of this aim was to 
distinguish between diffuse fibrosis and patches or strands of fibrosis and relate the findings 
to arrhythmogenesis.
A major question about AF is whether specific regions of the atria are critical to 
sustaining the arrhythmia. Most of this research has been done by examining high-density 
cardiac electrical recordings to locate regions of stable high-frequency activation during 
persistent AF [34,35]. There is some evidence that targeting therapy at these driving sites 
can result in long-term freedom from AF [36]. This evidence suggests that these local 
regions of high-frequency activation may be driving the entire fibrillatory behavior in the 
atria, and the rest of the atria may be a passive bystander subject to the high-frequency 
activation. There is some evidence for the spatiotemporal stability of these driving sites over 
the time course of AF [34,35]. This spatiotemporal stability suggests a stable substrate,
6which may anchor these driving sites to particular locations. Aim 3 examined whether 
fibrosis is the anchor for high-frequency activating driving sites during AF. Fibrosis is a 
good candidate because it is implicated in conduction slowing and block, which may be 
critical for formations of rapid reentrant activity [33, 37, 38].
Aim 3 is to evaluate the relationship between fibrotic myocardium determined by 
magnetic resonance imaging and local drivers of persistent AF. The hypothesis of this 
aim was that regions of high fibrosis create sites of rapid activations to sustain fibrillation. 
When AF is induced in hearts without a history of AF, it is characterized by a slow, global 
activation rate and broad, organized wavefronts. However, AF in hearts with a history of 
sustaining the arrhythmia is different, and is characterized by a much faster global activation 
rate and more disorganized wavefronts [26]. This disorganization of wavefronts is thought 
to make the arrhythmias more likely to be sustained for longer episodes [39]. Fibrosis 
has been implicated in causing dissociation of conduction during AF, but it is unclear 
whether it also may anchor regions of rapid high-frequency activity [28, 40]. A possible 
mechanism of how fibrosis may anchor sites of rapid high-frequency activation is that it may 
cause conduction slowing or block to break up broad more organized wavefronts into many 
disorganized wavefronts, which would result in discrete regions of rapid activation rates 
near regions of fibrosis. This aim combined many techniques that are traditionally used to 
examine the cardiac substrate and cardiac conduction in isolation, including whole-chamber 
electrical mapping of the atrium as well as both MRI and pathological quantification of 
fibrotic myocardium. By combining these techniques, a holistic examination of both cardiac 
substrate and organization of fibrillation could be made to link the spatial organization of 
fibrotic myocardium with regions that are driving AF.
In summary, the three aims to this dissertation are:
• Aim 1: Characterize how the activation rate and conduction velocity of the proximal 
conduction system change during the time course of VF.
• Aim 2: Determine how local fibrotic tissue architecture and densities in chronic AF 
relate to conduction changes that facilitate reentrant activity.
• Aim 3: Evaluate the relationship between fibrotic myocardium determined by mag­
netic resonance imaging and local drivers of persistent AF.
Although these aims use different substrate investigation and electrical recording tech­
niques, they share the common feature of examining conduction properties from an identified 
cardiac substrate. The results of the research driven by these aims showed that although
7fibrillation is characterized by turbulent cardiac activity, that it is not completely stochastic. 
Specifically, the results showed that the cardiac substrate can manifest in specific electro­
physiology properties that relate to the initialization and maintenance of fibrillation. These 
aims were completed using animal models of fibrillation. Possible future research would be 
to determine whether the findings and conclusions of these aims will translate to improving 
our understanding of human fibrillation.
1.2 Organization of Dissertation by Chapter
This dissertation is organized into eight chapters. Chapter 2 provides an overview of 
cardiac electrophysiology from the cellular to whole-tissue levels under normal physiological 
conditions. Chapter 3 provides an overview of cardiac electrophysiology during arrhythmia, 
focusing on the known and proposed mechanisms of cardiac fibrillation. Chapter 4 explains 
the challenges and the methodology of the imagining and electrical recoding techniques used 
to compare cardiac structure and function. Chapter 5 presents a published manuscript in 
PLOS One, which examines conduction properties of the ventricular conduction system 
during prolonged ventricular fibrillation. Chapter 6 presents a published manuscript in 
the Journal of Cardiac Electrophysiology that examines the conduction properties of atrial 
fibrotic tissue, and how these properties relate to the initiation of atrial fibrillation. Chapter 
7 presents a manuscript which examines the relationship between fibrosis and high-frequency 
activation sites within the atrium during atrial fibrillation. Chapter 8 concludes the 




Cardiac heart disease is the most common cause of morbidity and mortality in the 
world [10]. Cardiac heart diseases often results in arrhythmia [2,10]. Due to the impact 
of arrhythmia, cardiac electrophysiology has been studied extensively by physicians, m ath­
ematicians, and engineers. These studies have resulted in many tools to examine cardiac 
electrophysiology from the subcellular level all the way to whole-heart. This chapter will 
begin by providing a background on the subcellular components that allow for excitability 
in cardiac cells. Then the chapter will detail the mechanisms of excitability of single cardiac 
cells and cell-to-cell coupling, and conclude with the organization of whole-heart conduction.
2.1 Generation of Electrical Potential in Cardiac Cells
Many cells can generate an electric current following exposure to an electric field. These 
cells are classified as excitable. Examples of excitable cells are neurons, which generate 
current for communication with other cells, as well as muscle cells, which generate current 
not only for communication but also for generation of a contraction force. Excitability in 
cells comes from two mechanisms. The first is the presence of a nonzero resting membrane 
potential and the second is the presence of gated ion channels. This section will detail the 
components of cardiac cell excitability.
2.1.1 T he Sarcolem m a
A 4-6 nm lipid bilayer, which is partially hydrophobic, surrounds cardiac cells and 
does not allow ions or many molecules to freely enter the cell. Water can diffuse through 
specific membrane transport proteins, known as aquaporins. Water is a dipolar molecule 
with a positive charge on hydrogen and a negative charge on oxygen. Electrostatic forces 
cause positively charged ions (cations) to attract to oxygen in water, and the negatively
9charged ions (anions) to attract to hydrogen. For an ion to break away from water and pass 
through the membrane of a cell, it would require a large amount of energy. Due to the the 
chemical composition of the lipid bilayer, it is impenetrable to the ions surrounded by water 
molecules. However, the plasma membrane of all cells, including cardiac cells, is made up 
of proteins that can form complex structures. One of these protein structures can conduct 
ions across the sarcolemma and is known as an ion channel. The ion channels of particular 
importance to cardiac cells have the characteristics of selectivity and rectification. Fig. 2.1 
shows a simple schematic of the sarcolemma.
The property of selectivity refers to the ion channel's selective permeability to specific 
ions [41]. The ions of primary interest to cardiac cells are Na+, Ca2+ , and K+, and diverse 
ion channels transport these ions. A large portion of the selectivity of an ion channel is 
determined by the size of the ion it is meant to conduct. Smaller ions have a more localized 
charge than larger ions, due to the larger ions having a decreased charge density. Water 
is attracted to ions due to electrostatic interactions; therefore, smaller ions bind water 
molecules strongly whereas larger ions bind water molecules weakly relative to the strength 
of water-water interactions [42]. The process of water surrounding an ion is known as 
hydration. The hydration of an ion depends upon its size; the more hydrated an ion, the 
larger the radius of the hydrated shell. For ions to conduct through an ion channel they 
must be dehydrated so that they can conduct through the selectivity filter, which separates 
the intracellular and extracellular spaces of a cell [43]. Ion channels undergo different state 
changes as a result of the arrangement of the amino acids that form the channel. This 
process is known as a conformational change. The three types of states are open, closed, 
and inactive. The open state is when a conformational change occurs that increases the 
lumen size and positioning polar amino acids to optimize ion conductance through the 
channel. The closed state is when ions cannot conduct through the channel. The inactive 
state is a state after open during which ions cannot conduct through the channel. Not all 
types of channels exhibit all conformational states; for instance, some channels only have 
open and closed states. Ion channels transition between states dependent on the kinetics of 
the channel, which may depend on time, voltage, stretch, phosphorylation, or the presence 
of a ligand.
The ion channel property of rectification refers to the nonlinear current voltage charac­
teristics, or the conductance of the channel [41]. If ion channels did not have rectification, the 
magnitude of current flow would be equal for the same absolute value of the electrochemical 
potential. However, for most ion channels the magnitude of current flow also depends on the
10
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Fig. 2.1: S chem atic  o f sarco lem m a. Cardiac cells are surrounded by a phospholipid 
bilayer. The phospholipids of the bilayer are arranged where the hydrophilic heads, shown 
in green, are exposed to water, and the hydrophobic tails, shown in yellow, are pointed 
towards each other. The bilayer creates an intracellular and extracellular space. Embedded 
in the sarcolemma are proteins such as ion channels.
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direction of ion movement into or out of the cells [41]. Rectification is thought to manifest 
due to several mechanisms, including conformational changes in ion channels, blocking of 
open channels by other internal ions that cannot travel through the ion channel, and other 
ion concentration gradients [44]. Some channels exhibit outward rectification, such as the 
delayed rectification K+ channel, which has large outward conductance for a depolarized 
cell, but little to no conductance when the cell is repolarized [44]. Other channels can 
exhibit inward rectifying, such as the inward rectifying K+, which has a large conductance 
for membrane potentials below -75mV, but has low conductance for higher membrane 
potentials [45].
2.1.2 M echanism s of a Cellular E lectrical P otentia l
Each ionic species has an equilibrium potential, known as the Nernst potential, which 
is a result of the diffusion and electrostatic gradients in a cell. Consider the case for a cell 
permeable only to K+ ions; the resting membrane potential would be the K+ Nernst poten­
tial, because K+ ions would conduct across the membrane until the electrochemical driving 
forces (diffusive and electrostatic) on the ions are in equilibrium. Once in equilibrium, there 
would be no driving force, and therefore no net movement of K+ ions, which would result 
in a steady state membrane potential. For example, Na+, K+ and Ca2+ ions each have 
their own Nernst potential. Once the membrane potential reaches an ion Nernst potential, 
there is no more electrochemical driving force for the ion, and there will be no more net 
movement of the specific ion. The Nernst potential for a specific ion, Ex, may be calculated 
using the Nernst equation as follows:
E _  R T  [X]0 
x z F  ln [X]i (21)
where [X]o and [X]j are the concentration of the ionic species inside and outside the 
membrane, T is tem perature of the environment, and z is the valance of the ion. The 
constants in the equation are the gas constant, R, and Faradays constant, F.
The Nernst potential takes into account driving forces as a result of both diffusion 
and electrostatic gradients for an ionic species. K+, Na+, and Cl- ions are not in equal 
concentration on either side of the cell membrane. As a result, K+, Na+ and Cl- all have 
different Nernst potentials. The resting membrane potential will not equal the Nernst 
potential for K+, Na+, and Cl-, but instead be a weighted average of all the membrane 
permeability ions. To calculate the resting membrane potential, the Goldman equation 
may be used. The Goldman equation takes into account all ionic species to which the
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membrane is permeable. The Goldman equation for a cardiac membrane permeable to only 
K+, Na+ and Cl- is shown as follows:
E =  R T  PNa[Na+]o +  P k  [K+ ] o  +  Pci [Cl- ]i
F  n PNa[Na+ ] i  +  P k [K + ] *  +  Pci[Cl- ]o ( . )
where P x  is the permeability of the membrane to ion X . The larger the permeability of 
the ion, the more ions influence resting membrane potential. The Goldman equation shown 
in Eqn. 2.2 is for only three ions, but this equation can be expanded to account for any 
number of membrane-permeable ions. Concentrations of the primary ions in cardiac cells 
at rest are shown in Table 2.1.
2.1.3 A ction  P otentia ls
The relative concentration of ionic species across a cardiac cell’s membrane determines 
the transmembrane potential. As a result of both diffusive and electrostatic driving forces 
cardiac cells have a negative resting membrane potential with respect to the extracellular 
space. In response to an electric field, cardiac cells can generate a current, which is the 
cellular property known as excitability. The excitability of cardiac cells is caused by changes 
in conductivity of voltage-gated ion channels, which allows the flux of ionic species. The 
flux of ionic species results in changes in the membrane potential. This process is called 
an action potential. The time course of an action potential is separated into four phases, 
which is based on the opening of specific ion channels [46]. The first phase, Phase 0, 
is the characteristic upstroke of the action potential. This phase is caused primarily by 
fast-acting Na+ channels in contractile cells. During this phase, Na+ channels undergo a 
conformational change from closed to open. Na+ ions are then free to conduct into the cell, 
down both a concentration and electrostatic gradient, which causes the membrane potential 
to increase towards the Na+ Nernst potential. Due to the kinetics of the Na+ channels, 
these channels go into an inactive state rapidly (within 1-2ms). Phase 1 is the initial 
depolarization, which is caused by transient outward K+ current, which in turn causes the
T able  2.1: Concentration of primary ions in cardiac cells at rest.





transmembrane potential to trend towards the K+ Nernst potential. Phase 2 is the extension 
of the action potential, which is caused by an outward K+ current and intracellular release 
of Ca2+ from the sarcoplasmic. Phase 3 is mediated primarily by K+ channels, I k  and 
I k s . The inward-rectifying K+ current, I x i r , activates later in Phase 3. This K+ current 
is primarily responsible for the resting membrane potential. Phase 4 differs between cells, 
depending on whether the cell can generate an action potential without exposure to an 
external electric field. Cells with this property are said to have automaticity. Phase 4 in 
these cells is composed of the funny current, I f , which is primarily Na+ and K+. In cells 
without automaticity, Phase 4 is rest, and a major current in this phase is IKir. In response 
to an electric field, ion channels can change their conductance, which is both time and 
voltage dependent. This dynamic change in conductance allows cells to generate an action 
potential. An example action potential is shown in Fig. 2.2.
After an action potential has been generated, there is an absolute refractory period 
until another action potential can occur. This absolute refractory period is caused by Na+ 
channels not being able to transition to an open state, regardless of membrane potential. 
The Na+ channels need to come out of inactivation before another action potential can 
occur. Na+ channels come out of inactivation by experiencing a negative potential for a 
prolonged period of time [18]. Cells have a resting membrane potential of approximately 
-70mV, which is near the K+ Nernst potential. The refractory period partially acts as a 
deterrent for arrhythmia formation. Generally, the refractory period of the tissue is longer 
than what it takes for an entire chamber to activate. The refractory period ensures that 
during normal electrophysiology conditions, all cardiac waves in a chamber dissipate by 
colliding into either refractory cardiac tissue, or other nonexcitable regions of the heart, 
before another heart beat is initiated.
2.1.4 E xcitation  C ontraction C oupling
Excitation contraction coupling is the mechanism by which electrical energy, in the 
form of ions, is transformed to mechanical energy, in the form of contraction of a single 
myocyte. This process is primarily mediated by Ca2+. When a cell is at rest, it has 
nanomolar concentrations of intracellular Ca2+ [47]. During Phase 2 of an action potential, 
L-type Ca2+ channels open, which causes Ca2+ to enter the cell. The L-type Ca2+ channels 
are in proximity to an intracellular organelle known as the sarcoplasmic reticulum. This 
proximity allows Ca2+ to quickly diffuse and bind to ryanodine receptors on the sarcoplasmic 
reticulum. When L-type Ca2+ binds to the ryanodine receptors, it causes the sarcoplasmic
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Time (ms)
Fig. 2.2: R e p re se n ta tiv e  ac tio n  p o te n tia l p ro d u c ed  by a  v e n tr ic u la r  card iac  
m yocy te. Membrane currents that contribute to the traditional shape and duration of 
an action potential. Arrows next to the currents indicate the direction of current flow (up 
arrow: outward current and down arrow: inward current).
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reticulum to release Ca2+ into the intracellular space. The newly released Ca2+ can then 
stimulate nearby ryanodine receptors to release even more Ca2+, and this process starts 
a positive feedback loop known as Ca2+-induced Ca2+ release, and this process results in 
millimolar intracellular Ca2+ concentration. The intracellular Ca2+ then diffuses to actin 
and myosin filaments to start the process of muscle contraction. Intracellular Ca2+ is then 
reduced again to nanomolar concentration due to several mechanisms, including uptake of 
Ca2+ back into the sarcoplasmic reticulum by the SERCA pump, ATP Ca2+ pump, and 
the Na+Ca2+ (NCX) exchanger [47].
2.2 Cell-to-Cell Coupling
Individual cardiac cells can generate an action potential in response to an electric field. 
Cardiac cells are coupled by proteins in the plasma membrane known as gap junctions. 
These gap junctions are connections between the intracellular space of neighboring cardiac 
cells. Therefore, when Na+ enters a cell, it will cause the potential to increase, which then 
sets up a electrostatic gradient to the coupled cells. Positive ions from the depolarized cell 
can then conduct through the gap junctions to depolarize neighboring cells. This coupling 
means if a cardiac cell generates an action potential, this action potential may spread and 
cause the generation of action potentials in its coupled cells. This coupling results in a 
cardiac cell being able to excite other nearby cells. This process can continue as long as 
cells are coupled to excitable cells that are not in refractory. This process is why cardiac 
conduction is often described as propagation of electrical waves.
The coupling of cardiac cells results in electrical wave propagation. Like any other wave, 
the electrical wave has a conduction velocity, which can be approximated from physiological 
properties of the cardiac cells as follows:
K  x  D x %ConductionVelocity =  \ --------—— (2.3)y RiC
dVwhere K  is a constant, D is the diameter of the cell, —— is the rate of depolarization, Ri isdt
the intracellular resistance of the gap junctions, and C is the capacitance of the cell. Cardiac 
electrical waves have anisotropic conduction properties, which is caused by a preferential 
expression on the short axis of cardiac cells, thus coupling longitudinally. Cells are also 
coupled in the transverse direction; however, this coupling is less than the longitudinal 
coupling. Using Eqn. 2.3 the difference in conduction can be explained by an increase in 
intracellular resistance in the transverse direction. Conduction velocity of cardiac waves is 
also affected by the curvature of the wave. For the same cardiac tissue, the concave waves
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propagate faster than planar waves, which propagate faster than convex waves [48]. The 
mechanism behind the differences in conduction velocity is due to the electrical load of other 
coupled cells to an excited cell. For a planar wave, each excited cell in the propagating wave 
has to depolarize only a single downstream cell. For a convex wave to propagate, the leading 
cell in the wave is now coupled not to only a single cell upstream, but also transversely to 
nearby cells. This increased coupling causes depolarizing currents in the propagating wave 
to be split between multiple cells, which will result in a reduced rate of depolarization, thus 
a reduced conduction velocity. Finally, a concave wave can propagate the fastest, because 
each cell in the propagating wave has fewer nearby cells to act as sinks as compared to a 
planar or a convex wave. The property of a cell being able to depolarize downstream cells 
relates to sources and sinks. If the source and sink are said to match, then propagation 
can occur because there are enough ions to depolarize downstream cells; however, if there 
is a source-sink mismatch, propagation will be slowed or even cease all together due to 
insufficient current to depolarize the cell and open voltage gated Na+ channels [5,48].
The safety factor is a quantitative measure to examine the source-sink relationship of 
cells and defines the success of cardiac propagation [49]. The safety factor is computed as 
the ratio of charge generated to charge consumed during the excitation cycle of a single cell 
in tissue and is computed as follow:
f A Icdt +  f A Ioutdt S a fe ty  Factor =  —---- f  4 -------A|Qm>0 (2.4)JA I ind't
where Ic is the capacitive current of the cell in question and I in and Iout are the axial 
currents in and out of the cell. The charge, Q, is the time integral of the current of an 
interval A  during which the net membrane charge Qm is positive [49]. If the safety factor is 
> 1, the source has enough current to depolarize the downstream cell. If the safety factor 
is < 1, then conduction propagation will not occur because there is not enough current to 
depolarize the downstream cell.
2.3 Organization of Whole-Heart Cardiac Activation
The heart is a four-chamber pump that functions to transport blood and nutrients 
through the body. The heart consists of the atria and the ventricles. The atria and 
ventricles are also subdivided into the left and right side. The right atrium (RA) and 
right ventricle (RV) pump deoxygenated blood to the lungs to become oxygenated, and the 
left atrium (LA) and left ventricle(LV) pump blood to the rest of the circulatory system. 
The ventricles are used as the primary driving force for circulation, whereas the atria help
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to completely fill ventricles. The organization of whole-heart cardiac activation during 
sinus rhythm functions such that blood passively flows to the ventricles from the atria, 
and then the atria contract during cardiac diastole to more completely fill the ventricles. 
During systole, the ventricles undergo coordinate contraction, due to excitation contraction 
coupling and cell-to-cell coupling, to circulate blood.
A specific sequence of electrical conduction is required to coordinate the activation of 
the atria and ventricles such that there is sufficient blood flow. This process begins at the 
SA node. The SA node contains specialized cardiac cells that have high expression of the 
inward funny current channels, which was discussed in Section 2.1.2. These cells have lower 
expression of fast-activating Na+ channels, and therefore Phase 1 is caused primarily by 
Ca2+. The LA begins depolarization slightly after the RA through a specialized conduction 
system at the Bachmann bundle. After the SA node initiates the cardiac sequence, cell- 
to-cell coupling will cause the entire atria to conduct and contract in a process known 
as excitation contraction coupling. The only electrical connection between the atria and 
ventricle for normal hearts is through the AV node. The AV node has specialized conduction 
cells that have a longer refractory period than myocytes, and conduction greatly slows in 
this region. This slowing of conduction results in more filling time for the ventricles. The 
ventricular conduction system is then excited by the AV node. The ventricular conduction 
system electrically connects the AV node to the ventricular myocardium and consists of 
specialized conduction cells that conduct rapidly but do not have a contraction function. 
This system at the proximal end to the AV node is called the His bundle, and the distal 
end is known as the Purkinje system. The ventricular conduction system is located near 
the septum that separates the LV and RV. The ventricular conduction system is electrically 
coupled with the VM only at specialized sites known as the Purkinje myocardial junctions 
(PMJs), which are spread throughout the endocardium in humans [50]. Once multiple sites 
on the endocardium are activated, VM to VM electrical coupling causes the rest of the 
ventricles to contract. This whole process, known as sinus rhythm, then repeats itself again 
with the Sinus node automaticity. Table 2.2 summarizes longitudinal conduction velocities 
for the different types of cardiac cells during normal sinus rhythm [51].
Similar to how different cell types have different conduction velocities, they also have 
differences in action potential morphology. Changes in action potential morphology are 
due to differences in specific ion channel densities as well as differences in the kinetics of 
ion channels. The most obvious differences in morphology can be seen in changes between 
cell types, such as between conduction system, atrial, and ventricular cells. For example,
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T able 2.2: Longitudinal conduction velocity of cardiac tissues.
Tissue Type Average Conduction Velocity (m /s)
Atrial 0.8
Ventricular 0.5
SA and AV node 0.05
His-bundle 2
Purkinje 4-5
SA and AV nodal tissue does not exhibit a rapid depolarization because these cells do 
not have fast-activating Na+ channels. Instead, the upstroke in these cells is primarily 
caused by Ca2+. The slow rate of depolarization is partially responsible for the slower 
conduction velocities in SA and AV nodal tissue. Ventricular conduction cells have a similar 
action potential morphology to atrial and ventricular cells, but there are also differences. 
Ventricular conduction cells have a more rapid depolarization than myocytes due to a 
higher density of fast-activating Na+ channels [12]. Ventricular conduction cells also have 
a longer action potential duration (APD) than both atrial or ventricular cells at slower 
cycle lengths [12]. Atrial and ventricular cells also have differences in action potential 
morphology. Generally, atrial cells have shorter APDs than ventricular cells. The shorter 
APD of atrial cells is primarily due to increased activity of K+ channels, which more quickly 
repolarize the cell [52]. Finally, there even exist regional differences in action potential 
morphology between the same cell type. Endocardial myocytes have a prolonged APD 
compared with epicardial ventricular myocytes. This difference is thought to be due to an 
increase in density of K+ channels near the epicardium, which quickens repolarization [53]. 
During normal physiological conditions, these differences in action potential morphology 
offer some protection against arrhythmias occurring. However, during arrhythmias, action 
potential morphologies quickly change, which can make arrhythmias more likely to be 
sustained [18,53]. Similar to how different cell types have different conduction velocities, 
they also have differences in action potential morphology. Changes in action potential 
morphology are due to differences in specific ion channel densities as well as differences 
in the kinetics of ion channels. The most obvious differences in morphology can be seen 
in changes between cell types, such as between conduction system, atrial, and ventricular 
cells. For example, SA and AV nodal tissue does not exhibit a rapid depolarization because 
these cells do not have fast-activating Na+ channels. Instead, the upstroke in these cells 
is primarily caused by Ca2+. The slow rate of depolarization is partially responsible for
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the slower conduction velocities in SA and AV nodal tissue. Ventricular conduction cells 
have a similar action potential morphology to atrial and ventricular cells, but there are also 
differences. Ventricular conduction cells have a more rapid depolarization than myocytes 
due to a higher density of fast-activating Na+ channels [12]. Ventricular conduction cells 
also have a longer action potential duration (APD) than both atrial or ventricular cells at 
slower cycle lengths [12]. Atrial and ventricular cells also have differences in action potential 
morphology. Generally, atrial cells have shorter APDs than ventricular cells. The shorter 
APD of atrial cells is primarily due to increased activity of K+ channels, which more quickly 
repolarize the cell [52]. Finally, there even exist regional differences in action potential 
morphology between the same cell type. Endocardial myocytes have a prolonged APD 
compared with epicardial ventricular myocytes. This difference is thought to be due to an 
increase in density of K+ channels near the epicardium, which quickens repolarization [53]. 
During normal physiological conditions, these differences in action potential morphology 
offer some protection against arrhythmias occurring. However, during arrhythmias, action 
potential morphologies quickly change, which can make arrhythmias more likely to be 
sustained [18,53].
A clinical method to characterize both sinus rhythm and arrhythmias noninvasively is 
through electrocardiography (ECG). The ECG measures the heart’s electrical conduction 
on the body surface. In a typical three-lead ECG, there are three recording electrodes. 
The difference of potential at two of the body surface electrodes can be used to create a 
lead. Several characteristics of the ECG waveforms have been used clinically to understand 
cardiac excitation. For sinus rhythm, the ECG has numerous complexes that correspond to 
various phases in the cardiac cycle. The first peak is known as the P wave, and it corresponds 
to the atrial depolarization. After the P wave, there is an isopotential line that corresponds 
to the delayed conduction through the AV node, which is known as the PR  interval. Next 
is the QRS complex, which corresponds to the ventricular depolarization. Then there is 
another isopotential line, known as the S-T interval, that corresponds to the plateau phase 
of ventricular cells. During the plateau phase of the ventricular cells, all the ventricular 
cells are depolarized, and therefore there is no dipole. Finally, the T wave is the final 
peak and corresponds to ventricular repolarization. Arrhythmia can be determined based 
on alteration in the ECG. For example, ventricular fibrillation is characterized by rapid 
nonregular QRS-like complexes due to the chaotic activation of the ventricles. Although 
there are atrial activations during VF, these atrial activations are masked by the larger 
ventricular activations. An ECG of AF is characterized as having no P waves, and therefore
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no coordinated atrial activation, and an irregular R-R interval. The signal inbetween the 
R-R interval appears like noise but it is uncoordinated atrial activation. Examples of ECGs 
for sinus and fibrillation arrhythmias are shown in Fig. 2.3. Although the ECG is an 
invaluable tool for diagnosing arrhythmias, it alone is insufficient to understand the base 
mechanisms of fibrillation. The studies in this dissertation utilize ECG recordings as well 
as measurements from electrodes placed directly on the heart surface, which is a more local 
measure of heart activity, to understand arrhythmogenesis and what sustains fibrillation.
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Fig . 2.3: E C G  o f sinus rh y th m  an d  o f fib rilla to ry  a rrh y th m ia s . Sinus rhythm is 
indicated by a clear P wave, QRS complex, and T wave. The RR interval indicates the time 
between ventricular activation and therefore is a measure of heart rate. The PR interval 
indicates the time for conduction to occur from the SA node to ventricular tissue. The 
QT interval indicates the time for ventricular depolarization and then repolarization. AF 
is indicated by irregular RR intervals as well as nondistinct P waves. VF is characterized 
by rapid irregular activity, in which no clear P waves or QRS waves can be detected.
CHAPTER 3
ARRHYTHMIAS OVERVIEW
Arrhythmias are broadly referred to as disorders in cardiac impulse formation and/or 
impulse propagation [2]. Depending on the specific type of arrhythmia, the health con­
cerns may be relatively benign, such as bradycardia; whereas others are more serious 
but can be effectively treated with pharmaceutical and/or surgical intervention, such as 
flutter/fibrillation-type arrhythmias. This section focuses on fibrillation, the most severe 
arrhythmia, which is defined as turbulent cardiac electrical activity whereby propagation 
of electrical waves through the heart is disrupted, with consequent production of wavelets, 
high-frequency rotating waves, and inability of the myocardium to contract [5]. This section 
will first broadly cover the major theories of how fibrillation is initiated and why it sometimes 
spontaneously terminates, and other times it is sustained indefinitely. Next this chapter will 
separate out specific mechanisms for fibrillation in the ventricles and the atria. Fibrillation 
in the ventricles and atria have many similarities, but a primary difference between them 
is that VF is an acute arrhythmia and AF is often a chronic arrhythmia. VF only lasts 
from seconds to minutes before it is either treated or becomes fatal. However, during this 
time, cardiac output approaches zero, which results in ischemic conditions that can greatly 
affect the electrophysiology. Fibrillation in the atria is not immediately fatal and therefore 
this arrhythmia can persist for years, causing many electrical and structural changes to the 
cardiac substrate, which affect the electrophysiology.
3.1 Canonical Mechanism of Fibrillation Initiation
There are many different theories regarding the mechanisms of fibrillation; however, 
most researchers agree on the importance of unidirectional conduction block and reentry 
[5,39,48,54-57]. Unidirectional conduction block is a mechanism for fibrillation in which 
an electrical wavefront propagates in one direction but blocks in another [39, 57,58]. This 
block may be structural, in the case of a conducting wavefront colliding into regions of
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unexcitable scar, but it can also be functional, where cardiac tissue in one direction is 
refractory and thus unexcitable [39,59]. Under normal physiological conditions, once an 
electrical wavefront interacts with an unexcitable obstacle, either anatomical or functional, 
it breaks into two wavefronts [60]. These two wavefronts propagate on the boundary of 
the obstacle and then recombine again once the obstacle is bypassed. However, in cardiac 
tissue with slowed conduction, the two wavefronts may not recombine again and instead 
may propagate in a circuitous pathway. Reentry is when the circuitous pathway loops back 
upon itself, and under certain situations this pathway may self-sustain. A simple schematic 
is shown in Fig. 3.1.
W hether or not reentry occurs is dependent upon the conduction velocity of the electrical 
wave as well as the action potential duration (APD) of the cardiac cells in the potential 
reentrant path [61]. This relationship has been formalized as follows:
Wavelength  =  CV x A P D  (3.1)
where CV is conduction velocity. Eqn. 3.1 describes a cardiac wavelength. Reentry can 
occur if the wavelength is equal to, or shorter than, the path length. Therefore, reentry 
is more likely to occur in cardiac tissue with slowed conduction and shorter APDs. These 
factors can cause rogue wavefronts to not collide into refractory tissue to dissipate before 
causing reentry [61-63].
3.1.1 Cardiac R estitu tion
Unidirectional conduction block is related to the property of restitution. Broadly, 
restitution is the dependence of a cardiac property on the previous diastolic interval [63-65]. 
Two characteristics of cardiac tissue that show restitution are action potential duration 
(APD) and conduction velocity, which are both critical to develop reentry [59,66]. Both 
the APD and conduction velocity restitution are dependent on the kinetics of ion channels. 
When heart rate increases, the APD shortens and conduction velocity decreases, which 
allows for a longer diastolic interval to preserve sufficient cardiac output even during varying 
RR intervals [39]. However, when the diastolic interval becomes very short, or there is a 
rapid change in the diastolic interval, the restitution properties can make fibrillation more 
likely to initiate [67,68].
The mechanism behind APD restitution is incompletely understood, but is thought to be 
due to the repolarization currents [64]. During an action potential, Ca2+ flows into the cell 
through L-type Ca2+ channels. The Ca2+ from the L-type channels stimulates ryanodine 







Slowed conduction resulting 
in uniconductional block sustained reentrant circuit
Fig. 3.1: S chem atic  o f re e n try  in  ca rd iac  tissue . Normal conduction where cardiac 
waves propagate in an antegrade direction in both the A and B pathways. Conduction waves 
in paths A and B collide and annihilate each other in pathway C. Under certain conditions 
such as ectopy, pathway A may conduct in the normal antegrade direction, but pathway 
B may not be fully recovered from refractory, which will result in slowed conduction and 
block in pathway B. The cardiac wave that propagated in pathway A will now not block 
pathway C and may conduct retrograde in pathway B if it is now out of refractory. If now 
pathway A is out of refractory as well, reentry has occurred and this process may continue 
indefinitely.
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induced Ca2+ release [47]. During a shorter diastolic interval, the L-Type Ca2+ channels 
have not fully recovered and therefore do not conduct as much Ca2+. This reduction in 
Ca2+ causes less activation of the ryanodine receptors and therefore less Ca2+-induced 
Ca2+ release from the SR [69,70]. The reduction in intracellular Ca2+ causes a shortening 
of phase 2 of an action potential and relates to a shorter APD. Prolonged conductance of 
K+ currents, specifically, I kr, may also cause a shortening in APD as a result of a shorter 
diastolic interval. Due to the kinetics of Ikr , this channel may not have time to close during 
Phase 3 of an action potential. If Ikr does not close during Phase 3, it will result in increased 
K+ conductance into the cardiac cell, which will decrease repolarization time. More recently, 
there has been evidence of Ca2+-activated K+ channel, known as apamin-sensitive small 
conductance Ca2+-activated K+ current, I k a s , which may be responsible for causing a 
short APD at a short diastolic interval that may contribute to recurrent arrhythmia [71,72]. 
Nolasco and Dhalen were the first to formalize the relationship between diastolic interval 
and APD by plotting the previous diastolic interval (x-axis) versus APD (y-axis), which 
became known as a restitution curve [73]. A representative restitution curve is shown in 
Fig. 3.2.
Conduction velocity restitution describes the process in which changes in diastolic 
interval are followed by changes in conduction velocity. Conduction velocity restitution 
is primarily due to the depolarizing currents, fast-acting Na+ channels, during Phase 0 of 
an action potential [74]. During a short diastolic interval, fast-acting Na+ channels may 
not have enough time to recover from an inactivated state, and therefore the ion channels 
cannot conduct because the ion channels are in refractory. If a premature stimulus excites 
the tissue, some of these ion channels will not be able to open; therefore the slope of the 
action potential will be reduced. In section 2.1.3, Eqn. 3.1 illustrates that the slope of the 
action potential activation is positively associated with conduction velocity in the tissue. 
Therefore if some of these channels cannot conduct, the result is a lower conduction velocity.
There are two types of restitution protocols, dynamic and standard. Both measure the 
diastolic interval prior to action potential’s APD. The main difference between dynamic 
and standard restitution protocols is that dynamic restitution takes into account cardiac 
memory, a mechanism in which delays in ionic currents, such as Ca2+ and K+, with 
slow recovery kinetics can accumulate over several cycles [64, 75]. Dynamic restitution 
is measured after a series of beats (typically about 10-30 beats to allow for steady state), 
which are known as the S1 phase. The cycle length of the S1 beats are then shortened 
until the diastolic interval is shorter than the effective refractory period of the tissue, and
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Diastolic Interval (ms)
Fig. 3.2: R e p re se n ta tiv e  re s t i tu t io n  curve. The restitution curves show little rate 
change at longer cycle lengths (D >300ms), however at shorter cycle lengths (D <150ms) 
the restitution curve begins to steepen (slope >1), which results in large changes in APD 
for small changes in diastolic interval. The restitution curve stops at 60ms, which is the 
effective refractory period (ERP).
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the stimulation cannot excite the tissue. Standard restitution is measured by applying a 
single S2 paced beat after a series of S1 beats. The S1 beat remains at a constant cycle 
length throughout the protocol, but the S1-S2 interval is reduced until the diastolic interval 
is shorter than the effective refractory period, and therefore the S2 does not cause cardiac 
tissue excitation. Although both measure restitution, they produce different results [76]. 
There would be no difference in the two measurement types if there was no cardiac memory 
(i.e., no transition time into steady state) [64]. A schematic of the protocol for dynamic 
and standard restitution is shown in Fig. 3.3.
The slope of the restitution curve relates to the stability of electrical properties within 
cardiac tissue [39,68,77]. When the electrical properties are stable, slight changes in diastolic 
interval are accompanied by slight changes in APD and conduction velocity. However, 
when the electrical properties are unstable (restitution slope >1), small changes in diastolic 
interval greatly change APD and conduction velocity, which are both important in the 
occurrence of unidirectional conduction block and the development of reentry pathways to 
initiate fibrillation.
3.1.2 Triggered A ctiv ity
Triggered activity describes focal impulse initiation in cardiac tissues that is dependent 
on oscillations in membrane potential after the upstroke of an action potential, in what 
are known as afterdepolarizations [78]. There are two types of afterdepolarizations. The 
first type of afterdepolarization is an early afterdepolarization (EAD), which occurs during 
the repolarization phase, Phase 2 or 3, of an action potential. The other type of afterde­
polarization is the delayed afterdepolarization (DAD). DADs occur when repolarization is 
complete. When an EAD or DAD depolarizes the membrane enough to initiate an action 
potential, that action potential is said to be triggered [79]. An example of an EAD and 
DAD is shown in Fig. 3.4.
EADs occur during Phase 2 or 3 of an action potential. The ionic mechanism responsible 
for EADs is incompletely understood but is thought to be due to the kinetics of primarily 
Ca2+ but also Na+ channels. EADs that occur during Phase 2 or early Phase 3 are thought 
to be due to L-type Ca2+ channels coming out of inactivation, which causes more Ca2+- 
induced Ca2+ release from the SR to initiate another action potential. The occurrence of 
the EAD during late Phase 3 may be due to Na+ channels coming out of inactivation [80]. 
Also, B-adrenergic stimulation may cause an increase in the N a+/C a2+ exchange from 
NCX to raise the membrane potential to initiate another action potential [51]. A final 
mechanism of EADs can occur during ischemia. During ischemia, the Na+/H+ exchange
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A) Dynamic Restiution Protocol
Pace S igna l
30 seconds
B) Standard Restiution Protocol
S I 400 ms S2 250 ms
Fig. 3.3: S chem atic  o f d yn am ic  an d  s ta n d a rd  re s t i tu t io n  p ro to co l. A) Dynamic 
restitution protocol. A series of paced beats are done until the tissue is in steady state. 
Then the APD restitution can be calculated as the S1 diastolic interval vs. the APD. B) 
Standard restitution protocol. A series of S1 beats, typically 7-10, are done followed by a 
single premature S2 beat. Then the APD restitution can be calculated as the S1 diastolic 
interval vs. the APD of the S2 paced beat.





Fig. 3.4: D ifferences b e tw een  early  and  delayed  a fte rd ep o la riza tio n s . A)
Representative example of an early afterdepolarization (EAD). EADs are more likely to 
occur during bradycardia due to the longer APDs and slower heart rate. If the EADs 
can prolong the APD enough, it may initiate another action potential. EADs can occur 
during Phase 2 or Phase 3 of an action potential. If the EAD occurs during Phase 2, 
as in this example, it is thought that L-type Ca2+ channels come out of inactivation to 
release more intracellular Ca2+. If the EAD occurs during phase 3, it is thought to be 
due to Na+ channels coming out of inactivation. B) Representative example of a delayed 
afterdepolarization (DAD). DADs are more likely to occur during tachycardia, and the ionic 
mechanism behind DADs is thought to be Ca2+ overload of the cell.
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removes intracellular H+ with an inward Na+ to try  to regulate pH. The increase in Na+ 
makes EADs more likely [18]. EADs are more likely to occur during bradycardia because 
during a slow heart rate, there is a prolonged action potential duration and there is more 
time for Na+ and Ca2+ channels to come out of inactivation [81].
DADs occur after complete repolarization of the cardiac cell. The ionic mechanism 
responsible for DADs is thought to be due to Ca2+ overload or ryanodine receptor dysfunc­
tion [39]. Abnormal release of Ca2+ from the SR has been shown to activate a composite 
inward current Iti [82]. Iti is composed of Ca2+/N a2+ exchange, a Ca2+ activated Cl+ 
channel and NSC Ca2+ channels [82-84]. DADs are more likely to occur during tachycardia 
because an increase in heart rate increases the frequency and amplitudes of the DADs [78].
3.2 Canonical Mechanisms of Fibrillation Maintenance
One theory of fibrillation is that it is sustained by spatially stable reentrant pathways. 
These spatially stable pathways are known as the mother rotors, and electrical wavefronts 
propagating from these mother rotors, known as daughter wavelets, cause the unorganized 
activity observed during fibrillation [85]. Evidence of this type of fibrillation has been shown 
in humans and animals as highly regular activation patterns on the endocardium and/or 
epicardium [86,87]. Due to the regularity of activations patterns of the heart, the fibrillation 
may have some organization and not be completely stochastic. Additional evidence from 
this type of fibrillation comes from examining the frequency content of the electrograms, 
which are recorded from many locations of the heart simultaneously. The frequency with 
the maximum peak in the power spectrum is related to the activation rate of the underlying 
cardiac tissue, and is called the dominant frequency [88]. If the fibrillation is stochastic, and 
there is not a specific region that is driving the arrhythmia, the power spectrum may look like 
white noise. However, if certain regions of the cardiac tissue are driving the arrhythmia, this 
method will show regions of the heart that have a high dominant frequency. Some studies 
have shown that during fibrillation, regions of high dominant frequency emerge, suggesting 
the presence of a driving site, which may be a mother rotor [89]. The mother rotor theory 
states that there are specific regions within the heart which are highly organized and that 
these regions sustain the fibrillation. This theory also suggest that the nondriving sites are 
just being passively activated by the driving site.
A competing theory to mother rotor is that fibrillation is maintained by many nonstable 
wavefronts known as wavelets [5,54]. These wavelets are nonstable because they are short 
lasting: the wavelets collide and block with other wavelets and do not propagate along a
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consistent reentrant pathway. There are still, however, some conduction properties, such as 
highly nonregular activation patterns on the endocardium and/or epicardium that make this 
fibrillation identifiable. Both computational and experimental data suggest that this type 
of fibrillation can occur [13,90,91]. The most traditional version of multiple wavelets theory 
is that fibrillation is highly unorganized, i.e., that certain regions of the heart are not any 
more likely to sustain fibrillation than any other region. However, this theory has recently 
been expanded to also state that there might be certain regions of the cardiac tissue that 
can maintain more reentrant pathways than other regions of the tissue. If certain regions of 
the heart can have more reentrant pathways, this implies that specific regions of the heart 
may have faster activation rates because they contain more possible pathways for reentry; 
however, the wavefront pathways are constantly changing and therefore inconsistent with 
the mother rotor [92].
Although both the wandering wavelet and mother rotor theories of fibrillation provide 
some insight into fibrillation mechanisms, a major limitation to these theories is that they 
neglect the cardiac structure and substrate in their formulation. Much evidence, however, 
supports the notion that cardiac substrate is critical to the formation of sustained cardiac 
fibrillation, specifically, when moving from generalized cardiac fibrillation to more specific 
examples of atrial or ventricular fibrillation. Simulation data have shown without specific 
regions of reduced conductivity that stable reentrant pathways could not be sustained [37]. 
Additional evidence has shown that without the ventricular conduction system, ventricular 
fibrillation is not sustained as long, and the arrhythmia has a slower activation rate [14]. 
These examples show why when transitioning from generalized theories of fibrillation to 
specific instances of fibrillation, the cardiac structure should not be ignored.
3.3 Ventricular Fibrillation
VF is the uncoordinated electrical impulse propagation and contraction of the ventricles. 
The uncoordinated contraction causes the cardiac output to go to zero rapidly, and if this 
arrhythmia is not corrected within 2-3 minutes it is fatal. The differences from generalized 
theories of fibrillation and VF are a result of ischemia and the ventricular conduction system.
3.3.1 Ischem ia in Ventricular Fibrillation
During prolonged VF, many cellular changes occur in myocytes as a result of ischemia 
and high-frequency activation. These cellular changes cause an increase in fibrillation cycle 
length and diastolic duration and a shortening of APD [19]. The cellular changes are
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a result of changes in normal biochemical and ion concentrations due to acute ischemia. 
These changes include an increase in extracellular K +, acidosis, an increase in intracellular 
Na+, and an increase in intracellular Ca2+ .
An increase in extracellular K+ causes the cell to have a higher resting membrane 
potential and a decreased action potential duration. The increase in membrane potential 
may transiently result in increased excitability due to the resting membrane potential being 
closer to the Na+ activation threshold, but if prolonged, this reduced membrane potential 
causes more inactivation of Na+ channels [18]. The inactivation of Na+ channels results in a 
less steep up-slope in membrane depolarization and thus a reduction in conduction velocity. 
There are three primary mechanisms for the increase in extracellular K +: a decrease in 
the extracellular space, a decrease in active K+ influx, and an increase in passive K+ 
efflux. A decrease in the extracellular space is caused by an accumulation of lactate and 
phosphate in the cell [93]. The increase in particles causes a diffusion gradient that in turn 
causes water to shift from the extracellular space into the intracellular space. Due to the 
decreased volume of the extracellular space, the relative concentration of K+ increases in 
the extracellular space. The second mechanism of increased K+ is due to the inhibition of 
the ATP NA+/K+pump. Under aerobic conduction, NADH and FADH2 are formed during 
glycosis, and in the citric acid cycle, transfer their electrons to O2 through the electron 
transport chain to produce ATP [18]. However, when oxygen falls below a critical level, 
the electron transport stops, which slows ATP production. A combination of less ATP, an 
increase in ADP, and an increase in oxygen free radicals has been shown to decrease ATP 
NA+/K+pump activity [94]. The decrease in pump activity causes less influx of K+ and 
thus it accumulates in the extracellular space. The final primary mechanism of increased 
extracellular K+ is due to increased passive efflux of K+. Passive efflux of K+ is thought to 
occur due to increased activity of KCL cotransport caused by intracellular swelling [18].
Under normal physiological conditions, the intracellular pH is more acidic than the 
extracellular pH. During ischemia, there is more CO2 retention and proton production, 
which further reduces pH in both the extracellular and intracellular space [95]. The 
reduced pH causes the inhibition of most of the primary ion channels, including Na+, 
Ca2+, and most K+ channels [18]. The inhibition of these ion channels has the overall 
effect of reducing action potential duration, slowing conduction velocity, and increasing the 
resting membrane potential. Furthermore, these changes make the occurrence of EADs 
more likely [80]. The increase in acidic conditions is a result of several key ion channels 
that regulate H+ being inhibited during ischemia. Under aerobic conditions, the Na+/H+
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exchange and the Na+-HCO3+cotransport actively remove protons from the intracellular 
space [96]. However, under ischemic conditions these channels have reduced activity due to 
a decrease in extracellular pH and an increase in intracellular Na+ [97,98].
Intracellular Na+ increases during ischemia. An increase in intracellular Na+ may 
cause reversal of the N a+/C a2+ exchanger to increase intracellular Ca2+, and increases 
the likelihood of arrhythmia [99]. The main mechanisms of an increase in intracellular Na+ 
are the Na+/H+ exchange moving H+ out of the cell and Na+ into the cell and, decreased 
activity of the NA+ K+pump [100,101].
Intracellular Ca2+ increases during ischemia, which causes modulation of many Ca2+ 
ion channels. L-type Ca2+ channels have increased inactivation under the presence of 
increased intracellular Ca2+, but other Ca2+ channels are more likely to activate, such 
as Ca2+-induced Ca2+ release from the sarcoplasmic reticulum [18, 102]. The primary 
effect of increased intracellular Ca2+ is an increased tendency towards EAD and DAD to 
either initiate or sustain arrhythmia [81]. The main mechanism of increased intracellular 
Ca2+ is the decreased removal of intracellular Ca2+ from the N a+/C a2+ exchange [103]. 
Furthermore, as ischemia sets in, less Ca2+ is stored in the sarcoplasmic reticulum due to 
Ca2+-induced Ca2+ release and inhibition of the re-uptake of Ca2+ by the sarcoplasmic 
reticulum [104].
Although many cellular changes occur as a result of ischemia and VF, many of these 
changes do not occur at once and instead have a complex time course. Due to the changes 
in electrophysiological properties, as a result of ischemia, it is hypothesized that there may 
be different mechanism of VF, depending on the duration [105]. Most simply, VF can 
be divided into either short duration VF or long duration VF [106]. A study by Li et al. 
measured endocardium activation patterns from a basket catheter placed in the left ventricle 
during VF. They found that during early VF (VF<3 min), the arrhythmia was maintained 
by nonstable reentry on the endocardium [13]. However, as VF progressed, the arrhythmia 
organized into two stable organization patterns. One of the organizational patterns was 
stable reentry on the myocardium. The other pattern was characterized by simultaneous 
activation of the endocardium, followed by a period of electrical silence, which was called 
ventricular electric synchrony (VES) [13]. VES is hypothesized to be a result of activation of 
rapid activation of the ventricular conduction system to drive the arrhythmia [13]. Changes 
to electrophysiological properties, such as activation rate and APD, of ventricular myocytes 
have been fairly well characterized over the time-course of VF [19]. However, these changes 
are much less known for the ventricular conduction system.
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3.3.2 C onduction  S ystem  and Ventricular Fibrillation
The ventricular conduction system has a unique structure that may be a primary 
driving factor for long-duration VF. During normal sinus rhythm, conduction occurs in 
the following order: AV node, proximal conduction system, distal conduction system, 
Purkinje myocardial junctions (PMJs), and VM. This direction of conduction is known 
as antegrade. As VF progresses and ischemia sets in, several electrophysiological changes 
occur in both the ventricular conduction system and the VM. One change is that the 
VM develops a longer period of refractory than the conduction system [107]. Another 
change during ischemic conditions is that distal Purkinje fibers are thought to develop 
abnormal automaticity and/or triggered activity. The triggered activity of the Purkinje 
fibers during prolonged VF may conduct up through the conduction system, perhaps as 
far as the proximal conduction system [12,108]. The limited number of PMJs located only 
in the distal regions of the ventricular conduction system, in combination with the fast 
conduction velocity of the conduction system, suggests that it is unlikely that activations 
through the ventricular conduction system will collide and block with other activations 
within the conduction system before activating large portions of the conduction system. 
Therefore, it is likely that triggered activity in Purkinje fibers can conduct through the 
ventricular conduction system and drive rapid activation at distant sites, even opening 
the possibility of biventricular communication through the bundle branches. Evidence 
for this theory that the ventricular conduction system can drive fibrillation comes from 
experimental studies in which the Purkinje system was chemically ablated. In these studies, 
animals in which the ventricular conduction system was intact developed an activation rate 
gradient between the endocardium and epicardium, with the endocardium having a higher 
activation rate as VF progressed. However in the experimental group, where the Purkinje 
system was chemically ablated, no activation gradient developed, and VF spontaneously 
terminated earlier [14]. Another study by Huang et al. confirmed that canines have a 
more rapid endocardium rate than the epicardium during prolonged VF, but that this 
activation gradient did not develop in pigs [15]. The presence of an activation rate gradient 
is due to species-specific structural differences in the Purkinje system. In pigs, the Purkinje 
fibers are nearly transmural throughout the ventricular wall, and are not located only on 
the endocardium as in dogs or humans [109]. Therefore, if the Purkinje system has rapid 
activation rates, it would affect both the endocardium and epicardium. These studies 
indicate that the ventricular conduction system has a more rapid rate than the VM, and 
may be driving prolonged fibrillation [13-15,105,110,111].
35
Although the evidence that the conduction system may have a primary role in maintain­
ing VF is compelling, our understanding is limited due to technical aspects of studying the 
conduction system. One primary limitation in studying the conduction system during VF is 
that the signals are low amplitude compared to the VM, and there exist no reliable methods 
to measure these signals. For this reason, most of what is known about the conduction 
system’s role in VF maintenance is not based on direct measurements from the conduction 
system, but instead its role is inferred from activation patterns present on the VM [13,112]. 
The studies that examine the conduction system directly measure only the Purkinje fibers 
at the distal end of the conduction system, but it is unknown what is occurring in other 
more proximal regions [14]. Aim 1 has two parts to address the limitations. The first part, 
which is technical in nature, is to develop novel signal processing techniques to distinguish 
the conduction system activation from AM and VM activity during VF. The second part 
is to answer a mechanistic question of whether the proximal conduction system, like the 
distal conduction system, is a driving force during the time course of VF, or whether it is 
passively being driven by the VM.
3.4 Atrial Fibrillation
AF is the uncoordinated electrical impulse propagation and contraction of the atria. 
The uncoordinated contraction causes blood to pool in the atria, which makes it more 
likely to clot and cause stroke [9]. AF is the most common cardiac arrhythmia, affecting 
over two million people in the United States, and its prevalence is expected to grow in the 
coming years [113,114]. AF is a serious health concern associated with cardiomyopathy 
and increased morbidity and mortality [115]. Furthermore, even though there are multiple 
treatment strategies for AF, even the most successful have AF-free survival of less than 60% 
after only one year of treatment [116,117].
3.4.1 Progression From Paroxysm al to  P ersistent AF
AF has been characterized to gradually progress from short-lasting paroxysmal episodes 
to eventually longstanding persistent AF. To study this progression, AF has been inves­
tigated extensively with animal models, in which the animals undergo rapid atrial pacing 
(RAP) with a pacemaker. In these studies, it was found that the irregular rapid activations 
of the atria induce electrical, structural, and contractile changes to make this arrhythmia 
more persistent, in what was termed “AF begets AF” [118,119]. Due to the progression of 
AF, it is thought that the arrhythmia may be a manifestation of a diseased atria [120,121].
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As AF progresses and cardiac substrate changes occur, the mechanism of the arrhythmia’s 
initiation and maintenance may change. During paroxysmal AF, it has been shown that 
the pulmonary veins can initiate ectopic beats, due to either abnormal automaticity or 
triggered activity, to initiate AF [122]. However, as AF progresses, it is thought that 
atrial structural remodeling outside the pulmonary veins may be the main mechanism for 
initiating or sustaining AF [28,91,123,124].
Electrical remodeling as a result of RAP has been shown to reduce the AERP in as little 
as 6 hours and can continue for weeks [125]. The lower AERP results in less excitability of 
Na+ channels at low cycles due to conduction velocity restitution [126,127]. Additionally, 
it was found that AF causes a shortening of the action potential duration. The decrease in 
action potential duration is primarily due to a decrease in L-type Ca2+ current [126,128]. 
This electrical remodeling can result in sustained AF. The higher susceptibility of AF is a 
result of decreased cardiac wavelengths. As shown in Eqn. 3.1, a decrease in conduction 
velocity results in a decrease in the cardiac wavelength. When the cardiac wavelength is 
short, small regions of atrial conduction block may serve as a site for initiation of reentry 
[129]. A decrease in cardiac wavelength would also result in an increase in AF stability, 
e.g., longer episodes of AF, because more reentrant wavelengths can exist in a smaller 
region of the atrium. If more wavelengths are within a region of tissue, sustained reentry 
is more likely to occur [90,130]. However, the electrical remodeling that occurs during AF 
is reversible following cardioversion and maintenance of sinus rhythm [131]. This finding 
has led to further research into examining structural and contractile remodeling that occurs 
during AF.
Three primary structural changes associated with AF are an increase in atrial cell size, 
an increase in intermyocyte distance, and an increase in fibrosis [129]. Atrial size increase is 
associated with the myolysis and pernuclear accumulation of glycogen. The increase in cell 
size is heterogeneous, with some cells being much more affected [132]. An increase in the 
intermyocyte distance is thought to be caused by an increase in extracellular matrix [40]. 
Fibrosis, which is a scarring process characterized by fibroblast accumulation and excess 
deposition of extracellular matrix proteins, has been shown to increase during AF [133]. 
Fibrosis has been shown to cause a disruption of side-to-side connections between muscle 
bundles, which results in a dissociation of conduction, and a zig-zag longitudinal conduction
[134]. The zig-zag longitudinal conduction can allow for reentry to occur in a much smaller 
region of tissue than would be possible when the cardiac tissue is tightly electrically coupled
[135]. Additionally, this electrical dissociation caused by fibrosis has been hypothesized
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to decouple the synchronization of the endocardium and epicardium layers [30,40, 136]. 
When the endocardium and epicardium layers are coupled, they activate simultaneously, 
therefore, propagation can be thought to occur in a two-dimensional medium. Once the 
layers desynchronize, the conduction medium is now three-dimensional and more circuitous 
pathways for reentry can occur. In line with these findings, patients with more fibrosis 
respond worse outcomes after treatment [137,138]. However, the mechanism is still unknown 
and debated.
AF results in uncoordinated contraction of the atrium. However, even after cardioversion 
to sinus rhythm, it can take up to a month before the contractile function of the atria is 
completely restored, with longer recovery times associated with longer durations of AF 
[139,140]. The mechanism behind the loss of contractile function even after conversion to 
sinus rhythm is thought to be caused by a reduction in L-type Ca2+ conductance [141].
The main electrophysiology properties that are associated with and promote AF are a 
decrease in AERP and a slowing of conduction [142,143]. However, it is unknown whether 
the relationship between a decrease in AERP and a slowing of conduction is cause or effect 
with patients who have AF. The classic “AF begets AF” shows that electrical remodeling 
caused by RAP can cause a decrease in AERP and conduction slowing to promote AF. 
However, most of this work has been done with animal models of AF. The RAP animal 
models, when extended to patients, then implies that patients who are prone to go into 
AF will have atrial remodeling to further promote the arrhythmia. Furthermore, these 
patients may not have much arrhythmogenic substrate before they first have AF. However, 
Sitles et al. found that patients who have had lone paroxysmal AF have an arrhythmogenic 
substrate, which included regions of slowed conduction during sinus rhythm [120]. Stiles et 
al. suggested that these patients, prior to going into AF, have an arrhythmogenic substrate 
and therefore are more likely to go into AF. Experimental research has shown that AF may 
either be a result of tachycardia-induced cardiac substrate, as suggested by AF begets AF, 
or that patients with a less healthy cardiac substrate are more likely to go into AF.
Regardless of whether AF progression is a result of tachycardia-induced remodeling, 
or atria that are already diseased are more likely to go into AF, the implication is that 
these changes make AF episodes last longer and are more likely to initiate. However, 
the mechanism behind what drives persistent AF is highly controversial and debated. 
The two main theories are based on the two mechanisms discussed in the canonical 
mechanisms of fibrillation maintenance. The first is that the substrate changes make 
more possible pathways for multiple wavelets type of AF to occur, and that there are 
not specific regions driving the arrhythmia. Multiple wavelets may be more likely to occur
38
in a remodeled atrium due to extracellular remodeling, which includes the development of 
fibrosis. Specifically, fibrosis may cause more disorganized conduction, and even result in 
endocardium to epicardium desynchronization [17,134]. Furthermore, desynchronization of 
the endocardium and epicardium allows for epicardium or endocardial breakthrough, which 
may help sustain the arrhythmia [91]. In the multiple wavelets theory, many regions are 
contributing to sustaining fibrillation. In the mother rotor theory, there are specific regions 
within the atrium driving the fibrillation, and it is argued that extracellular remodeling may 
be the reason. Regions of fibrosis may cause regions of abrupt conduction slowing [31] and 
have heterogeneity of repolarization kinetics [129], which may predispose these regions to 
maintain rapid reentrant/focal activity [144]. A stable reentrant pathway, or a rotor, may 
occur due to vortex shedding of a cardiac wave as it bypasses an inexcitable object [145]. 
The proposed mechanism of vortex shedding setting up stable rotors is explained in Fig. 
3.5. Although controversial, there is some evidence to support the notion that the presence 
of stable rotors is the main driver and mechanism of persistent AF in patients [87,124,146].
3.5 Treatment Strategies
Treatment strategies for fibrillation are numerous and diverse, and include the use of 
pharmaceuticals, devices, and permanently altering the cardiac substrate.
3.5.1  A n tiarrh yth m ic  D rugs
Antiarrhythmic drugs are used to alter the ion channel kinetics of cardiac cells to 
make arrhythmias less likely to initiate and to be sustained [41,147]. This pharmaceutical 
approach is generally the first-line approach to control arrhythmias [148]. These drugs 
are divided into five classes based on their main mode of action on the cardiac cells [51]. 
Class I antiarrhythmics inhibit abnormal depolarizations by preferentially interfering with 
Na+ channels. There are three types of Class I antiarrhythmics that are classified based 
on their effect on the action potential morphology. The first is a class Ia that lengthens 
the action potential. Examples of these drugs are disopyramide and quinidine. Class Ib 
antiarrhythmics shorten the action potential; examples of this class of drugs are Lidocaine, 
Mexiletine, and Tocainide. Class Ic does not significantly affect action potential morphology. 
Class II antiarrhythmics are beta-adrenergic blockers that suppress sympathetic activity 
on the heart. This class of antiarrhythmic primarily slows conduction through the AV 
node. Examples of these drugs are Metoprolol and Atenolol. Class III antiarrhythmics 
predominantly block K+ channels, thereby prolonging repolarization time. The longer
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Possible Mechanisms of Vortex Shedding
Fig. 3.5: Schem atic of in itia tio n  of a ro to r due to  v o rtex  shedding. A) Cardiac 
wave shown in black is approaching an inexcitable cardiac tissue shown in blue. B) Cardiac 
wave interacts with inexcitable cardiac tissue and begins to bypass the tissue. C) When 
cardiac wave bypasses tissue, a source sink mismatch forms at the boundary of the object. 
This source sink mismatch causes a convex wave shape at the boundary of the inexcitable 
object where conduction slows. D) If the curvature of the wave is large enough, the wave can 
start to rotate around an inexcitable center known as a singularity point. This rotational 
conduction around an inexcitable core is known as a rotor.
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action potential durations in combination with the unaltered conduction velocities results 
in fewer pathways available to initiate or sustain reentry. These drugs also lessen formation 
of ectopic formation and EADs. Examples of these drugs are Sotalol and Ibutilide. Class 
IV antiarrhythmics are Ca2+ channel blockers. These drugs reduce conduction through the 
AV node, and therefore have an effect similar to Class II antiarrhythmics, but still allow 
the body to retain adrenergic control of heart rate and contractility. An example of this 
drug is Verapamil. The final class of antiarrhythmic drugs are Class V drugs, which work 
by other mechanisms than those discussed for the other classes. An example of a class V 
antiarrhythmic is Digoxin, which decreases conduction through the AV node by increasing 
vagal activity via central action on the central nervous system.
3.5 .2  D ev ice  T herapy
Electrical shocks have been shown to terminate fibrillation. The mechanism relates 
to how cells respond to an external electric field. In response to an electric field, little 
current enters a cell due to the relatively high membrane impedance in comparison to the 
impedance of the extracellular space [149]. The internal voltage of the cell, therefore, does 
not drastically change during exposure to an external electrical field, but the extracellular 
voltage does change. As a result, the membrane potential, which is the difference between 
the internal and external voltage across the membrane, can rise above the activation 
threshold for the cell. If enough cells are activated with an electric field, then all propagating 
fibrillatory waves will collide with refractory tissue and the arrhythmia will terminate. 
Fibrillation can be treated with these electric shocks being applied externally, as by an 
external cardiac defibrillator, or internally, as by an internal cardiac device (ICD).
External cardiac defibrillation functions by placing two paddles on either side of the 
chest cavity, and then delivering energy to the chest. This energy then creates an electrical 
field that depolarizes large regions of the cardiac tissue. The depolarization causes the 
myocytes to become refractory, thus stopping all electrical activity. The refractory period 
of the entire cardiac tissue allows time for sinus rhythm to resume. This type of device 
is primarily used in emergency settings and can also be used to treat ventricular or atrial 
fibrillation.
Internal cardiac devices (ICDs) are commonly used for patients who are at high risk for 
ventricular fibrillation. Although ICDs can stop AF, the current injections are often too 
painful without sedation to be used for nonfatal arrhythmias [150]. ICDs function much like 
a local external cardiac defibrillator, but instead of creating an electrical field to depolarize 
the entire heart, ICDs inject current densities through an implanted lead to a specific site
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on the ventricles. The current densities can be large enough to depolarize large regions of 
the ventricles which then makes the tissue refractory, thus causing cessation of the cardiac 
waves. A risk factor of this therapy is that large current densities can cause irreversible 
cardiac damage, which can make the tissue more arrhythmic in the future [151-153]. For 
this reason, there is active research in developing low-energy defibrillation techniques to 
limit the risk of injury, and also to make defibrillation less painful so that it can be used 
for patients with AF [154-158].
3 .5 .3  A b la tion
Cardiac ablation is a procedure to apply energy to the cardiac tissue, through either 
radiofreqeuncy or cyrothearpy, to create a permanent scar that does not conduct. Cardiac 
ablation is an invasive procedure in which a catheter is inserted into a patient’s blood vessel 
to provide access to the heart. Ablation is routinely used to treat patients who are at high 
risk for arrhythmias and do not respond to antiarrhythmic drugs [148]. Catheter ablation 
has the most success in treating tachycardia, where the goal is to ablate the origin of the 
arrhythmia [159]. The arrhythmia origin can either be an ectopic focus, caused by abnormal 
automaticity or triggered activity, or a region of stable reentry as shown earlier in Fig. 3.1. 
Ablation can be effective treatment in both cases but for different reasons. Ablation of 
an ectopic focus will kill the cluster of myocytes that have the abnormal automaticity or 
triggered activity; thus the arrhythmias will cease. Ablating the site of stable reentry will 
create inexcitable scar in the pathway of the reentrant circuit. For reentry to continue, a 
different path must be taken, and if there are no alternating pathways that satisfy Eqn. 
3.1, discussed earlier, the arrhythmia will cease.
Although ablation has vastly improved over the past decades and has had success in 
treating tachycardia, determining the correct locations for ablating fibrillatory arrhythmias 
remains a challenge. Ablation is not used to treat patients susceptible to VF, since it is 
unknown where to target. However, ablation is standard for treating patients susceptible 
to AF if other methods have failed. Paroxysmal AF is thought to be driven by ectopic 
triggers from the pulmonary veins [160]. To treat tachycardia, triggers are directly ablated 
to terminate the arrhythmias. A similar method can be applied to paroxysmal AF, where 
the triggers are in the pulmonary veins, but instead of directly ablating the pulmonary 
veins, they are completely encircled with scar tissue. The scar tissue causes ectopic triggers 
from the pulmonary veins to collide and block with scar tissue around the pulmonary veins 
before interacting with propagating cardiac waves in the rest of the atria. Pulmonary vein
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isolation for paroxysmal AF has been successful in treating the arrhythmia, but there has 
been less success in treating persistent AF [161]. Though the exact mechanism is unknown, 
it is believed that pulmonary vein isolation has poor outcomes in persistent AF because 
persistent AF causes atrial remodeling, creating regions outside the pulmonary veins that 
can initiate and drive the arrhythmia [26,124,162].
Many ablation strategies for treating persistent AF have been attempted but so far 
none have been proven to be more effective than pulmonary vein isolation in a randomized 
multiclinic study [148]. The treatment strategies in general try to find regions of the atrium 
that are sustaining the arrhythmia, although there is still no consensus on whether such 
regions exist. One targeted ablation strategy is to find regions of tissue that have complex 
fractionated atrial electrograms (CFAEs) [163]. Sites that contain highly fractionated elec­
trograms are thought to be regions of conduction block, conduction slowing, or wavebreak, 
which all have arrhythmogenic properties [164]. However, these sites have not been found 
to be spatially stable, and ablation of these sites has not proved to be more effective than 
pulmonary vein isolation [165]. The nonstability of these sites suggests more of a multiple 
wavelets theory of fibrillation, since the driving sites are throughout the heart and are 
not spatially-temporally stable. Another proposed ablation targeting strategy is to ablate 
regions with high-frequency activations in the heart. A study by Kalifa et al. found that 
high-frequency sources drive some types of AF [166]. However, other studies have found 
that sites of high-frequency activation are not spatially-temporally stable throughout AF, 
making them not viable ablation targets [167,168].
Targeting sites of CFAEs and high dominant frequency for ablation has not been 
successful in treating persistent AF, but there is promising research in the area of finding 
other ablation targets [169]. One such target are rotors, which are localized sources that 
are thought to drive AF [35]. Furthermore, some evidence suggests that ablation of these 
sources has better outcomes than randomized ablation [36]. These rotors have been found 
clinically by examining activation movies to identify sites of rotational activity around a 
core [87]. However, the reproducibility of identifying rotors still remains suspect, and other 
groups have not been able to treat AF by ablating rotors, and therefore this research needs 
to be further validated [170].
CHAPTER 4
CARDIAC STRUCTURE AND FUNCTION 
COMPARISON
This chapter provides an overview of techniques to bridge the domains of cardiac 
structure and electrical function. The generalized framework for each of these aims follows 
four stages. The first stage is to discriminate the cardiac substrate into different categories. 
The second stage is to acquire functional electrical measurements from these different 
substrates. The third stage is to register the structural and functional measurements to 
determine whether different cardiac substrates have different functional properties. The 
fourth stage is to determine how these differences in electrical properties relate to fibrillation.
4.1 Overview of Methods for Determining 
Cardiac Substrate
The aims in this dissertation use a combination of three techniques to determine the 
cardiac substrate. These techniques include differentiation of substrate-based on electro­
gram timing and morphology, differences in histology, and MRI-based interrogation. Each 
technique has several advantages and disadvantages, which is why multiple and overlapping 
techniques are used for each aim. Electrogram-based approaches are the least specific, and 
therefore can be used only if there is a drastic difference between cell types. Histology-based 
methods can have micrometer resolution, but these methods are typically used to examine 
only smaller regions of tissue. MRI-based methods are the most global, i.e., these methods 
can examine the entire heart; however, this method is also the most controversial and has 
only millimeter sensitivity.
4.1 .1  E lectrogram -based  In terrogation
Electrogram-based interrogation of cardiac substrate examines features of electrograms 
to discriminate cardiac substrate. The physiological basis to this approach is that there are 
differences in action potential shape and timing based on the cell type. A simple form of
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this approach, which is used throughout the aims, is to distinguish ventricular from atrial 
electrograms. This distinction is done by comparing electrogram timing to the complexes 
in the ECG. The different complexes in the ECG correspond to the atrial and ventricular 
activity. If an electrogram shows activation during the P wave, it is an atrial signal, and if 
the electrogram shows activation during the QRS complex, it is a ventricular signal. This 
approach does, however, become more complicated during fibrillation because there is less 
coupling between the two chambers, and atrial activations may be overshadowed if they are 
simultaneous with the QRS.
Electrogram-based interrogation of the substrate is a primary tool used in aim 1 to 
discern the ventricular conduction system from atrial and ventricular tissue. This approach 
is used because there is no visible difference, without magnification, among His bundle, 
atrial, and ventricular tissue. However, there are differences in the timing of local activations 
with respect to the ECG, which can be observed during sinus rhythm. In an ECG, the P 
wave corresponds to atrial activation. Therefore, if an electrode is placed anywhere on 
the atrium, the local activation will occur sometime during the P wave. Likewise, local 
ventricular activation will occur sometime during the QRS complex. During sinus rhythm, 
conduction occurs from the atrium to the ventricles through the AV node and ventricular 
conduction system. Therefore, the ventricular conduction system, including the His bundle, 
will have local activation sometime in between the P wave and QRS complex. The His 
bundle is a very thin structure in proximity to VM and AM. An electrode on the His 
bundle can often detect both VM and AM activity along with the His bundle, which results 
in an electrogram showing three distinct activations during sinus rhythm, with the first 
corresponding to the P wave, the second in the PR interval, and the third corresponding 
to the QRS. Using this technique the His bundle can be identified. Fig. 4.1 shows an 
example of an electrode plaque measuring atrial, His bundle, and ventricular activity 
and the corresponding ECG. A limitation to this approach is the unknown relationship 
between AM, His, and VM activation during VF. Therefore, examining the ECG and the 
electrograms during VF is of little use. His, VM, and AM activations can be differentiated 
by calculating the gradient of the divergence of the unipolar electrograms, which is known 
as the Laplacian. The gradient of electrograms within a region of tissues is proportional to 
the current flow between the regions of tissue. By evaluating the divergence of the gradient, 
current sources and sinks can be evaluated. Any Laplacian signal above the isopotential 
line is a current source, and negative Laplacian values are current sinks. Evaluating the 







Fig. 4.1: R ecordings from  an a rray  placed over th e  H is bundle. A) Strong 
ventricular, His, and atrial signals were recorded during sinus rhythm from the three 
regions of the 8x8 electrode array, 300 um spaced electrodes, shown in red, green, and 
blue, respectively. Electrograms at sites 1, 2, and 3 are shown in B). B) A pseudo ECG, 
unipolar electrogram (from sites 1, 2, and 3 in A), during sinus rhythm. Each recording 
was 500 ms in duration. The unipole at site 2 shows ventricular (red arrows), His (green 
arrows), and atrial (blue arrows) deflection.
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fibrillation [171,172]. The Laplacian signals can be calculated using a standard central 
difference approach according to Punske et al. [172]:
jr Vw  +  Ve  +  Vn  +  Vs  f . , sVc ----------------4-------------, (4.1)
where V is the voltage, subscript C refers to the central electrode, and the other subscripts, 
W, E, N, and S, refer to the relative positions of the other electrodes in the compass 
directions. Activation of the underlying cardiac tissue is the zero crossing of the Laplacian, 
when the tissue is turning from a sink to a source. Fig. 4.2 compares a unipolar electrogram, 
the derivative of the unipolar electrogram, and the Laplacian of the unipolar electrogram. 
The advantage of utilizing the Laplacian is that stage three of the generalized approach is 
trivial because the registration of the cardiac substrate with the functional measurements 
is completed in the process of determining the substrate.
A limitation to electrogram-based interrogation is that it requires there to be drastic 
differences in the electrograms, and for these differences to be known. Aims 2 and 3 examine 
healthy and more fibrotic atrial tissue; however, there is not strong evidence of differences in 
electrogram characteristics between fibrotic and atrial tissue. Some studies have examined 
sites of fibrotic tissue, as determined by MRI, and have shown that these sites may be more 
fractionated or have lower voltage [173]. However, others studies disagree by showing that 
fibrotic tissue may have normal electrophysiological characteristics during sinus rhythm, and 
regions of low voltage may be present due to reasons other than fibrotic tissue [165]. Many 
studies have examined the impact of fibrotic tissue on cardiac conduction; however, most 
of these studies determine the location of fibrotic tissue as sites of low voltage and CFAEs 
[165]. These results are somewhat controversial because they have limited histological data 
to compare with their electrogram-based approaches. Therefore, there are more robust 
methods than electrogram-based approaches to characterize the fibrotic tissue, including 
histology and MRI.
4.1 .2  H isto logy-b ased  Interrogation
Histology is the gold standard for evaluating cardiac substrate. However, acquiring 
cardiac histology in human patients is often not possible. For this reason, cardiac substrate 
is often evaluated using animal models [29,136]. Masson’s trichrome staining, shown in 
Fig. 4.3, is a technique used to separate tissues into three color groups: red for myocytes, 
blue for collagen/fibrotic tissue, and white for nonfibrotic extracellular content. From these 









Fig. 4.2: C om parison  betw een  un ipo lar an d  Laplacian  e lectrogram s. A temporal 
derivative and Laplacian are computed from a unipolar electrogram. Activation from the 
unipolar electrogram is the steepest downslope, which is the local minimum of the temporal 
derivative. Activation in the Laplacian occurs when the tissue transitions between a current 
sink to a current source, which is the zero crossing. The dashed line shows the activation 
times for the signals. The recording is 60 ms in duration.
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Fig. 4.3: M asson’s trich rom e s ta in  of card iac tissue. A) Left atrial tissue acquired 
from an explanted heart. The black and red spots in the corner of the histology in A) are 
tissue dyes which were used to mark the orientation of the electrode plaque on the histology. 
B) Example of a Masson’s trichrome stain of left atrial tissue. Red indicates myocytes, blue 
is collagen/fibrosis, and white is extracellular content. Each square is one quarter of the 
mapped region that was reconstructed to the full sample.
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4 .1 .3  M R I-based  Interrogation
Cardiac MRI is one of the few nonivasive methods used to validate cardiac scar and 
fibrosis [174,175]. The difference between scarred and healthy tissue can be detected with 
MRI because the magnetic resonance characteristics of protons vary between tissues. These 
tissue-level differences can be detected by measuring the T1 relaxation time (longitudinal re­
laxation time), which is how fast protons reequilibrate their spin following MRI pulses [175]. 
T1 varies by water content, fibrosis, and extracellular volume [176]. This finding makes 
possible noninvasive detection of fibrosis. This technique is traditionally used to determine 
the mean T1 time of a heart, where lower T1 times correspond to a more fibrotic heart 
after contrast injection. However, the technique can be expanded to determine regional 
differences in T1 by means of T1-mapping MRI. This measurement requires acquisition 
of both a T1-weighted image, IT1w, and a proton-density-image, IPD, after gadolinium 
contrast injection [177]. From these images, a pixel by pixel T1 map can be computed by 
solving the Bloch equation governing T1 relaxation:
I^i 1 — p-T d / ti Tn
J P D  =  M0 MO ,Tl =  -  ln(1 - e - TD /Ti ) (4.2)
where M0 is the unknown equilibrium magnetization and Td is the saturation recovery 
time delay (a set parameter). W ith this technique, normal tissue can be distinguished from 
more fibrotic tissue. The only limitation is the resolution of the acquired MRI. Fig. 4.4 
shows a segmentation of a T1-mapping MRI of a LA. The regions of low T1, shown in blue, 
correspond to an increase in fibrosis as determined by histology.
4.2 Overview of Methods to Measure Cardiac Electrical 
Behavior
Electrical potentials are measured to determine conduction properties of an arrhythmia. 
There are many methods to measure and analyze electrical potential. Each measurement 
and analysis tool has inherent limitations, and therefore the goal is to choose the mea­
surement and analysis system that minimizes the effect the limitations will have on the 
overall results. This section will detail different methods for measuring electrical potential, 
including intracellular versus extracellular measurements, and then will focus on different 
approaches to analyzing fibrillation.
4.2 .1  M easuring  E lectrical P o ten tia l
Traditionally, electrical potential from cardiac tissues has been measured from elec­
trodes, which act as the interface between cardiac tissue and measurement equipment.
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Fig. 4.4: T1 m apping  can d e te rm ine  regional differences in fibrotic  tissue. Left 
panel shows a segmented LA shell with blue regions showing the regions with the lowest 
10% of T1 values, indicating fibrotic areas. On the right panel is Mason’s Trichrome stained 
tissue from a region with low T1 (panel B) and high T1 (panel C).
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Measurement equipment, usually in the form of a data acquisition system (DAQ), can 
measure potential, but the mode of transmission is in electrons. In the body, however, 
electric potential interacts with ions. Therefore, the electrode is a transducer that converts 
ionic current into electrical current so that it can be measured. Two major types of potential 
measurements can be made, depending on where the recoding and reference electrodes are 
placed. Intracellular electrograms are made when the recoding electrode is placed inside 
the plasma membrane and the reference electrode is placed in the extracellular space. For 
the second type of measurement, both the recording electrode and the reference electrode 
measure extracellular potentials.
Intracellular electrograms measure the sum of all currents that are moving in the 
intracellular space with reference to the extracellular space. Intracellular electrograms are 
primarily recorded with either glass pipette electrodes or utilizing voltage-sensitive dyes. 
Glass pipette needle electrodes puncture the individual cells, which allows the measurement 
of the intracellular space. These measurements can be technically difficult to acquire because 
the glass needle tip can easily break. Drugs, which stop the heart's mechanical motion 
while leaving the electrical properties intact, are often used to limit the likelihood of the 
glass needle breaking. These types of drugs are known as electrical mechanical uncouplers. 
A limitation to this technique is that it is difficult to have many simultaneous glass 
pipette recordings, and therefore these measurements are not suitable for understanding 
whole-heart or even regional-based conduction properties. Glass pipette measurements 
are ideal, however, for measuring properties within the intracellular space, such as Ca2+ 
currents, or action potential morphology under different conditions. Voltage-sensitive dyes 
are another method to measure intracellular electrograms, and this method can be applied 
over a large region of tissue. Voltage-sensitive dyes function by binding to the membrane 
of cardiac cells. The voltage-sensitive dye can then be excited by a specific wavelength 
of light. Once excited, the dye then emits fluorescent light, which is a function of the 
membrane potential [178]. The fluorescent light can then be recorded with an array of 
photodiode arrays or from charge-coupled device cameras. The major limitation of optical 
mapping is that heart motion can create artifacts. Each pixel in the camera recording space 
is assumed to record the same region of cardiac tissue throughout an optical mapping study. 
However, if the heart is moving, each recorded frame could be measuring fluorescence from 
a different location. For this reason, electrical mechanical uncouples are often used [179].
Extracellular electrograms measure changes in currents propagating in the extracellular 
space. The two primary extracellular electrograms are unipolar and bipolar. A unipolar
52
electrogram is when the recording electrode is placed on the tissue of interest, and the 
reference electrode is placed far away (ideally, infinitely far away). An action potential mea­
sured from extracellular electrodes looks different from an intracellular electrode, although 
they do contain similar information. The first complex in an intracellular electrogram 
corresponds with the depolarizing of the cell, where the maximum negative value of the 
first temporal derivative corresponds to activation. This first complex occurs as Na+ enters 
the cell through gap junctions, but the extracellular electrogram is measuring the flux in 
extracellular current in response to Na+ flow. As a depolarizing wave is approaching the 
electrode, it measures a more positive value. As the wavefront leaves, it measures a negative 
value. After the activation phase, the measurement will read an isopotential zero; this occurs 
while the cell is depolarized. During this time, intracellular Ca2+ release is prolonging the 
action potential, but there is little extracellular current. During repolarization, K+ begins 
to repolarize the cell. The repolarization causes the T wave of the unipolar signal. The 
maximum upstroke of the T wave is the repolarization time. The T wave can have many 
different morphologies, depending on the repolarization of the cardiac tissue compared 
to the reference [180]. If the measured site depolarizes relatively early compared to the 
reference, the T wave is always positive. If it has relatively late repolarization, the T wave 
will be always negative. If a region of tissue repolarizes inbetween global early and late 
repolarization, the result will be a biphasic T wave (Fig. 4.5). From unipolar signals, 
the action potential duration can be estimated using the definitions of activation as the 
steepest downslope of the activation complex and repolarization as the steepest upstroke of 
the T wave. Another feature of interest in unipolar signals is the amplitude. Scar tissue, 
whether caused by infarct or ablation, has a lower unipolar amplitude. Even though a single 
action potential for a given cell type has approximately the same amplitude, due to the all 
or nothing response of an action potential, the unipolar electrogram records many nearby 
cells. If some of the myocytes within the electrode’s recording field are scarred and no longer 
excitable, fewer of the myocytes will activate. When fewer myocytes activate there is less 
extracellular current flux, which is directly related to the unipolar electrogram’s amplitude.
The other type of extracellular electrogram is a bipole. This measurement consists 
of subtracting two nearby electrodes from each other. The resulting signal measures less 
far-field signal; however, it loses many of the characteristics of unipolar electrograms that 
make it comparable to an intracellular electrogram. The main reason for the differences 
is that traditional bipolar electrograms can detect the magnitude of current only in the 
direction of the electrodes. For example, consider a propagating wave. If the electrodes are
53
Fig. 4.5: E x trace llu la r versus in trace llu la r e lectrogram s. A) and  C): simulated 
unipolar electrogram (UEG). B) and  D): simulated action potential (AP) at the same 
locations as A and C, illustrating the reference markers. The dashed line in each panel 
marks the local repolarization time (TR). T90, instant of 90% Tup, instant of steepest 
upstroke of the T wave; Tdown, instant of steepest downstroke of the T wave; Td2, instant 
of minimum second derivative of the UEG. Reproduced with permission from Potse et al. 
[179]
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orthogonal to the wave, the bipolar electrogram will detect a large signal because as the wave 
passes the recording site, there is a period where one electrode may detect depolarization 
while another electrode in the set still is not detecting current flux, since the wave has not 
yet reached it. However, for this same wave, if the electrodes are parallel to the wavefront, 
both electrodes will detect the depolarization simultaneously, and thus no signal will be 
measured. For this reason, a bipolar is considered a directional measurement. However, 
coaxial bipolar electrograms do not have this directionality issue [181]. An example of 
differences in bipolar electrogram morphology and cardiac wavefront direction is shown in 
Fig. 4.6. One similarity to unipolar signals is that bipolar electrograms are considered to 
detect activation at the point of steepest downslope. However, due to the dependence of 
direction, these measurements have less meaning in amplitude, and have no indication of 
repolarization. During fibrillation, these measurements become harder to interpret due to 
constantly changing and unknown wavefront directions. Bipolar electrograms are often used 
clinically due to the removal of far field noise, which makes detecting activations simpler.
4.2 .2  C ardiac E lectrical M apping
Knowing only the activation of a single electrogram is insufficient to determine whole- 
heart conduction. For this reason, many electrograms are often measured simultaneously, 
and from these measurements different maps can be made to understand cardiac conduction. 
There are three primary methods used for analysis of fibrillation organization from recorded 
electrograms, which include: examining the electrogram's amplitude, frequency, or phase 
characteristics, although new promising research is examining how to combine some of these 
metrics [182]. Every signal, including a cardiac electrogram, contains amplitude, frequency, 
and phase information. By analyzing these features of electrograms, conduction and the 
organization of fibrillation can be quantified.
The first class of mapping focuses on the time domain of electrograms and examines both 
voltage and relative activation times. The simplest form of this map is a voltage map. The 
voltage map shows the measured potential at each recording site for a given instant. In these 
maps, polarized tissue (approximately -80 mV) corresponds to tissue at rest, whereas more 
positive potentials indicate tissues in different stages of an action potential. These maps 
are most commonly used for optical mapping because they require high spatial resolution 
intracellular recordings. Clinical voltage maps are made from extracellular recordings and 
measure the amplitude of a detected activation. These maps can be made from both 
unipolar and bipolar maps; however, bipolar lead placement with the wavefront must be
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A) Bipolar leads orthogonol to approching cardiac wave
0  0 mV
B) Bipolar leads parrallel to approching cardiac wave
0 mV
C) Unipolar recording insensitive to cardiac wave direction
0 mV
Fig. 4.6: B ipo lar e lec trog ram  m orphology versus e lec trode  position . A Bipolar 
lead orthogonal to approaching wavefront. A bipolar electrogram is measured because 
one electrode measures extracellular current flux before the other electrode in the bipole. B 
Bipolar lead parallel to approaching wavefront, which results in a low-amplitude electrogram 
because both electrodes measure the extracellular current flux simultaneously, and therefore 
the activation is seen as common mode noise and subtracted. C Unipolar electrogram is 
invariant to wavefront direction.
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considered for the bipolar voltage maps. Features of interest are regions of low voltage that 
are thought to be scar tissue, caused by either ablation or diseased tissue. These maps 
are used after ablation to detect whether the ablation resulted in scar. Another type of 
time domain mapping examines the relative timing between tissue activation. Activation 
is usually considered the local minimum of the temporal derivative of the electrogram. 
Activation detection can be done for each electrode and the time of activation can be 
plotted from each electrode that constructs an activation map. If the electrodes are close 
enough, an electrical wavefronts pathway can be determined. A metric that can be defined 
from activation mapping is how much fractionation is present in an electrogram during 
fibrillation. A highly fractionated electrogram will have many activations within a time 
window often smaller than the refractory period of a single myocyte. If an electrogram 
contains several activations within a single cell’s refractory period, it is known as a complex 
fractionated atrial electrogram (CFAE). Detecting activations can be subjective due to the 
need to define a threshold for what local minimum of the derivative should be considered an 
activation. One impartial way to examine the presence of CFAEs is by computing Shannon’s 
entropy. The significance of CFAEs remains controversial. Some reports have found that 
regions of complex fractionation are due to fibrosis, whereas others have shown that regions 
of CFAEs could also be functional, and not related to fibrosis [183]. Another common time 
domain analysis technique that utilizes activation detection is how regular the cycle length 
is during fibrillation. One metric that can examine this regularity is reg-idx. Reg-idx 
is computed as the standard deviation of the cycle length of an eletrogram’s activations 
divided by the mean cycle length. As reg-idx approaches zero, the electrogram has a more 
regular cycle length, and as reg-idx approaches 1, it becomes less regular. Fig. 4.7 shows 
some examples of time domain analysis of cardiac signals.
Another class of analysis examines the frequency content of electrograms. The frequency 
content can be analyzed by computing a Fast Fourier transform (FFT) over at least several 
seconds of fibrillation. The FFT converts a signal from one domain, such as the time domain, 
into the frequency domain. Specifically, the FFT decomposes a signal into sinusoids of 
different frequencies that could reconstruct the original signal, and is computed as follows:
N -1
X k  = ^  x n e -i2nkN . (4.3)
n= 0
From the FFT, a power spectrum can be computed. The peak of this spectrum is related to 
the activation rate of the tissue if certain conditions are met [88]. The dominant frequency 
finds the local maximum of the power spectrum within a certain range of physiologically
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Fig. 4.7: T im e dom ain  activa tion  de tec tio n  and  signal processing. A) Example 
of determining activations for a unipolar signal. Local minimums of the first derivative 
are selected as activation times. From these activation times, several parameters can be 
computed, such as cycle length, standard deviation, and reg-idx. The relatively high reg-idx 
value indicates that this region of tissue does not have a regular cycle length. B) Example 
of examining relative activation times from multiple electrodes. Unipolar electrograms were 
obtained from a basket catheter, which is shown under fluoroscopy. Activation mapping 
shows the relatively early and late activations for a 120ms window during fibrillation.
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viable activation frequencies. A problem with this method is that the dominant frequency 
may not always reflect activation rate, especially for highly fractionated electrograms [184]. 
Despite this limitation, dominant frequency analysis is still widely used to approximate 
activation rates [38]. Another method to quantify the power spectrum is the organizational 
index. This metric analyzes the frequency range of electrograms. Narrow-frequency-ranged 
electrograms have a higher organizational index and are thought to be sites of rotors or focal 
activity to drive an arrhythmia [124]. The advantage of the spectral analysis methods is 
that it does not require defining activation, which can often be subjective and not apparent. 
Furthermore, with this method each electrogram is analyzed separately and does not require 
information from nearby electrodes. For this reason, this method is most appropriate 
for examining data with sparse spatial resolution. If the fibrillation is stochastic, and 
not one region is driving the arrhythmia, the power spectrum may look like white noise, 
or may change over time. However, if certain regions of the cardiac tissue are driving 
the arrhythmia, this method would show regions of the atria that have consistently high 
dominant frequency. Fig. 4.8 shows an example of the spatial distribution of dominant 
frequency on the endocardium of the LA during AF.
The final common cardiac mapping method is to examine an electrogram’s phase 
information. The phase of a signal shows the different stages of a signal that is divided 
into 2n radians. If a signal is not completely random, there should be some relationship 
between past and present samples of that signal. This relationship can be shown using 
phase space plots, which were developed in the field of state-space mapping of nonlinear 
dynamics [185]. In a phase space plot, a signal is plotted versus a time-delayed version of 
itself. If there is a relationship between the current sample and past samples, the phase 
space plot will show organization. Specifically, the plot will take some shape and rotate 
around a central point known as an attractor. Therefore, in cardiac systems, if there is 
an organization to the conduction, the phase space plots should show rotation around an 
attractor. Examples of phase plots for different signals are shown in Fig. 4.9. The phase 
from the phase space plot can then be calculated for any time instance by computing the 
angle from the attractor to a point on the phase space plot. When acquiring data for 
analyzing cardiac signals, often an array of electrodes is used so that many points on the 
cardiac tissue can be recorded simultaneously. A phase angle can then be computed for every 
electrode within the mapping region, and plotting the phase for every electrode location 
is known as a phase map. Points of interest on a phase map are locations where there 
are phases from —n to n around a central point. This central point is known as a phase
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Fig. 4.8: S pectra l analysis. A) Electrograms from basket catheter placed in LA of 
animal in chronic AF. The preprocessing phase includes QRS subtraction to remove far- 
field ventricular activity from the atrial electrograms. B) Compute power spectrum from 
electrogram data. The dominant frequency of each electrogram was found as the local 
maximum in the power spectrum from 4-12Hz. The spatial distribution of the dominant 
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Fig. 4.9: P hase  A nalysis. Examples of signals and corresponding phase space plots 
are shown. In the phase space plots, the x and y axes show signal amplitude and the 
z axis is time. Phase space view 2 is looking down on z axis. A) Sinusoid signal and 
corresponding phase space plots. Relationship between previous input and current input 
is constant throughout time, which is shown by the circle with constant amplitude in the 
phase space. B) White noise and corresponding phase space plots. As expected, the phase 
space plots show no relationship between past and current input so there is no organization 
in the phase space. C) Atrial flutter electrogram and corresponding phase space plots. 
Phase space plots show a more triangular shape, which corresponds to the sharp edges in 
the time domain. The phase space does show organization around a point through time, 
which is due to the consistent, regular atrial activations. D) Atrial fibrillation electrogram 
and corresponding phase space plots. Phase space plots show much less organization than 
the atrial flutter phase space plot. The phase space does not show organization because 
fibrillation is a highly unorganized arrhythmia defined by many dynamic pathways for 
cardiac wavefronts.
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singularity, and it is thought that these locations are pivot points for reentrant circuits and 
rotors [186]. An example of a phase map is shown in Fig. 4.10. Phase-mapping techniques 
and identifying singularity points have been applied to cardiac arrythmias to try to locate 
regions of stable reentry or rotors [35, 57,185].
4.3 Methods for Determining and Registration 
of Cardiac Functional and Substrate Data
This next section will specify the generalized framework- stage 1: Discriminate the 
cardiac substrate into different categories, stage 2: Acquire the electrical measurements from 
these different substrates, Stage 3: Register the structural and functional measurements, 
Stage 4: Determine if different structures promote fibrillation- will be applied to each aim. 
In summary, the three aims in this dissertation are:
• Aim 1: Characterize how the activation rate and conduction velocity of the proximal 
conduction system change during the time course of VF.
• Aim 2: Determine how local fibrotic tissue architecture and densities in chronic AF 
relate to conduction changes that facilitate reentrant activity.
• Aim 3: Evaluate the relationship between fibrotic myocardium determined by mag­
netic resonance imaging and local drivers of persistent AF.
4 .3 .1  R ation a l for M eth o d s in A im  1
Aim 1 uses a high-density electrode plaque and examines sinus rhythm and fibrillation 
in an isolated perfused rabbit heart. The main challenge with aim 1 was to find a way to 
discriminate between AM, VM, and His bundle signals. To overcome this challenge, the 
Laplacian method was used to find clear activations for each type of cardiac tissue. In 
this aim, stages 1 and 3 of the generalized framework are completed simultaneously. The 
high-density electrode plaque is placed between the RA and RV, which is in the approximate 
location of the His bundle. Activations of the Laplacian electrograms can then be compared 
with the waves and complexes in the ECG to identify atrial, ventricular, and His bundle 
tissue (stages 1 and 3). Once this identification process is completed, fibrillation can be 
induced and functional measurements can be acquired (stage 2). Due to the unambiguous 
activation times that could be found with the Laplacian method, time domain analysis and 
creating activation maps were appropriate for this aim and were used to determine the 
electrophysiological properties of the VM and His Bundle, thus completing stage 4.
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Fig. 4.10: P hase  M ap. Phase map showing a singularity point based on basket data. 
The x axis is the spline numbers A-H and the y axis is the electrode numbers on the 
corresponding spline.
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4 .3 .2  R ation a l for M eth od s in A im  2
Aim 2 examines the onset of AF in an open chest preparation of a chronic AF goat. 
Stage 1 in this aim is to separate out regions of fibrotic tissue and further subdivide fibrotic 
tissue based on its architecture. Masson’s trichrone staining of histology from the mapped 
region was used to locate fibrotic tissue. The open chest preparation allows for extracting 
histology in the same location from which functional electrical measurements were acquired. 
Stage 2 of aim 2 uses both a S1 and a S1-S2 pacing protocol. Conduction velocity at the 
various coupling intervals is then computed. Atrial signals are small compared to ventricular 
signals, but since the recordings are acquired during sinus rhythm, activation mapping is 
again the most appropriate method for characterizing conduction velocities that require 
determining activations times. Stage 3 was completed by registering the orientation of the 
histology with the electrode plaque. This registration was done by carefully marking the 
extracted histology so that its orientation relative to the recording plaque was known. Stage 
4 then compared the architecture of fibrotic tissue, as determined by histology, with the 
conduction data obtained with the pacing protocols.
4 .3 .3  R ation a l for M eth od s in A im  3
Aim 3 uses basket catheters to electrically map AF in chronic AF canines in vivo. 
Stage 1 in this aim uses T1-MRI to determine regions of the LA that are fibrotic. Although 
T1-Mapping MRI is one of the few validated methods to measure fibrotic tissue noninvasivly, 
histology was taken from the animals a few months after the in vivo experiments. Stage 
2 of aim 3 used basket catheters to electrically map large regions of the endocardium. 
Although much of the LA can be covered with these baskets, they have high interelectrode 
distances and can have poor contact with the atrial wall. Stage 3 of Aim 3 is done 
by creating an electroanatomical map during the in vivo study. Tthe electroanatomical 
map is made by placing a catheter inside the LA and recording the 3D position of the 
catheter. The catheter is then moved around the endocardium of the LA, which creates a 
geometry. This geometry was then merged with the T1-Mapping MRI geometry. The merge 
is accomplished by selecting known corresponding points between the two geometeries. 
Examples of corresponding points are the four pulmonary veins, the gaps between the 
pulmonary veins, the mitral valve, and the appendage. Stage 4 of this aim is challenging 
due to the limitations of the basket catheter, and the LA signals are often of low amplitude, 
which makes activation detection difficult. Furthermore, the large interelectrode distances, 
4 mm, make it difficult to determine wavefronts. For example, if an activation occurs at
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an electrode, then after a short delay, an activation is detected on a nearby electrode. It 
is not clear if these activations occurred from the same wavefront, or if during the delay, 
the original wavefront that caused an activation may have dissipated or turned. Thus 
the activation detected on the nearby electrode may be from a different wavefront. For this 
reason, this aim examined each electrode individually with both time and frequency domain 
techniques. To remove far-field ventricular activity, a QRS subtraction algorithm was used, 
and this technique is shown in Figure 4.11. The QRS-subtracted unipolar signals were 
analyzed with time and frequency domain techniques to find activation rate and regularity 







QRS free atrial signal
1 second
Fig. 4.11: QRS su b trac tion . The QRS of an ECG is determined, which is indicated by 
the arrows, using peak detection. A window encompassing the QRS and T wave is defined, 
which is shown in blue. This window around the ventricular activity is then projected onto 
each unipolar signal. The median of at least 10 of these windows was computed to create 
a template of the ventricular activity. A template will be created for each unipole. This 
template is then subtracted from each unipole for every QRS determined from the ECG. 
The resulting signal is an atrial unipole free from ventricular activity.
CHAPTER 5
CONDUCTION PROPERTIES OF THE HIS 
BUNDLE DURING PROLONGED 
VENTRICULAR FIBRILLATION
The distal regions of the ventricular conduction system, specifically the Purkinje fibers, 
have been implicated in driving long-duration VF. Most of this evidence comes from 
measurements from the ventricular myocardium, and from these measurements the role 
of the conduction system is inferred. This chapter is a published journal article, which is 
reprinted with permission from Plos One. The article includes a description of a method 
to reliably differentiate conduction system activity from ventricular activity during VF. 
Utilizing this method, it was found that the distal ventricular conduction system has a 
faster activation rate than the underlying VM during prolonged VF.
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Abstract
Background: The Purkinje fiber system has recently been implicated as an important driver of the rapid activation rate 
during long duration ventricular fibrillation (VF>2 minutes). The goal of this study is to determine whether this activity 
propagates to or occurs in the proximal specialized conduction system during VF as well.
Methods and Results: An 8x8 array with 300 p.m spaced electrodes was placed over the His bundles of isolated, perfused 
rabbit hearts (n = 12). Ventricular myocardial (VM) and His activations were differentiated by calculating Laplacian recordings 
from unipolar signals. Activation rates of the VM and His bundle were compared and the His bundle conduction velocity 
was measured during perfused VF followed by 8 minutes of unperfused VF. During perfused VF the average VM activation 
rate of 11.04 activations/sec was significantly higher than the His bundle activation rate of 6.88 activations/sec (p<0.05). 
However from 3-8 minutes of unperfused VF the His system activation rate (6.16,5.53,5.14,5.22,6.00, and 4.62 activations/ 
sec significantly faster than the rate of the VM (4.67,3.63,2.94,2.24,3.45, and 2.31 activations/sec) (p<0.05). The conduction 
velocity of the His system immediately decreased to 94% of the sinus rate during perfused VF then gradually decreased to 
67% of sinus rhythm conduction at 8 minutes of unperfused VF.
Conclusion: During prolonged VF the activation rate of the His bundle is faster than that of the VM. This suggests that the 
proximal conduction system, like the distal Purkinje system, may be an important driver during long duration VF and may 
be a target for interventional therapy.
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Introduction
Sudden cardiac death due to ventricular fibrillation (VF) is one  
o f the leading causes o f  death in the developed w orld[l]. 
Furthermore, sudden cardiac death is often unexpected, occurring 
without any predetermined risk [2]. Implantable cardiac defibril­
lators (ICD’s) have greatly reduced mortality due to VF, likely due 
to defibrillation shocks being applied to the myocardium soon after 
the onset o f  V F [3]. H owever this treatment is only available for 
those that have been clinically diagnosed as high risk for VF, For 
those without IC D ’s, V F  often persists for 5 -1 0  minutes before 
defibrillation shocks can be applied[4]. Since the probability o f  
successful resuscitation from V F decreases 10% for every minute 
o f  VF, the survival rate for out o f hospital sudden cardiac arrest is 
low [5]. Successful resuscitation rate is thought to decrease during 
prolonged V F because o f  electrophysiological changes to cardiac 
tissue under ischemic conditions [6]. These electrophysiological 
changes may cause permanent cardiac damage [7] and can result 
in failure to defibrillate successfully [8].
T he Purkinje fiber system has recently been implicated as an 
important driver o f VF activation in the maintenance o f  long  
duration VF (V F >2 min) [9-11]. Distal Purkinje fibers have been  
shown to develop triggered activity during V F due to the ischemic 
conditions which is thought to drive this rapid activation [6,12]. 
However it is unclear whether this rapid activation rate is limited 
only to the distal regions o f the conduction system, or whether it is 
observed or conducts to the proximal regions o f  the conduction 
systems as well.
D ue to the several minute delay o f  therapy for patients after the 
onset o f VF, it is necessary to study the electrophysiological 
properties o f  the ventricular conduction system during prolonged 
VF to aid in the development o f therapies to improve patient 
outcome. In this study, electrophysiological properties o f  the 
conduction system o f  interest are the activation rate o f  the His 
bundle compared to the V M  and the His bundle conduction 
velocity during the time course o f  VF. The ventricular conduction 
system has a  m uch higher conduction velocity than the V M  and 
only interacts with the V M  at specialized junctions known as the
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Purkinje-myocardial junctions (PMJs) [13]. Due to the faster 
conduction velocity and limited access sites into the ventricular 
conduction system from the myocardium, activation in the distal 
Purkinje system may travel quickly throughout the conduction 
system. We tested the hypothesis that the proximal regions o f  the 
ventricular conduction system, like the distal conduction system, 
have a faster activation rate than the underlying ventricular 
myocardium (VM) during prolonged VF.
Methods
All animals were managed in accordance with the G uide fo r  the 
Care and  Use o f  Laboratory A nim als [14], and the protocol was 
approved by the Institutional Animal Care and Use Committee o f 
the University o f Utah. All efforts were made to minimize 
suffering.
Animal Preparation
Twelve male N ew  Zealand white rabbits (3 .960 .2  kg) were 
anesthetized with an intramuscular injection o f 15 m g/kg  
ketamine, and 7.5 m g/k g  xylazine followed by an intravenous 
injection o f5  m g/kg ketamine, 2.5 m g/k g  xylazine, and 500 IU  of 
heparin. The hearts were excised rapidly and Langendorff- 
perfused with Tyrode solution (in m m ol/L  130 NaCL, 1.2 
N aH 2 PO 4 , 1 M gCl2 , 4 KCl, 1.8 CaCl2 , N aH C O 3  20.8, dextrose 
11, and 0.04 g / l  bovine albumin). Flow rate was adjusted to 
maintain a pressure at 2 5 6 3  mmHg. The hearts were also 
superfused with warm Tyrode solution, with temperature main­
tained at 3 7 6 0 .5  0C. The Tyrode solution was oxygenated with
O 2 and C O 2 to maintain a pH  o f  7 .4 6 0 .1 .
Instrumentation and Experimental Protocol
An incision in the right atrium was made to expose the His 
bundle, which is found along the atrial-ventricular boundary high 
on the R V  septum. Unipolar V M  and His bundle activity were 
recorded using an 8 x 8-electrode plaque with electrodes spaced 
0.3 mm apart with a reference electrode in the solution bath. 
Electrograms were low pass filtered at 1640 H z, sampled at 8 
K Hz, and recorded at 24 bit resolution (Active Two System, 
Biosemi, Inc, Amsterdam, Netherlands). Electrodes were placed in 
the perfusate on either side o f  the heart (one near the atrium and 
the other near the ventricle) to calculate a bipolar pseudo-ECG. 
V F was induced with 15—30 seconds o f 50 Hz burst pacing, with 
amplitude o f 5 mA through bipolar leads placed in the right 
ventricular apex. After 30 seconds o f sustained VF, perfusion was 
stopped and VF persisted until it spontaneously terminated. The 
electrode plaque was lifted off o f  the myocardium and His bundle 
using a micromanipulator every 30 seconds to avoid ischemia of 
the His bundle.
Measurements and Data Analysis
His, VM , and atrial myocardium (AM) activations were 
differentiated by calculating a 5-point Laplacian from the unipolar 
electrograms. The Laplacian signals were calculated according to 
Punske et al. [15]. In brief, a standard centra! difference approach 
was used as shown in the formula,
( V w  Z V £ Z V n  Z V s ) m 
v c ----------------- 4-------------- , UJ
where V  is the voltage, subscript C refers to the central electrode, 
and the other subscripts, W, E, N, and S, refer to the relative 
positions o f the other electrodes surrounding the central electrode 
according to the compass regions. If the electrode site was on the
corner or edge o f  the array, values from the two or three nearest 
sites were averaged and subtracted from the central electrode site.
Channels that contained strong His and V M  activations were 
used for the analysis o f activation rate and conduction velocity. An 
activation rate for the His and V M  was determined by averaging 
the cycle length o f the first 10 successive activations o f each 
minute, up to 8 minutes, o f VF. Activations times were 
determined using a thresholding approach with manual oversight 
via custom software developed in M ATLAB (Mathworks, Inc., 
MA, USA). This software computed a 21-point temporal 
derivative o f the Laplacian. During sinus rhythm, the local 
maximums o f  this filtered signal were taken as the activation times. 
Activation times during VF were determined by finding local 
maximum that had a peak that was at least 50% o f the sinus 
rhythm local maximums. An activation map for each o f the 10 His 
activation used to calculate the activation rate was made to 
determine His conduction velocity. For each o f the 10 activation 
maps a His conduction velocity was calculated by subtracting the 
activation times from the most proximal and distal activation 
along the His bundle fiber, then dividing by the distance between  
those electrodes. The average ofthese 10 His conduction velocities 
were then taken as the conduction velocity for sinus, perfused, and 
for the 8 minutes o f  unperfused VF. The data are publically 
available at USPACE (http://content.lib .utah .edu/cdm /ref/ 
collection/uspace/id/9710).
Statistical Analysis
Results are expressed as m ean 6S D . The overall difference 
between V M  and His bundle activation rate and the effect o f time 
on His bundle conduction velocity was tested with repeated- 
measure A N O V A  (XLSTAT Version 2014. 1.08). Differences 
between the activation rate o fthe V M  and His bundle for perfused 
VF and each minute o f unperfused V F were tested using a post- 
hoc paired t-test with a Holm-Bonferroni correction for multiple 
comparisons. His sinus conduction velocity was compared with 
unperfused V F and 1—8 minutes o f VF with an unpaired t-test 
with a Holm-Bonferroni correction for multiple comparisons. The 
null hypothesis o f no difference for all tests was rejected if the 
probability value was less than 0.05.
Results
Hearts in which unperfused V F persisted less than 2 minutes 
were excluded from the analysis (n =  2). The average duration of  
sustained VF was 9.13 m inutes64.52 minutes (n =  10). For sinus 
rhythm, perfused VF, and for minutes 1 ^  o f VF, data from 10 
hearts was analyzed. VF spontaneously terminated as time 
progressed so that at 5 minutes, n =  8, at 6 minutes n =  5, and at 
7—8 minutes, n =  6. At 6 minutes o f  unperfused VF, a time point 
was excluded from the analysis because VF spontaneously 
converted to V T  for 30 seconds then converted back into VF. 
In one heart, unperfused V F self-terminated during the 6th minute 
but was burst paced for 10 seconds, which reinitiated V F for 
another 13 minutes.
Figure 1A is a representative example from one experiment of  
the location o f the three primary cardiac signals (VM, AM  and 
His) recorded on the electrode plaque once the Laplacian had 
been computed. The His bundle signals were always in a thin line, 
(2 to 3 electrodes wide, by 3 to 5 electrodes long), in between 
predominate AM  and V M  signals. Figure 1B shows example 
unipolar and Laplacian recordings o f the AM, V M  and His signals 
from the array.
Figure 2 shows the processing o f electrograms to determine the 
activations rates for the His bundle and the VM . The raw
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Figure  1. Recordings from an array placed over the His bundle 
of an isolated rabbit heart. A) Strong ventricular, His, and atrial 
signals were recorded during sinus rhythm from the 3 regions of the 
8x 8 array, 300 mm spaced electrodes, shown in red, green, and blue, 
respectively. Electrograms at sites 1, 2, and 3 are shown in B) A pseudo 
ECG, unipolar electrogram (from site 2 in A), and 3 Laplacian recordings 
(from sites 1, 2, and 3 in A) during sinus and VF. Each recording was 
500 ms in duration. The unipole at site 2 shows ventricular (red arrows), 
His (green arrows), and atrial (blue arrows) deflection, while the 
Laplacians isolate the strongest local signal and eliminate far field 
signals. During VF, it is difficult to distinguish different activation types 
with the unipolar signal, but the different Laplacians facilitate waveform 
identification.
doi:10.1371/journal.pone.0101666.g001
electrograms contain little information about the activation times 
o f the tissue. Using the minimums o f the derivative is a standard 
method to detect activation times of cardiac tissue, however it is 
still not clear whether the activations are local or from far field 
signals. Furthermore the temporal derivative often produces 
multiple local minimums, making the choice o f the activation 
time ambiguous. D ue to these limitations, distinguishing His- 
bundle and V M  activation during VF was difficult with the 
unipolar electrograms and derivatives. In theory, Laplacian signal
Figure 2. Signal processing to detect activation times for His 
and VM signals. His and VM signals were recorded at the location 2 
and 3 from Figure 1A, respectively. The raw electrograms contain little 
information to detect activation times. The 21-point dV/dt of the 
electrograms shown above contains too much far field activation for 
robust local activation time detection. The Laplacian isolates the 
strongest local signal, attenuating far field signals. With baseline noise 
the zero crossing is not always clear therefore the 2 1-point derivative of 
the Laplacian was calculate which produced clear peaks, which allowed 
for activation detection with a thresholding approach to detect 
activation times. Each recording was 500 ms in duration. 
doi:10.1371/journal.pone.0101666.g002
shows activations at the zero crossing, however with baseline noise 
the zero crossing was not always clear therefore further processing 
was required. The 21-point temporal derivative o f the Laplacian 
produced unambiguous peaks which were used to find activation 
times for the His and VM .
Figure 3 shows example recordings o f the filtered His bundle 
and V M  signals for sinus, early and late VF. The local maximums 
in the signals shown in Figure 3 were the activation times used to 
calculate an activation rate for the His bundle and V M  and 
conduction velocity for the His bundle. During sinus rhythm the 
His bundle and V M  activations were coupled because the His 
system activates the VM . Conversely, the His bundle and VM  
activations became uncoupled during VF.
The repeated-measures A N O V A  showed a statistically signifi­
cant effect o f cell type (His or VM) on activation rate and that time 
had a significantly effect on V M  activation rate. However, time did 
not have a statistically significant effect on His bundle activation 
rate over the 8 minute time course o f VF. This is shown by the 
similar activation rate o f the His bundle during the eight minutes 
o f unperfused VF. The activation rate for the His bundle and V M  
are shown as a function o f time for both the His and V M  with the 
error bars reporting the standard deviation o f the measurement, 
representing the differences among animals (Figure 4). During 
perfused VF, at time 0, the average V M  activation rate was 
significantly higher than the His rate. At 1-2 minutes there is no 
significant difference between V M  and His activation rates, 
however at the 3 -8  minutes the His bundle activates faster than 
the VM.
Tim e had a statistically significant effect on His conduction 
velocity. The His conduction velocity decreased from 94% at 
perfused VF to 67% o f the sinus conduction velocity at 8 minutes 
of unperfused VF (Figure 5). The His conduction velocity at 
unperfused VF, 1 minute and 5 minutes o f VF was not significant 
different than sinus His conduction velocity. 5 minutes of VF
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Figure 3. His and VM dV/dt of Laplacians during time course of
VF. Early VF recording during perfused VF. Late VF is after 4 minutes of 
unperfused VF. Each recording was 500 ms in duration. 
doi:10.1371/journal.pone.0101666.g003
trended towards significance, with a corrected p-value of 0.053, 
and likely was not significant due to the large standard deviations. 
The sinus rate was 0 .4 6 6 0 .0 8  m /s  with n =  10. The conduction 
direction in the His bundle was antegrade, His bundle to VM , 
during sinus rhythm and nearly entirely retrograde, V M  to His 
bundle, during VF (Figure 6) (1 out of 650 examined activations 
were antegrade during VF).
Discussion
The main findings of this study are as follows: 1) Calculating a 
Laplacian from unipolar electrograms aids in the identification of
His-Purkinje signals. 2) The His bundle activation rate does not 
significantly change over the time course of VF. 3) During early 
VF, the V M  has a higher activation rate than the His bundle, but 
from 3 minutes on, this relationship reverses, and the His bundle 
activates faster than the VM . 4) Conduction in the His bundle is 
nearly entirely retrograde during VF and conduction velocity 
gradually decreases during the time course of VF.
Laplacian signals have been used previously to accurately detect 
activation times during V F[15,16]. Unique to this study is the 
utilization of Laplacian signals to distinguish local His bundle 
activations from the underlying V M  activations. The traditional 
method to detect activation within cardiac tissue is to take the time 
o f the minimum temporal derivative o f the signal[17]. This 
method can produce multiple peaks, making identifying an 
activation time unclear, and therefore subject to arbitrary 
criteria[18,19]. The Laplacian reduces far field effects, emphasiz­
ing local activity. This technique has been particularly useful when 
attempting to identify activations o f the conduction system in VF  
when the relative timing o f the conduction system and the 
underlying V M  activation are unknown. During sinus rhythm, 
activation propagates through the conduction system to the 
working myocardium, therefore, the conduction system activation 
temporally precedes the activation of the local VM . The zero 
crossing o f the Laplacian occurs when the local tissue is 
transitioning from a current source to a current sink and therefore 
is considered the activation. The slope o f the Laplacian is also at a 
maximum as the activation passes immediately beneath the central 
electrode o f the Laplacian. By calculating the temporal derivative 
o f the Laplacian, clear peaks can be distinguished which allows for 
a thresholding method to calculate an activation rate. The 
derivative of the Laplacian simplifies the detection o f local 
activation time and provides some immunity to noise inherent in 
these signals.
During perfused VF the activation rate o f the V M  is 
significantly higher than the His bundle. This is consistent with 
the traditional theory that VF is maintained through rapid
Figure 4. Mean and standard deviation of His and VM activation rate during eight minutes of unperfused VF. The average sinus rate
for the rabbits was 3.4660.61 activations/sec for both the His bundle and VM. *denotes p<0.05.
doi:10.1371/journal.pone.0101666.g004
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Figure 5. Mean and standard deviation of His conduction velocity as a function of VF duration. Values were normalized to mean His 
sinus conduction velocities. A repeated-measures ANOVA analysis showed that time has a significant effect on His Bundle conduction velocity. 
*denotes a significant difference (p<0.05) between non-normalized sinus conduction and the corresponding time point. 
doi:10.1371/journal.pone.0101666.g005
reentrant wavefronts within the V M [20-22]. However after 1— 
2 minutes of VF a transition occurs in which the His bundle 
activates faster than the VM . The V M  activation rate decreases 
quickly during VF while the His bundle activation rate does not 
significantly decrease. It is possible that the activity in the 
conduction system may be overdrive suppressed by the rapid 
activation rate in the V M , and that the conduction system does not 
drive VF activation until the V M  rate has slowed below the 
inherent activation rate o f the conduction system. This finding 
suggest that the proximal conduction system may be an important 
driver of V F > 2  minutes and is consistent with a more recent 
theory that the ventricular conduction system may have a critical 
role in VF maintenance, particularly after the first couple of 
minutes[10,18,23—26]. Three-dimensional simulations o f the 
ventricles that attempt to include the conduction system suggest 
that the ventricular conduction system may be an important 
source for focal activity and may have a critical role in the 
development and sustaining of reentry during V F[27,28]. A recent 
study demonstrated that ablation of the purkinje fibers slowed the 
activation rate during prolonged VF, and VF spontaneously 
terminated earlier than in control hearts[11]. This observation 
supports the simulation data that the ventricular conduction 
system may be required to maintain long duration VF.
Tim e may have a significant effect on the V M  but not on the 
His bundle due to several mechanisms. First the His bundle has 
less metabolic load than the V M  and therefore may take longer to 
deplete its reserved resources[29]. Second, much o f His-Purkinje 
system is located directly on the endocardial surface and it may 
receive substantial nutrients from the fluid in the L V  cavity. Our 
preliminary results suggested that if the electrode plaque was left 
on the His bundle for extended periods (> 1  min), the His bundle 
developed slowed conduction or even blocked (unpublished data). 
Finally differences in ion channel kinetics and restitution 
properties o f the ventricular conduction system and VM [26], 
may be responsible for the observed differences in the His and VM  
activation rate as a function o f time.
The His bundle may have a slower activation rate than the VM  
during early VF but more rapid activation rate during prolonged 
VF due to several mechanisms. During sinus rhythm the V M  has a 
shorter refractory period than the conduction system therefore 
electrical wavefronts on the myocardium may not be able to 
activate the conduction system at such a rapid rate [29]. As VF  
progresses and ischemic sets in, several electrophysiological 
changes occur in both the ventricular conduction system and the 
VM . One change is that the V M  develops a longer refractory 
period than the conduction system [29] and the V M  cannot 
maintain as high o f activation rate. Another change during 
ischemic conditions is that distal purkinje fibers are thought to 
develop abnormal automaticity and/or triggered activity during 
ischemic conditions [6,12,26]. Triggered or abnormal automatic- 
ity in the distal purkinje fibers may conduct to the His bundle but 
block at the VM , due to several reasons. The first reason is due to 
the longer refractory period o f the V M  as compared to the 
conduction system. Second, there is a source-sink mismatch 
between the distal purkinje fibers and the V M [30—32]. This 
mismatch results in conduction occurring more readily from VM  
to distal purkinje fibers than from distal purkinje fibers to the 
V M [31]. The combination o f longer refractory period o f the V M  
as compared to the ventricular conduction system and the 
presence of a source sink mismatch between the distal purkinje 
fibers and the V M  could result in a higher activation rate in the 
His bundle than the VM . Reentry involving both the V M  and the 
conduction system [27] is another mechanism that could cause a 
more rapid activation rate in the ventricular conduction system. A 
single ventricular wavefront may conduct into the ventricular 
conduction system to the His bundle. D ue to the limited access 
sites into the conduction system and the fast conduction velocity, a 
single V M  wavefront, either propagating on the V M  or which 
propagated through the conduction system, may activate the 
conduction system multiple times.
The His bundle conduction velocity reported for sinus rhythm 
in this study of 0 .4 6 6 0 .0 8  m /s  (n=  10) was similar to previous
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A) ANTEGRADE

















Figure 6. Exam ple of His bundle antegrade and retrograde  
conduction. The plaque shown is a 8x 8 array with 300 um electrode 
spacing, which covers a 2.1 mm x 2.1 mm region of the endocardium. 
Regions not containing strong His activity are shown in gray. A) 
Conduction during sinus rhythm was in the antegrade direction. B) 
Conduction in the His bundle during VF was almost always in the 
retrograde direction. The example shown is during perfused VF. 
doi:10.1371/journal.pone.0101666.g006
conduction velocity restitution[34]. The decrease in conduction 
velocity during the time course o f VF is most likely due to a 
combination o f ischemia and a rise in resting potential and 
inactivation of Na+ channels during prolonged VF[35].
Recently published studies support the hypothesis that the distal 
conduction system is responsible for driving the rapid activation 
rate during long duration V F [10,18,23-26]. Studies of long  
duration VF have shown that activation patterns o f the Purkinje 
system and working myocardium often propagate in patterns 
similar to the spread o f activation through the conduction system 
during sinus rhythm[10,36]. This work is the first to show direct 
evidence that the proximal ventricular conduction system activates 
more rapidly than the underlying working myocardium during 
long duration VF. The ventricular conduction system has a much 
faster conduction velocity than the VM , and only interacts with 
the V M  at limited sites known as PMJs which are located only in 
the distal regions of the ventricular conduction system[13]. 
Therefore it is likely that once a distal Purkinje fiber is activated, 
it will quickly activate a large region o f the conduction system, and 
as this study suggests, even conduct to the His bundle. The limited 
number o f PMJs located only in the distal regions o f the 
ventricular conduction system, in combination with the fast 
conduction velocity of the conduction system suggest that it is 
unlikely that activations through the ventricular conduction system 
will collide and block with other activations within the conduction 
system before activating large portions o f the conduction system. 
Therefore it is likely that triggered activity in Purkinje fibers can 
conduct through the ventricular conduction system and drive 
rapid activation at distant sites, even opening the possibility of 
biventricular communication through the bundle braches.
Limitations
A rabbit VF model was used for our study of properties of the 
His bundle during VF. VF is more difficult to initiate and maintain 
in rabbits than larger hearts such as humans. While it was difficult 
to initiate VF in rabbits, once it initiated, it was sustained for 
extended periods o f time (with two exceptions). Another limitation 
is the use o f an isolated heart preparation. In this preparation, the 
autonomic nervous system is severed which may influence VF. 
Due to these limitations the results o f these findings may not 
directly translate to humans. In spite o f these limitations, the 
isolated rabbit heart model is widely used and well accepted for 
studying V F [37-39]. A final limitation is that we mapped only a 
small region of the V M  near the His bundle and atrial tissue 
therefore there may be regions o f faster V M  activation that were 
not a measured.
reported ventricular conduction system velocities of 
0 .6 0 6 0 .0 9  m /s  (n = 3)[33]. The direction of conduction in the 
His bundle was nearly entirely retrograde during VF, consistent 
with activation propagating from the distal purkinje fibers through 
the bundle branches back to the His bundle. Antegrade 
conduction in the His bundle may only be observed if activation 
emerged from the AV node or through automaticity or triggered 
activity in the His bundle itself. However novel to this study was 
recording changes in His conduction velocity during the time- 
course o f VF. Conduction in VF was slower for perfused VF with a 
normalized conduction velocity of 94% of sinus rhythm, which 
gradually decreased to 67% of sinus rhythm conduction at 
8 minutes o f VF. The initial 6% decrease in conduction velocity 
from sinus to perfused VF may due to the slower retrograde than 
antegrade conduction in the ventricular conduction system[34] or 
slowing associated with the higher activation rate in VF[35] due to
Conclusion
In early VF (perfused VF), the V M  has a faster activation rate 
than the His bundle. W e concluded that the V M  is likely the major 
driver o f early VF, with the conduction system being driven by the 
activation o f the VM . After 3 minutes o f VF, the activation rate of 
the His bundle is faster than that o f the VM . This observation 
suggests that activations in the distal ventricular conduction system 
propagate through the conduction system to activate the His 
bundle and may drive activation at distant sites. This finding 
supports the conclusion that the conduction system plays a critical 
role in the mechanisms o f prolonged VF maintenance and may be 
a target for interventional therapy.
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CHAPTER 6




Patients with paroxysmal AF often transition between sinus rhythm and AF. However, 
the mechanism of how this transition occurs is not well understood. For AF to initiate, 
there must be both a trigger and a substrate that facilitate reentrant activity. The trigger 
is often caused by a premature atrial contraction or focal activations within the atria. This 
chapter examined the interactions between triggers for AF and the cardiac substrate. This 
article shows that long strands of fibrotic tissue are related to conduction slowing to make 
the tissue more susceptible to fibrillation. This chapter is a published journal article, which 
is reprinted with permission from the Journal of Cardiovascular Electrophysiology.
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Diverse Fibrosis Architecture and Premature Stimulation 
Facilitate Initiation of Reentrant Activity Following Chronic
Atrial Fibrillation
NATHAN ANGEL, M.S.,*,! LI LI, P h .D .,* ROB S. MACLEOD, Ph .D .,*,!  NASSIR MARROUCHE, 
M.D.,*,! RAVI RANJAN, M.D., P h .D .,*,!  and DEREK J. DOSDALL, P h .D .*, ! , !
From the ‘Comprehensive Arrhythmia Research & Management Center, Division of Cardiovascular Medicine, Salt Lake City, Utah, 
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Fibrosis Architecture and Conduction in Chronic AF. Introduction: Patients with paroxysmal 
atrial fibrillation (AF) often transition between sinus rhythm and AF. For AF to initiate there must be both a 
trigger and a substrate that facilitates reentrant activity. This trigger is often caused by a premature atrial 
contraction or focal activations within the atrium. We hypothesize that specific architectures of fibrosis 
alter local conduction to enable AF.
Methods and Results: Control goats (n =  13) and goats in chronic AF (for an average of 6 months, 
n =  6) had a high-density electrode plaque placed on the LA appendage. Conduction patterns following 
a premature atrial contraction, caused by an electrical stimulation, were quantified to determine regions 
of conduction slowing. These regions were compared to architecture, either diffuse fibrosis or regions of 
obstructive fibrosis, and overall fibrosis levels as determined by histology from the mapped region. The 
chronic AF goats had more obstructive fibrosis than the controls (17.5 ±  8.0 fibers/mm2 vs. 8.6 ±  3.0 
fibers/mm2). Conduction velocity of the AF goats was significantly slowed compared to the control goats in 
the transverse direction (0.40 ±  0.04 m/s vs. 0.53 ±  0.15 m/s) but not in the longitudinal direction (0.70 ±
0.27 m/s vs. 0.76 ±  0.18 m/s).
Conclusions: AF-induced atrial remodeling leads to increased obstructive fibrosis and conduction velocity 
slowing transverse to fiber orientation following premature stimuli. The decrease in conduction velocity 
causes a decrease in the cardiac wavelength, and increases the likelihood of reentry and AF onset. (J 
Cardiovasc Electrophysiol, Vol. 26, pp. 1352-1360, December 2015)
atrial fibrillation, conduction, electrophysiological mapping, fibrosis, remodeling
Introduction
Atrial fibrillation (AF) is the most common cardiac arrhyth­
mia, affecting over 2 million people in the United States, 
and its prevalence is expected to grow in the coming years.1 
AF is a serious health concern and is a high risk factor for 
stroke1 and cardiomyopathy.2 In paroxysmal AF, the pul­
monary veins have focal activations that can initiate and drive 
AF. Ablating around the ostia of pulmonary veins to isolate 
these focal sources from the rest of the left atrium has shown 
success in treating paroxysmal AF.3 However, ablation has 
poor outcomes for treating more extreme forms of AF, per-
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sistent and longstanding persistent.3 The current hypothesis 
for these poor outcomes in treating persistent AF is that the 
atrial structural remodeling, most notably the development 
of fibrosis, may cause conduction slowing in regions of the 
myocardium beyond the pulmonary veins that can initiate 
and maintain AF.4,5 To improve outcomes for persistent AF, 
it is of utmost importance to study the structural changes 
associated with this disease as well as the mechanistic links 
between such changes and reentrant activity.
AF persistence has been shown to increase with arrhyth­
mia duration, due to both structural and electrical remodeling 
of the atria.4,6-8 In animal models electrical remodeling can 
occur as soon as 6 hours, with a decrease in atrial effective 
refractory period (AERP).9 As AF transitions from paroxys­
mal to persistent, many structural changes occur that make 
AF episodes more common and increased in duration, a phe­
nomenon that has come to be known as "AF begets AF."8,10 
A major component of atrial structural remodeling is the in­
crease in fibrosis,4,7,11 which has been linked to a decrease 
in endocardial and epicardium synchronization7 and an in­
crease in conduction anisotropy,12 both of which facilitate 
AF maintenance. Furthermore, the amount of fibrosis pre­
ablation has been linked to post-ablation outcomes, which 
indicates that atrial fibrosis is a major component of atrial 
structural remodeling that stabilizes AF.13
Although these studies suggest that AF fibrosis affects 
global conduction and AF maintenance, the associated mech­
anisms of initiation of AF are unknown. Patients who have
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for transition to occur there must be a trigger followed by 
a transition via reentrant activity into fibrillation. This trig­
ger is often caused by a premature atrial contraction or focal 
activations within the atrium. We hypothesize that specific fi­
brosis architectures, i.e., the spatial organization, density, and 
extent of fibrosis, alter local conduction such that the cardiac 
tissue is more vulnerable to initiating AF. We have classi­
fied atrial fibrosis into 2 distinct categories and attempted 
to determine how local fibrosis architecture alters conduc­
tion during a triggered event and the subsequent transition 
between sinus rhythm and AF. We have also been able to 
determine whether these conduction changes facilitate reen­
trant activity to initiate AF. Our findings suggest that long 
continuous strands of fibrosis, termed obstructive fibrosis, 
but not of nonobstructive diffuse fibrosis alter local conduc­
tion to facilitate the initiation and development of sustained 
atrial fibrillation, but only during a premature simulation.
Methods
We carried out animal studies in accordance with 
the Guide for the Care and Use o f Laboratory Animals,14 
under a protocol approved by the Institutional Animal Care 
and Use Committee of the University of Utah. All efforts 
were made to minimize suffering.
Experimental Preparation
Animals
Mixed breed goats (n =  6, 34 ±  5 kg) were implanted 
with pacemakers and chronic AF was induced with rapid 
atrial pacing (RAP). Control goats (n =  13, 37 ±  7 kg) were 
used for comparison and both groups underwent the same 
electrophysiological and histological study.
Pacemaker Implantation and Programming
Procedures for the pacemaker implantation and program­
ming have been described in detail previously.11 In brief, 
mixed breed goats were fasted 12-24 hours prior to surgery, 
anesthetized with propofol (5-8 mg/kg iv), and maintained 
with inhaled isoflurane dosed to effect (1.5-4%) in inspired 
oxygen. A subcutaneous pocket on the lateral neck was made, 
and a neurostimulator (Itrel 3 or InterStim, Medtronic, Min­
neapolis, MN, USA) was implanted to serve as a pacemaker.
A pacing lead (Medtronic) with active fixation was intro­
duced into the right atrium through a jugular vein. After 
at least a 1-week recovery period, pacemakers were pro­
grammed to stimulate continuously at 50 Hz with 1 second 
of stimulation followed by 1 second without stimulation at 
2-3 times the diastolic pacing threshold. Every 1-2 weeks, 
the ECG was recorded, the rhythm was evaluated, and the 
pacemaker turned off to determine if AF was sustained for a 
minimum of 20 minutes. Once AF was sustained, the pace­
maker was programmed to stimulate 1 second every minute 
to reinitiate AF if the heart spontaneously returned to sinus 
rhythm.
Terminal Study
An open-chest electrophysiological study was performed 
on control goats that were not paced and chronic AF goats 
(RAP 6 ±  1 months). Animals received unlimited water 
but no food for 12- 24 hours prior to the experiment. The
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goats were anesthetized with propofol (5-8 mg/kg iv), intu­
bated, and maintained with inhaled isoflurane dosed to effect 
(1.5-4%) in inspired O2 under positive pressure ventilation. 
An orogastric tube (S-50-HL, 1/2-in. inner diameter, 3/4-in. 
outer diameter, Tygon Tubing) was advanced into the rumen 
to evacuate gas and prevent bloat. A medial thoracotomy was 
preformed to expose the heart. Chronic AF goats had their 
pacemakers turned off; then they were defibrillated with 1-5 
50 J biphasic QRS synchronized shocks delivered with pad­
dles placed on either side of the atrium from a defibrillator. 
Electrophysiological measurements did not begin for at least 
10 minutes after cardioversion.
Electrical Mapping Procedure and Analysis
An electrode array consisting of 256 electrodes arranged 
in a 16-by-16 grid with uniform interelectrode spacing of
1 mm was placed on the LA appendage. The electrograms 
recorded from the electrodes were referenced to a remote 
electrode placed in the left hind leg. In addition to recording 
unipolar electrograms from the electrode plaque, an ECG, 
a ventricular electrogram, and a pacing signal were also 
simultaneously recorded. The ventricular electrogram was 
recorded with a single, ventricular hook electrode that was 
referenced to the left hind leg. All signals were band passed 
filtered between 0.3 and 500 Hz, had a gain of 100, were 
digitized at 12-bit resolution, and sampled at 8 KHz with a 
custom-built data acquisition system.
The electrophysiological study consisted of 3 pacing pro­
tocols. Monophasic stimuli were used for pacing and were 
produced using a custom build current controlled stimulator. 
In all the pacing protocols, stimulation pulses were applied 
to a pair of electrodes at the center of the plaque. The first 
protocol was a standard restitution protocol that consisted of 
a series of 10-, 400-millisecond S 1 pulses followed by a pre­
mature S2.15 The S2 cycle length was decremented from 350 
milliseconds by 10 milliseconds until loss of atrial capture. 
After loss of atrial capture at the 10-millisecond resolution, 
the S2 cycle length was increased by 5 milliseconds to de­
termine the AERP within 5 milliseconds. The last S2 pulse 
cycle length that caused atrial capture was considered the 
AERP. The pulse width for this protocol was 2 milliseconds 
at a current of twice the diastolic threshold, which was de­
termined as the minimum current for atrial capture at a cycle 
length of 400 milliseconds.
The second pacing protocol was a dynamic restitution 
protocol, which consisted of 30 SI stimuli for entrapment, 
followed by 15 seconds of continuous SI pacing.15 Atrial 
capture was determined after the entrapment period. The SI 
cycle length was decremented from 350 milliseconds by 10 
milliseconds until loss of atrial capture and the last SI pulse 
cycle length that caused atrial capture was considered the 
Sl-AERP.
The third protocol was an AF inducibility test, which con­
sisted of burst pacing the atrium at 50 Hz for 30-45 seconds 
at twice the diastolic pacing threshold. If AF persisted for up 
to 10 minutes it was considered sustained. The pulse width 
for this protocol was 0.5 milliseconds at a current of twice the 
diastolic threshold, which was determined as the minimum 
current for atrial capture at a cycle length o f400 milliseconds.
If any of the protocols induced AF, it was allowed to 
persist for at least 10 minutes to determine whether the ar­
rhythmia would self-terminate. If AF did not self-terminate
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Figure 1. Dividing mapped region into longitudinal and transverse prop­
agation direction. Mapped region divided into 2 transverse and 2 longitu­
dinal directions. An extra beat is considered either longitudinal or trans­
verse if it is within ±  45° (within dashed lines). Green box shows the 
histology sample to confirm that the longitudinal direction as determined 
with the isochrone map agrees with the myocardial fiber direction as de­
termined through histology. For a high quality, full color version of this 
figure, please see Journal o f Cardiovascular Electrophysiology’s website: 
www.wileyonlinelibrary.com/joumal/jce
after 10 minutes, the heart was defibrillated with one to five 
50 J biphasic QRS synchronized shocks delivered with pad­
dles placed on either side of the atrium from a defibrillator. 
Care was taken to ensure that the recording plaque did not 
move during defibrillation. Electrical recordings were then 
resumed after 10 minutes of sinus rhythm. Arrhythmias were 
classified as sustained AF, nonsustained AF, or extra beats. 
Sustained AF was AF lasting at least 10 minutes, nonsus­
tained AF was AF lasting from 5 s to 10 minutes, and short 
cycle length excitations lasting less than 5 seconds were clas­
sified as extra beats.
Differences between AF initiations were determined by 
examining the direction of propagation of extra beats across 
the mapping surface. Only the first extra beat after an S2 
was analyzed and the propagation direction spontaneously 
resulting from the S2 was determined as either longitudinal 
or transverse (within ±  45°) in relation to the generalized 
fiber orientation. The longitudinal direction was assessed 
by determining the direction of fastest conduction based on 
isochrone activation maps created during beats paced at 400- 
millisecond cycle lengths from the center of the mapped 
region and was verified with myocardial fiber orientation 
from histology (Fig. 1). The transverse fiber orientation was 
assumed to be 90 degrees from the longitudinal fiber orien­
tation, this assumed fiber direction agreed well with the fiber 
direction as determined through histology. Each animal was 
then grouped into 1 of 2 groups based on whether extra beats 
propagated primarily in the longitude or transverse directions 
across the recording plaque and a Fisher’s exact test was 
used to determine differences between the AF and control 
groups.
We measured conduction velocity transverse and longi­
tudinal to the generalized fiber orientation for an SI of 400 
milliseconds, and during an S2 of 160 milliseconds. Con­
duction velocity was quantified with a previously validated 
algorithm that can distinguish between transverse and lon­
gitudinal conduction.16 In brief, this algorithm creates an 
isochrone map based on the activation times from the elec­
trograms on the plaque. Activations were taken as the local 
minima of the first temporal derivative of the unipolar atrial 
electrograms. Conduction velocity was calculated by select­
ing 15-25 activation times within a region of the plaque. 
Each activation time point contained x and y spatial informa­
tion that corresponded to the relative distances between the 
electrodes. From the temporal (activation times) and spatial 
information (distance between points), a conduction velocity 
was determined by using a least square fitting of the time 
and space information to a plane. The conduction velocity 
and angle of propagation were determined from the fitted 
parameters as described previously.16,17 By this method, 2 
transverse and longitudinal conduction velocities were found 
for each isochrone activation map. For each animal, an aver­
aged longitudinal and transverse conduction velocity for both
Sl-400 milliseconds and S2-160 milliseconds, respectively, 
were found by averaging the results from 2 to 3 activation 
maps. An anisotropy ratio was calculated from these conduc­
tion velocities, which is the ratio of longitudinal to transverse 
conduction velocity. A higher anisotropy ratio indicates more 
anisotropy and a value of 1 indicates isotropic conduction.
Histological Data Acquisition and Analysis
After the electrophysiological study the heart was excised 
and the LA region that contained the high-density recording 
plaque was removed and placed in a 10% buffered formalin 
solution. All 6 AF goats and a randomly selected 6 of the 
control goats had histological tissue samples stained with 
Masson’s trichrome after a 1-month fixation period and eval­
uated for fibrosis. Histology was sectioned parallel to the 
epicardium at a depth of 500 fim  below the epicardium with 
a thickness of 4 /xm. Images from the samples were im­
ported into ImageJ software (National Institutes of Health) 
for fibrosis quantification. The images were segmented into 
3 color groups: red for myocytes, blue for collagen/fibrosis, 
and white for nonfibrotic extracellular content. Each color 
was manually sampled 7-12 times per image, after which 
a hidden Markov model was used to automatically segment 
the entire image into the 3 colors. The hidden Markov model 
outputs the total percentage for each color in the image and 
the percentage of blue served to estimate the total amount of 
fibrosis in the tissue sample. The percent fibrosis was then 
compared with both longitudinal and transverse conduction 
velocity.
Atrial fibrosis was further quantified and to 2 groups, 
nonobstructive and obstructive fibrosis. Obstructive fibrosis 
was considered fibrosis that was at least the length of a my­
ocyte (100 /Lim), thus potentially disrupting transverse cell 
to cell conduction. Nonobstructive fibrosis was fibrosis that 
was less than 100 fim. This classification was done by exam­
ining the maximum length of fibrosis strands in the histology 
images using a custom MATLAB program. In brief, this pro­
gram imported the segmented ImageJ images, which were 
segmented into blue, white, and red. These images were then 
converted into a binary image where the blue was a value
78
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Figure 2. Determining obstructive fibrosis. A and B: Raw histology from 
a control and AF animal. C and D: ImageJ 3 color segmentation. Red 
indicates myocytes, blue indicates fibrosis/collagen, and white indicates 
nonfibrotic extracellular content. E and F: Binary image with white showing 
fibrosis. The white fibrosis has been binary dilated by 5 pixels (2.52 um). 
Yellow has been overlaid onto fibrosis strands that are greater than 100 
fim in length, which is considered obstructive fibrosis. E has 4 fibrotic 
groups and F has 8 fibrotic groups that met the 100 fjum threshold to be 
considered obstructive fibrosis. For a high quality, full color version o f this 
figure, please see Journal of Cardiovascular Electrophysiology’s website: 
www.wileyonlinelibrary.com/joumal/jce
of 1 and the red/white had a value of 0. A binary dilate 
of 5 pixels, 2.52 fim, was then applied to the binary im­
age. An 8 neighbor connected components analysis from 
the MATLAB image processing toolkit was then applied 
to the binary image to find regions of continuous fibrosis. 
The maximum distance of each fibrotic connected compo­
nent for each image was then computed. Strands greater 
than 100 /xm were considered obstructive fibrosis since they 
could disrupt an entire cell’s transverse conduction. Figure
2 shows an example of how obstructive fibrosis was quanti­
fied. The local fibrosis densities and architecture of fibrosis 
in our histological samples were compared with local con­
duction data, as determined through the electrical mapping 
studies.
Statistical Analysis
Differences in AERP and Sl-AERP between control and 
chronic AF goats were examined with unpaired f-tests. Dif­
ferences between initiation of sustained AF, nonsustained 
AF, and extra beats between the control and AF groups were 
determined with a Fisher’s exact test. Extra beat propaga­
tion direction between the control and chronic AF goats 
was examined with a Fisher’s exact test. Differences be­
tween conduction velocity (average transverse and average 
longitudinal) between the AF and control groups were de­
termined with an unpaired f-test at both 400-millisecond and 
the 160-millisecond cycle length. Differences in percent fi­
brosis between the AF and control groups were determined 
with an unpaired f-test. Differences in the anisotropy ratio 
between the AF and control groups were determined with 
an unpaired /-test. Differences in the number of obstructive 
fibrotic strands per square mm between the AF and control 
groups were determined with an unpaired f-test. Differences 
in the density of fibrosis predicting the direction of slowest 
conduction between the AF and control groups were deter­
mined using a 1-sided chi-square. Statistical tests in which
Figure 3. Example of extra beat propagation direction of chronic AF vs. 
control. A: An atrial electrogram that shows the initiation of extra beats fol­
lowing the S2 pacing pulse. The first extra beat at the initiation o f extra beats 
was examined to determine its propagation across the recording plaque. B: 
The SI column shows isochrone activation maps after an SI pacing pulse, 
which was used to determine fiber orientation. The extra beat column shows 
isochrone activation maps o f an extra beat following an S2-induced beat. 
The arrow shows the direction o f extra beat propagation. For a high qual­
ity, full color version of this figure, please see Journal of Cardiovascular 
Electrophysiology’s website: www.wileyonlinelibrary.com/joumal/jce
Results 
AERP and AF Inducibility
AF was persistent in all RAP goats prior to the electro- 
physiological procedure. In 2/6 of these chronic AF goats, AF 
could not be cardioverted to sinus rhythm and the protocol 
could not be completed. There was a significant shortening of 
AERP (controls: 147 ±  21 milliseconds vs. chronic AF: 118 
±  23 milliseconds, P <  0.05) but not the Sl-AERP (controls: 
180 ±  53 milliseconds vs. chronic AF: 169 ±  15 millisec­
onds, P >  0.05) in the chronic AF goats as compared to the 
controls. The RAP goats had sustained AF more often than 
those in the control group; however, there was no significant 
difference in frequency of nonsustained AF or extra beats. 
All 6 of the chronic AF goats had sustained AF whereas 2/13 
of the control goats showed sustained AF during the elec- 
trophysiological study. Nonsustained AF occurred in 9/13 
of the control goats. A total of 20 extra beats following the 
S2 pacing pulse were observed in 6/13 of the control goats. 
Extra beats (n =  22) were observed in 4/6 of the AF goats. 
The 2 chronic AF goats that did not have extra beats could 
not be defibrillated; therefore, the S1-S2 protocols could 
not be performed on these animals. The extra beats in the 
hearts of the control goats propagated longitudinally along 
the fiber (19/20 beats), with 6/6 of the goats having extra 
beats that propagated primarily in the longitude direction. In 
the AF goats, the extra beats propagated transversely to the 
fiber orientation (14/22 beats), with 3/4 of the goats having 
extra beats that propagated primarily in the transverse direc-
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TABLE 1
Summary of AF Inducibility
Control Data AFData
Goat Number Sustained AF NonSustained AF Extra Beats Goat Number Sustained AF NonSustained AF Extra Beats
1 No No No 1 Yes Yes Yes
2 Yes Yes Yes 2 Yes Yes Yes
3 No No No 3 Yes Yes Yes
4 No Yes No 4 Yes Yes Yes
5 No Yes Yes 5 Yes No* No*
6 No Yes Yes 6 Yes No* No*
7 Yes Yes Yes Totals 6/6 4/4 4/4
8 No No No
9 No Yes Yes
10 No Yes Yes
11 No Yes No
12 No No No
13 No No No
Totals 2/13 8/13 6/13
AF =  atrial fibrillation.
’Animals could not be defibrillated.
direction of the AF goats compared to the controls. Table 1 
summarizes AF inducibility.
Conduction Velocity
Conduction velocity of the AF goats was significantly 
slowed compared to the control goats in the transverse direc­
tion (0.40 ±  0.04 m/s vs. 0.53 ±  0.15 m/s, P <0.05) but not 
in the longitudinal direction (0.70 ±  0.27 m/s vs. 0.76 ±0.18  
m/s) following a premature atrial contraction, caused by an
S2-160 milliseconds. There was no significance difference in 
either transverse (0.63 ±  0.14 vs.0.58 ±  0.19 m/s) or longi­
tudinal conduction (0.96 ±  0.21 m/s vs. 0.87 ±  0.18 m/s) at 
an SI o f400 milliseconds between the AF and control goats. 
Figure 4 shows examples of transverse slowing in the AF 
goats as compared to the controls following S2 stimulation. 
Figure 5 shows an example of the initiation of extra beats 
and AF when the conduction velocity restitution becomes 
steep. Figure 5C shows an increase in the anisotropy for the 
AF animals as the coupling interval decreases. There was no 
significance difference in anisotropy ratio at an SI of 400 
milliseconds (1.55 ±  0.42 vs. 1.57 ±  0.33) or an S2 of 160 
milliseconds (1.72 ±  0.55 vs. 1.47 ±  0.25) between the AF 
and control animals.
Histology Analysis
The AF goats had a higher density of fibrosis as compared 
to controls (5.2 ±  0.7% vs. 3.5 ±  1.0%, P <0.05) and more 
diverse fibrosis architecture. The AF animals had more ob­
structive fibrosis than the controls (17.5 ±  8.0 fibers/mm2 
vs. 8.6 ±  3.0 fibers/mm2, P <0.05). The control group had 
more nonobstructive, diffuse fibrosis than the AF animals 
(1109.3 ±  308.5 fibers/ mm2 vs. 718.1 ±  380.0 fibers/mm2, 
P =  0.07, N.S.) however, the result did not meet significance. 
The organization of this obstructive fibrosis was in strands 
that were located primary parallel to myocyte bundles, po­
tentially interrupting transverse connections between cells. 
Figure 6 shows specific examples of the different fibrosis 
architectures in chronic AF and control animals.
The density of fibrosis in the chronic AF goats, but not 
the controls, predicted the direction of slowest conduction. 
Fibrosis density was analyzed in both the longitudinal and
Figure 4. Examples o f transverse conduction slowing during a premature 
stimulus. Examples from 2 AF animals and 2 control animals are shown. 
Activation maps were created from an S2 stimulation at 160 milliseconds. 
The white dashed lines indicate the generalized fiber direction as determined 
from SI pacing and confirmed with histology. The 2 activation maps from 
the chronic AF group show that the transverse conduction was greatly 
slowed compared to the controls as a result o f a premature. This finding was 
consistent across all the AF animals. For a high quality, full color version 
of this figure, please see Journal of Cardiovascular Electrophysiology’s 
website: www.wileyonlinelibrary.com/joumal/jce
transverse directions. These densities were then compared 
to the conduction velocities in these regions (Fig. 7). In 3/4 
of the AF animals, the direction of highest fibrosis density 
predicted the direction of slowest conduction. In 1/6 of the 
control animals the direction of highest fibrosis predicted the 
direction of slowest conduction (P < 0.05 for AF vs. control).
Discussion
The major findings of this study are as follows: (1) AERP 
was significantly reduced as a result of chronic AF but 
SI-AERP is not. (2) Conduction velocity was significantly
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Figure 5. Examples o f conduction velocity restitution. A: Longitudinal conduction velocity restitution curve for a control and chronic AF animal. B: 
Transverse conduction velocity restitution curve for a control and chronic AF animal. C: Anisotropy ratio restitution curve for a control and chronic AF 
animals. Extra beats are indicated with a * and sustained AF is indicated with a #. The control and AF animals began initiated extra beats when restitution 
started to become steep at an S2 o f 140 milliseconds and 160 milliseconds, respectively. When the S2 coupling interval was further reduced the chronic AF 
animal initiated sustained AF at an S2 o f 140 milliseconds. Both chronic AF and controls had nonlinear restitution curves as the coupling interval reduced; 
however, in the chronic AF animals the anisotropy ratio increased, whereas in the controls it saw little change.
Figure 6. Architecture o f fibrosis is more diverse in chronic AF as compared 
to control. The control groups had low levels o f diffuse fibrosis (location 1) 
with few strands of obstructive fibrosis. The chronic AF group had regions 
o f myocardium with obstructive fibrosis (location 2 and location 3) that are 
indicated by the long, compact groups offibrotic strands located primarily 
along the generalized longitudinal cell direction. Examples o f obstructive fi­
brosis are shown with arrows in location 2 and is circled at location 3. For a 
high quality, full color version of this figure, please see Journal ofCardiovas­
cular Electrophysiology’s website: www.wileyonlinelibrary.com/joumal/jce
slower in chronic AF, but only in the transverse direction fol­
lowing a premature atrial contraction, indicating that there is 
functional slowing in chronic AF but only at short coupling 
intervals. (3) Extra beats in chronic AF propagated across 
the mapping region via transverse conduction; however, in 
the controls the extra beats propagated across the mapping 
region via longitudinal conduction. (4) Chronic AF goats 
developed diverse structures of fibrosis (i.e., obstructive fi­
brosis) that were less common in controls, and this difference 
was quantitatively defined.
The AERP values we obtained (controls: 147 ±  21 mil­
liseconds and chronic AF: 118 ±  23 milliseconds) agree with 
a study by Schotten et al. that showed that after 5 days of RAP 
the LA AERP decreased from a baseline of 132 ±  19 millisec­
onds to 72 ±  7 milliseconds.9 The AERP relates to fibrillation 
initiation and maintenance through restitution. The restitu­
tion hypothesis states that an action potential duration resti­
tution slope of > 1 alterations between short and long APD, 
or altemans, can occur.15,18,19 Alterations in action potential 
durations will cause heterogeneity in repolarization gradients 
and may result in unidirectional conduction block, which can 
initiate spiral wave reentry.15'20"22 Our data also support the 
finding that the initiation of extra beats and AF occurs when 
the conduction velocity restitution curve became steep. The 
atrial myocardium of our chronic AF animals could capture 
at shorter cycle lengths as compared to the controls. This 
indicates that hearts experiencing chronic AF can, at least
transiently, support more rapid activations, which could lead 
to alterations in APD, thus causing a greater chance of AF 
initiation. The S1-AERP, obtained from a dynamic restitution 
protocol, did not show any differences between the AF and 
control groups. The main difference between dynamic and 
standard restitution protocols is that dynamic restitution takes 
into account cardiac memory,19,23 a mechanism in which de­
lays in ionic currents, such as calcium and potassium, with 
slow enough recovery kinetics can accumulate over several 
cycles. Another possible mechanism is that rapid pacing can 
induce changes in gene expression 23 During the S 1-AERP 
protocol the myocardium was in a steady state due to the 
uniform pacing. Cardiac memory may have a more primary 
role in determining AERP during uniform activations (steady 
state) than any structural/functional remodeling as a result of 
AF. However, the S2 (nonsteady state)-AERP did show a dif­
ference, suggesting that the structural/functional remodeling 
as a result of AF does have a major role in determining AERP 
after a premature atrial contraction. This supports Kawara 
et al., ’s findings that suggested that conduction slowed as a 
result of a premature stimulus but not at slower pacing cycle 
lengths.24
AF is also known to alter cardiac conduction anisotropy, 
which under normal conditions arises because conduction 
velocity is faster along the direction longitudinal to the my­
ocytes compared to transverse. This anisotropic condition is 
due to both fiber orientation of the myocytes and the higher 
density of gap junction connecting the cells in the longitudi­
nal direction. Verheule et al. also showed that atrial fibrosis 
causes further conduction anisotropy in the longitudinal vs. 
transverse directions.7 Our results agree with the finding that 
conduction anisotropy increases during atrial remodeling but 
only after a premature stimulus. This finding agrees with 
those from Kawara et al., who suggest that in the ventricles, 
fibrosis only causes transverse conduction slowing follow­
ing a premature stimulation.24 Their explanation was that 
the long strands found in stringy fibrosis cause slowing of 
conduction. Our results demonstrate that AF-induced fibro­
sis shares similar effects to what has been shown previously 
only in ventricular preparations with extensive fibrosis.
Extra beats in chronic AF propagated across the mapping 
region via transverse conduction; however, in the controls the 
extra beats propagated across the mapping region via longi­
tudinal conduction. This finding was observed by Kawara 
et al. in which they found that large patches of what they 
called patchy fibrosis could block longitudinal conduction,
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Figure 7. Fibrosis densities and conduc­
tion slowing. (A) The chronic AF ani­
mals had increased longitudinal conduc­
tion velocity with increased fibrosis at an 
S2 of 160 milliseconds (correlation P =
0.02) but not at SI o f 400 milliseconds 
(P = 0.43). (B) The chronic AF animals 
had no correlation with fibrosis densities 
and transverse conduction velocity at an 
S2 of 160 milliseconds or SI o f400 mil­
liseconds, but was trending towards sig­
nificance (P= 0.12 andO.IO). (C) Control 
animals had no correlation with longitu­
dinal conduction velocity at an S2 o f 160 
milliseconds or SI o f 400 milliseconds 
(P =  0.93 and 0.75). (D) Control ani­
mals had no correlation with transverse 
conduction velocity at an S2 of 160 mil­
liseconds or SI o f400 milliseconds (P =
0.67 and 0.72).
thus causing conduction transverse to fiber orientation. There 
may be large patches of fibrosis outside the mapped region 
in the AF animals that cause this shift in longitudinal to 
transverse conduction.
There was more fibrosis in the chronic AF animals than 
in the control goats but, more importantly, the fibrosis ar­
chitecture was different. The AF goats had more obstructive 
fibrosis and less nonobstructive fibrosis than the controls, 
which demonstrates a difference in the structure of the fibro­
sis. As AF develops, the strands of fibrosis that are nonob­
structive may start to connect, forming obstructive fibrosis 
that may slow or even block transverse conduction. The orga­
nization of this obstructive fibrosis was in strands that were 
located primary along cells, potentially interrupting trans­
verse connections between cells. This obstructive fibrosis ar­
chitecture is similar to interstitial fibrosis, which has been de­
scribed to appear in intermuscular spaces previously devoid 
of collagen.25 Krul et al. classified LA appendage fibrosis 
and related the fibrosis to conduction properties in humans. 
They found that regions of thick interstitial collagen were as­
sociated with increased longitudinal conduction velocity and 
transverse activation delay.26 These long strands of fibrosis 
located parallel to the myocytes may expand the distance be­
tween neighboring cells, reduce the electric conductance, and 
explain why the transverse conduction velocity was slowed 
while longitudinal was not.7,27,28 Our results are similar to the 
findings of Krul et al. in humans for transverse conduction 
slowing. Although we did not observe a significant increase 
in longitudinal conduction velocity as was found by Krul 
et al., we did observe the correlation between increased longi­
tudinal conduction velocities with increased levels of fibrosis, 
which is similar to what they showed in left atrial appendage 
samples with thick collagen strands. The increase in longi­
tudinal conduction velocity with increased fibrosis may also 
be explained due to the structure of the fibrosis. The fibrosis 
appears to be deposited parallel to myocytes, thus obstructing 
the transverse conduction, and potentially causing a source- 
sink mismatch. This source-sink mismatch may not only 
slow transverse conduction, but may also shunt conduction
along the longitudinal direction, thus increasing longitudi­
nal conduction velocity. This may explain why many studies 
show an increase in conduction anisotropy following devel­
opment of fibrosis in animal models of AF7 as well as in 
human ventricular tissue24 and human atrial tissue.28
The chronic AF goats had higher incidence of sustained 
AF than the control goats, which may be the result of slowed 
conduction in the AF animals. Conduction in the AF animals 
slowed because of 2 mechanisms. First, conduction slowed 
transverse to fiber orientation only during short cycle lengths, 
which could result from a premature atrial contraction or due 
to the rapid activation rate that is present during AF. The sec­
ond mechanism of conduction slowing that we observed was 
that extra beats propagated transversely to fiber orientation, 
instead of longitudinally, during AF. Under normal physio­
logical conditions this directional variance alone would slow 
conduction due to conduction anisotropy. However, in the 
chronic AF animals this slowing was even further exagger­
ated, which would result in more AF susceptibility due to 2 
mechanisms. The first, more classical method is that slowed 
conduction would result in more possible pathways for reen­
try due to the decreased wave length (wavelength =  conduc­
tion velocity x APD). For reentry to occur the wavelength 
must be shorter than the reentrant path. Therefore a smaller 
wavelength will allow for more possible reentrant pathways 
and make AF more likely to be initiated and sustained.29,30 
The second mechanism of slowed conduction velocity in­
creasing AF susceptibility is due to an increase in rotor sta­
bility. Rotors circulate around an unexcitable center known 
as a singularity point.23 For the singularity to remain unex­
citable, and for the rotor to be sustained, the cardiac tissue 
must have a so-called source-sink mismatch, which results 
in slowed conduction velocity and a steep curvature around 
the singularity point.21"23 Debate continues as to whether 
or not calculating wavelengths has relevance to explaining 
reentry and fibrillation due to antiarrhythmic drugs that de­
crease conduction velocity yet still terminate AF.31 Slowed 
conduction has been shown in patients with paroxysmal AF, 
suggesting that it may be critical to sustaining AF,32,33 and
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this may occur either by the classical view of decreasing 
wavelengths, or the more modem view of setting up steep 
curvature for rotors.21,22,30
There was no statistical difference in conduction velocity 
at slow cycle lengths and in Sl-AERP between the AF 
and control goats, indicating that during normal physio­
logical conditions, such as sinus rhythm, the AF affected 
myocardium and the control myocardium exhibit similar 
conduction. However, once a premature atrial contraction 
occurs, the AF cardiac substrate affects the local conduction 
differently than the non-AF substrate. Such a response 
suggests that the AF fibrosis may produce a substrate 
that has little effect during sinus rhythm, but following a 
premature atrial contraction may display the conduction 
slowing that could lead to reentry and AF.
Clinical Implications
The clinical relevance of these findings is that reentrant 
activity observed in patients with chronic AF may be a 
result from 2 separate but necessary components. First, 
reentry is more likely to occur due to slowed conduction that 
occurs only due to premature contractions. This has been 
shown in human data, which found that AF could initiate 
via spiral wave reentry at sites of dynamic conduction 
slowing.34 Therefore, patients who have more premature 
atrial contractions or increased activity of focal sources 
will be more likely to cause this functional slowing as a 
result of the short coupling interval to initiate and sustain 
AF. The second component is the architecture of fibrosis. 
We observed obstructive fibrosis that significantly slowed 
transverse conduction. Markides et al. reported that patients 
with paroxysmal AF have an abnormal atrial substrate with 
regions of slowed conduction, specifically where there is 
an abrupt change in subendocardial fiber orientation, and 
under certain pacing parameters these regions of conduction 
slowing could cause block.33 If patients have substantial ob­
structive fibrosis, it will make these regions of abrupt changes 
in fiber orientation more susceptible to conduction block, 
thus increasing the likelihood of AF. These findings suggest 
that both a tendency of frequent premature contractions and 
specific fibrosis architecture are required for development of 
sustained AF.
Limitations
This study was limited to AF developed through rapid 
atrial pacing without the presence of any existing heart dis­
ease. Although such a scenario may apply to some of the 
human patient population, more often AF is accompanied by 
some form of heart disease that may induce substrate changes 
in the atrium. In addition, this study was performed in goats 
and, although goat and human hearts are of roughly similar 
size, there may be meaningful differences in electrophysi­
ology. Hence, the results of these findings may not directly 
translate to humans. In spite of these limitations, the chronic 
rapid atrial paced AF goat model is widely used and well 
accepted for studying AF.6"8,11 Another limitation is we took 
only a 4 um thick sample of histology 500 /zm from the 
epicaridal surface to determine a generalized fiber direction.
A remodeled atrium has very complicated atrial structure 
including a dissociation of epicardium and endocardium.6,7 
Therefore, we used a generalized fiber direction in our clas-
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sifications and electrophysiological measurements. Our his­
tology measurements included determination of fibrosis but 
no measure of alternation within the gap junctions. Sev­
eral studies have shown that gap junctional remodeling dur­
ing AF may lead to conduction slowing.4,35 A final limita­
tion is that only a region of the left atrial appendage was 
mapped and our findings may not translate to the rest of the 
atrium. We made electrophysiological measurements on the 
left atrial appendage because our mapping protocol required 
a large continuous surface to calculate accurate conduction 
velocities.
Conclusion
Structural and electrophysiological remodeling in chronic 
AF leads to extra beat propagation and conduction veloc­
ity slowing transverse to fiber orientation. These 2 mech­
anisms combine to decrease global conduction velocity, to 
decrease the cardiac wavelength, and to increase the likeli­
hood of reentry. This sequence may lead to more extra beats 
and the establishment of stable reentry in tissue with struc­
tural and electrical remodeling. The major histological dif­
ference between chronic AF and control hearts is the amount 
and architecture of the fibrosis. Histology from goats with a 
history of chronic AF had much more obstructive fibrosis, 
which may lead to the conduction slowing and alteration in 
conduction pathways to make the tissue more susceptible 
to AF.
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CHAPTER 7
RELATIONSHIP BETWEEN REGIONS OF 
HIGH-FREQUENCY ACTIVATION AND 
FIBROSIS FOLLOWING CHRONIC 
ATRIAL FIBRILLATION
This study determined the relationship between fibrosis and AF maintenance. As AF 
persists, single episodes of AF last longer before the patient transitions into sinus rhythm. 
In some cases, AF can become permanent. The second study examined how patients who 
are prone to AF transition into this arrhythmia from sinus rhythm, and the third project 
examines why some patients may never transition from AF to sinus rhythm. Specifically, 
this project examines the relationship between fibrosis and the drivers of AF. Fibrosis was 
found to anchor rapid activations within the LA, and removing these driving sites may 
improve treatment outcomes.
7.1 Introduction
Atrial Fibrillation (AF) is the most common cardiac arrhythmia. AF patients experience 
significant increases in morbidity and mortality and are at increased risk for strokes [187]. 
Radiofrequency ablation is routinely used to treat AF and even though it is the most 
successful treatment strategy the recurrence rate continues to be very high at 40-60% [188].
Typically, AF starts as brief, self-terminating episodes (paroxysmal AF) with gradual 
increase in AF burden, ultimately lasting long periods of time and becoming persistent [189]. 
The pulmonary veins are known triggers for paroxysmal AF, and isolation of these triggers 
from the rest of the atrium through ablation can successfully treat paroxysmal AF [190]. 
However, pulmonary vein isolation often results in poor long-term success for patients with 
persistent AF [161]. Structural remodeling that occurs due to AF may lead to regions in 
the atria, outside the pulmonary veins, that can drive AF [57]. Focal impulse and rotor 
modification (FIRM)-guided ablation has shown some success in treating persistent AF by
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locating and ablating these driving sites [36]. However, the stability of these sites over 
prolonged recording periods remains controversial, and it is not clear if there is a structural 
component to the cardiac substrate that may, at least transiently, stabilize rapid foci or 
reentrant activity to a location.
Myocardial fibrosis is a well-established marker of adverse structural remodeling in a 
variety of heart diseases, including AF [24]. Higher levels of fibrosis, as determined by 
late gadolinium enhancement magnetic resonance imaging (LGE-MRI) prior to an ablation 
has been linked to poorer ablation outcomes [137]. MRI, specifically postcontrast T1- 
Mapping MRI, is one of the few validated noninvasive methods for determining cardiac 
fibrosis [191]. We tested the hypothesis that regions of the atria with significant fibrotic 
structural remodeling anchor rapid focal or reentrant activity which drive AF and that 
cardiac T1-mapping MRI can noninvasively locate these sites.
7.2 Methods
All animals were managed in accordance with the Guide for the Care and Use of 
Laboratory Animals, and the protocol was approved by the Institutional Animal Care and 
Use Committee of the University of Utah.
7.2.1  E xp erim en ta l P rep aration
Animal Model: Mongrel dogs (n= 12) weighing 25-35 kg were used for this study. 
Neurostimulators were implanted in 6 of the dogs and chronic AF was induced with rapid 
atrial pacing (RAP). The other 6 dogs were used as controls for the electrophysiological 
study and were not evaluated with MRI.
7.2.2  M R I S tu d y
In 5/6 of the chronic AF dogs, the cardiac substrate was evaluated with high-resolution, 
whole-heart T1-Mapping MRI at baseline, before the RAP began. In one animal, pacing 
was started before a baseline MRI was acquired. All of the chronic AF dogs were again 
evaluated with whole-heart T1-Mapping MRI after 183 months of AF and 1-3 weeks prior 
to a detailed electrophysiological study.
7 .2 .3  E lectrop h ysio log ica l S tu d y
A detailed electrophysiological (EP) study was done in both the controls and in the 
chronic AF animals. For the chronic AF animals the EP study was done 1-3 weeks after 
whole-heart T1-mapping.
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For the chronic AF animals, an electrical anatomical map (EAM) of the left atrium 
(LA) was made and was merged with the Corview segmentations of Tl-Mapping MRI using 
the EnSite mapping systems fusion application. The Corview segmentation contained the 
LA wall and the regions of fibrosis as determined by Tl-Mapping MRI. A 64-pole basket 
catheter (Constellation, Boston Scientific Corp, Natick, MA, USA) was then placed into the 
LA. The size of the basket catheter was 38 mm for the controls and 48 mm for chronic AF. 
The MRI segmentation and basket placement within the fused geometry is shown in Fig. 
7.1. An ECG and endocardial unipolar electrograms from the 64 electrodes of the basket 
catheter were recorded for up to 30 minutes of AF. AF was induced in the controls with 
30 seconds of 50 Hz burst pacing at 5 mA from a quad catheter placed in the right atrium. 
If AF was not induced or sustained less than 30 minutes in the controls, burst pacing was 
reapplied with a maximum of five attempts.
The ECG and unipolar electrograms were evaluated in the time and frequency domain to 
determine whether specific regions of the LA had stable regions of high dominant frequency 
(DF). The ECG and unipolar electrograms were sampled at 4096 Hz with 24-bit resolution 
with an Active Two mapping system (Active Two System, Biosemi, Inc, Amsterdam, 
Netherlands). Far-field ventricular activity was reduced using a well-documented QRS 
subtraction algorithm [88]. The QRS-subtracted unipolar signals were then analyzed with 
DF spectral analysis. High-DF sites were determined as the highest 10% DF sites for each 
minute of AF, and had to be at least 1 Hz higher than the average of the DF from the 
rest of the LA. The high-DF sites for each minute of AF were placed in a spatial map of 
probability to determine stability of the sites during the 30 min AF episode. Stable sites 
of high-DF were determined as an electrode site with 75% or higher stability over the time 
course of the AF episode.
The sites of stable high-DF activation organization were quantified using a regularity 
index (reg-idx). The reg-idx was computed for each channel and then averaged among the 
stable high-DF sites and among the other electrodes within the LA for each animal.
The sites of stable high-DF were directly compared with the sites of Tl-Mapping MRI 
determined fibrosis by exporting the electrode location’s position with reference to the 
Tl-Mapping MRI segmentation in the chronic AF animals. Each electrode was projected 
onto the closest location on the LA wall segmentation using a linear least squares approach. 
Each position on the LA wall was assigned a binary value of whether it is a region of 
healthy or fibrotic tissue, where fibrotic tissue corresponded to the lowest 10% T1 values 
within the entire LA wall. Every stable high-DF site for each animal was then classified 
as either on border zones of fibrosis or in regions of healthy tissue. Border zones were
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Fig. 7.1: D eterm in ing  regions of fibrosis using T 1-M apping  M R I. A) One axial 
slice from a series of 52 slices of the T1 Map. LA blood pool segmentation is in green. B) 
LA wall segmentation, shown in grey, and the lowest 10% T1 values in blue from the T1 map 
slice in A). C) 3D segmentation of LA wall and lowest 10% T1 values. This segmentation is 
imported into the EnSite mapping system for merge with the geometric shell created from a 
mapping catheter. D) Basket catheter shown in segmentation merged with EnSite created 
EAM of the LA. Grey is the LA wall and the blue are the regions of lowest 10% of T1 value.
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determined as electrode locations on or within 2 mm of fibrosis. For each chronic AF animal 
a percent of the number of stable high-DF sites on the border zones was then computed. 
The average distance between the stable high-DF sites and closed region of dense fibrosis 
was also computed.
7.2 .4  H isto logy
Histological tissue samples stained with Massons trichrome were collected from 4/6 of the 
chronic AF animals after the animals were sacrificed. Multiple tissue samples were collected 
from regions of T1-Mapping MRI-determined fibrosis and from nonfibrotic areas of the LA. 
Images from the samples were imported into ImageJ software (National Institutes of Health) 
for fibrosis quantification. For each animal the percent fibrosis was averaged among tissue 
samples obtained from fibrotic regions as well as nonfibrotic areas of the LA.
7.2.5  S ta tistica l A nalysis
Paired t-test was used to analyzed continuous variables (T1 relaxation time, amount of 
fibrosis from histology, DF, and reg-idx) A chi-square test was used to determine whether 
regions of stable high-DF were observed in the fibrotic border zones more often than in 
nonfibrotic zones. The expected value was the percent of the electrodes that were within 2 
mm of fibrosis. Results were considered significant at p<0.05.
7.3 Results
As AF progresses, it resulted in significantly lower T1 relaxation time (Baseline: 593±41 
ms vs. Chronic AF: 463±79 ms, p<0.05). In the chronic AF animals, the regions of lowest 
10% T1 values had an average T1 time of 283±32 ms, and these regions were in patches and 
not diffuse throughout the LA wall for all of the chronic AF animals. Histology confirmed 
that regions of T1-Mapping MRI-detected fibrosis had higher fibrosis densities (Fig. 7.2) 
as compared to other LA regions. (20.0±1.1% vs. 11.5±2.3%, p<0.05) (Fig. 7.3).
All of the chronic AF animals could sustain AF for the full 30 minutes, whereas none of 
the controls could. One of the controls sustained AF for 14 minutes and another two had 
AF sustain less than 1 minute. In the other 3/6 of the controls no AF was induced. In 
the one control that sustained AF for the 14 minutes, there were no stable high-DF sites 
(Fig. 7.4). The chronic AF animals had at least one site of stable, high-DF for at least 22.5 
(75%) of 30 minutes of AF. The mean DF was 8.5±1.2 Hz and the stable high-DF sites had 
a mean DF of 10.3±1.1 Hz (p<0.05). The DF value for the stable sites sometimes varied by 
as much as 1 Hz throughout the 30 minute AF episode, however, these sites still remained
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Fig. 7.2: T 1-M apping  m agnetic  resonance im aging and  histological correlation .
A ) Segmented left atrial geometric shell with gray showing healthy myocardium and blue 
showing the regions with the lowest 10% T1 values, indicating fibrotic areas. B) Massons 
Trichrome staining from yellow circle shown in A), indicating a fibrotic region. C) Massons 
Trichrome staining from red circle in A) indicating a nonfibrotic region.
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Fig. 7.3: T l-M ap p in g  M R I-d e tec ted  F ibrosis agrees w ith  H istology. A) Decrease 
in T1 times following chronic AF. B) Regions of fibrosis as detected by T1-Mapping MRI 
have increased fibrosis as determined by histology. Lower T1 times corresponds to more 
fibrosis.
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Fig. 7.4: E xam ple of nonstab le  h igh-D F sites in left a tr iu m  w ith ou t a  h is to ry  of
A F. Example of the spatial instability of high-DF sites in a control animal that maintained 
AF for 14 minutes. X axis shows the spline numbers A-H and Y axis show electrode numbers 
on the corresponding spline. Each electrode site contains the incidence that it had a DF 
value within the top 10% over the AF episode. DF values for 3 locations, labeled 1-3, are 
shown over the time course of a 30 min AF episode.
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higher than other nearby locations (Fig. 7.5). In all the animals, the DF value from the 
stable sites agreed well with the activation rate of the tissue (Fig. 7.6).
The reg-idx at the high-DF sites in the chronic AF animals was significantly less than the 
reg-idx at other locations within the LA (0.25±0.06 vs. 0.31±0.04, p<0.05). This indicates 
that the sites of high-DF also have a more regular cycle length, thus are more organized. 
An example of the regularity of activations at a high-DF site vs. another location in the 
LA is shown in Fig. 7.7.
In the chronic AF animals, 82% of stable high-DF bordered regions of fibrosis as 
determined by T1-Mapping MRI (Fig. 7.8). The average distance of the stable high-DF 
sites to the closest region of dense fibrosis was 1.4±1.2 mm. Although the fibrotic border 
zones consisted of a large region of the basket-mapping field in some animals, this was 
primarily due to the constraint that if a basket could be placed in multiple locations, the 
location with the highest DF was used for the analysis. Fibrosis was defined as regions of 
the LA wall with the lowest 10% of T1 values, therefore at most the fibrotic regions would 
occupy 10% of the entire LA.
7.4 Discussion
The major findings of this study are as follows: 1) High-resolution T1-Mapping MRI 
can determine LA wall areas with dense fibrosis. 2) During chronic AF, but not in controls, 
there are specific regions within the LA that have stable sites of high-DF over a prolonged 
recording period. 3) These sites of stable high-DF have more regular activity than other sites 
in the LA. 4) The sites of stable high-DF anchor to the border of dense fibrotic regions.
Whole-heart T1-Mapping MRI can noninvasively detect regions of the LA with signif­
icant fibrotic atrial structural remodeling. Postcontrast T1 measurements have primarily 
been used to detect changes in ventricular tissue after myopathy or AF [192]. In addition 
this technique has been validated in ventricular tissue to show an increase in collagen in a 
wide range of cardiac diseases [193]. However, more recent reports have used postcontrast 
T1 measurements to predict ablation success before ablation. A study by Marrouche et 
al. which found that atrial tissue fibrosis estimated with LGE-MRI was associated with 
recurrent arrhythmia [137]. One limitation with LGE-MRI, however, is in measuring diffuse 
fibrosis [194]. T1 MRI can measure diffuse fibrosis by measuring absolute values of the T1 
relaxation time for each voxel and hence can be used to not only localize fibrosis by means 
of relative enhancement but also compare fibrosis changes over time in the same subject 
using this quantitative measurement [177]. The finding by Marrouche et al. suggest that
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Fig. 7.5: S tab ility  of high-D F sites in chronic A F. A) Examples of spatial stability 
of high-DF sites over 30 minute time course of AF averaged every minute for three chronic 
AF animals. X axis shows the spline numbers A-H, and Y axis shows electrode numbers on 
the corresponding spline. Each electrode site contains the incidence that it had a DF value 
within the top 10% over the AF episode. B) DF values for three locations, labeled 1-3, are 
shown over the time course of a 30 min AF episode.
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Fig. 7.6: D F m ap corresponds to  th e  activa tion  ra te . A) DF map from 1 minute 
of the 30-minute time course of atrial fibrillation. Labels 1) and 2) indicate regions with a 
DF of 10.0 and 8.2 Hz. B) Electrogram and FFT from regions 1) and 2) on the DF map. 
Location 1) has 20 activations in 2 second (approximately 10 Hz) and location 2 has 16 
activation in 2 seconds (approximately 8 Hz).
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Fig. 7.7: h igh-D F sites have h igher reg-idx as com pared  w ith  o th e r sites in LA.
Electrogram and first derivative are shown for a high-DF site and another site in the LA. 
Local minimums of the first derivative are selected as activation times, shown as blue dot 
on dV/dt. From these activation times the reg-idx was computed for the high-DF sites and 
was compared with the other LA sites. The bar graph summarize the regularity data for 
all the subjects.
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Fig. 7.8: R ela tionsh ip  betw een  regions of high-D F and  fibrosis. Four example 
spatial probability plots of DF and regions of fibrosis. X axis for each plot shows the 
spline numbers A-H and Y axis shows electrode numbers on the corresponding spline. Each 
electrode sites contains the incidence that it had a DF value within the top 10% over the 
atrial fibrillation episode. Examples 1-3 show examples of the DF on the border of fibrosis.
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fibrotic atrial structural remodeling that occurs during AF may facilitate the arrhythmia’s 
maintenance. As AF was induced with RAP in the animals, T1 times significantly decreased, 
indicating that atrial structural remodeling was occurring. Furthermore, the chronic AF 
animals, like the study by Marrouche et al., had specific regions within the LA that had 
more fibrotic remodeling than other regions.
Our findings indicate that during chronic AF, but not in controls, there are sites within 
the LA that anchor rapid reentrant or focal activity as determined through DF analysis. 
The controls either did not sustain AF or, in the one case that they did, the high-DF sites 
were not stable. AF may have terminated spontaneously due to the lack of fibrotic areas 
providing stability. This finding indicates that the chronic AF substrate may anchor regions 
of high-DF. Some prior reports disagree about the stability of high-DF sites [34,195]. Salent 
et al. reported nontemporally stable high dominant frequency by determining whether 
the dominant frequency in sequential time windows varied by more than ±0.25 or ±0.50 
Hz [195]. Although our results indicate stable regions of the sites of highest DF, our findings 
also agree with Salent et al. in that our sites of stable high-DF had a dynamic DF value, 
however this value was in the highest quartile DF over the 30 minute recording period as 
compared to other LA regions. This indicates that although the DF value may vary more 
than 0.50 Hz, these stable sites still have the highest activation frequency and therefore are 
likely driving the arrhythmia. A study by Jarman et al. also reported temporal and spatial 
instability of high-DF sites. This study found nonstability by examining sequential 6.8 
seconds of data. In 33% of cases a site of high-DF would disappear from a region, and then 
reappear at a later time (within 1-3 6.8-second time windows) [34]. Our study averaged 
six 10-second DF windows to have one DF value for each minute of AF. By taking an 
average DF for each minute of AF we found spatial stability of these high-DF sites over the 
time course of 30 minutes. This suggest that although sequential 6.8 second windows may 
have both temporal and spatial instability, during prolonged recording periods, the sites of 
high-DF tend to occur at specific sites. A recent study by Swarup et al. reported that over 
the time span of several tens of minutes that they observed spatial temporal stability of 
rotors or focal sources utilizing phase mapping [35]. The sites of stable high-DF reported in 
this study may correlate with these sites and detection of these sites with spectral analysis 
may require these prolonged recording periods.
Our study found that sites of stable high-DF during chronic AF have more organization 
than other sites within the atrium. Swarup et al. reported that patients in AF have stable 
rotors or focal sources which are driving the arrhythmia, however it was not clear what
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was stabilizing this rapid activity [35]. Recently, Hansen et al. found that fibrosis-insulated 
atrial bundles could sustain intramural reentry [38]. The high-DF sites found in our study 
had more regular activations than other sites within the atrium, which suggest that these 
sites may be the rotors or focal activity found by Swarup and Hansen et al.
The sites of stable high-DF tend to anchor on the border of dense fibrosis. These border 
regions may cause regions of abrupt conduction slowing, which may predispose these regions 
to maintain rapid reentrant/focal activity [29,196]. Cabo et al. reported that inexcitable 
objects with sharp edges may cause vortex shedding to cause the initiation of high-frequency 
excitation of the heart [60]. Specific regions of dense fibrosis may cause source sink mismatch 
and act as an inexcitable object to cause the initiation of stable high-frequency sources. 
Although our study found that sites of stable high-DF occur on the border of fibrosis, many 
fibrotic borders zones did not contained stable sites of high-DF. The study by Cabo et 
al. also reported the requirement of reduced sodium conductance and sharp edges of the 
inexctiable object. Therefore the formation of stable high-DF sites may require specific 
sites of fibrosis that have a reduction of sodium conductance and sharpness of edges.
7.5 Limitations
This study was limited to RAP-induced AF models, and although this is similar to AF 
developed through rapid focal pulmonary vein firing, a human patient population may have 
a variety of mechanisms of AF development. For these reasons longstanding persistent AF 
in humans may have different electrophysiological properties than the RAP chronic animal 
model of AF. Longstanding persistent AF in humans is often entrenched in patients over 
the time course of many decades. However, such animal models have been used in the 
past and have provided significant insights into AF mechanisms. Another limitation is the 
difficulty of merging the EnSite and T1-Mapping MRI geometries by selecting corresponding 
points between the two models. The effect of selecting incorrect corresponding points was 
minimized by using several landmarks in the LA, including the pulmonary veins.
7.6 Conclusions
Heterogeneous atrial remodeling, specifically fibrosis, arising from chronic AF provides 
a substrate that anchors sites of high-DF, and this anchoring of high-frequency sources is 




This dissertation shows that the cardiac substrate helps initiate and/or sustain abnormal 
cardiac conduction. Novel imaging and electrical recording techniques were used to bridge 
the domains of cardiac substrate and functional electrical measurements. Although fibril­
lation is characterized by a disorganization of wavefronts, it is not completely stochastic. 
Specifically, the results of this dissertation show that the cardiac substrate can manifest 
in specific electrophysiology properties, which may drive the arrhythmia. Aim 1 measured 
the activation rate of the conduction system compared to the VM during VF. During 
short-duration VF, the activation rate of the VM is significantly higher than the His bundle. 
This finding is consistent with the traditional theory that VF is maintained through rapid 
reentrant wavefronts within the VM. However, after 1-2 minutes of VF, a transition occurs 
in which the His bundle activates faster than the VM. The VM activation rate decreases 
quickly during VF whereas the His bundle activation rate does not significantly decrease. 
Ischemia changes the electrophysiology of both the conduction system and VM, such that 
there is a transition of the driver of VF from the VM to the conduction system. Furthermore, 
the His bundle being a potential driving site is an example of how the cardiac substrate, 
e.g., differences between the ventricular conduction system and the VM, causes deterministic 
properties of fibrillation. The next two aims focused on how structural changes that occur 
during AF relate to increased likelihood of initiation and maintenance of this arrhythmia. 
Aim 2 found that long strands of fibrosis alter conduction such that the tissue is more 
arrhythmogenic. Specifically, this aim found that in chronic AF, fibrosis strands located 
primarily along cells potentially obstruct the transverse connection between cells. The 
fibrosis strands may result in slowed or blocked transverse conduction. Aim 3 expanded 
on aim 2 to determine how regions of the most dense fibrosis in the LA relate to the rapid 
activations in the atrium. The conclusion of aim 3 was that the sites of most rapid activation 
anchor to the borders of fibrosis. This aim found that even though AF is highly disorganized 
in its activation, fibrosis can predict where the most rapid sites of activation will be.
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8.1 Future Work
Although we found that the cardiac substrate can manifest in certain conduction 
properties, it is still unclear what effect the substrate has on the properties of fibrillation 
and whether this information can be used to help patients. The cardiac substrate was 
shown to manifest in specific electrophysiological properties, but it is still not clear whether 
fibrillation has a chaotic yet deterministic organization, or whether fibrillation still has 
more stochastic properties than organized properties. This question becomes central when 
trying to develop clinical uses for the findings in this dissertation. There are two possible 
parallel paths for future studies based on the findings of this dissertation. The first is to 
understand the implications of these findings and to expand the scope of the projects for 
a more mechanistic understanding of structure and function in fibrillation. The second, 
parallel path is to develop clinically useful applications of the findings of each aim.
8.1 .1  C on d u ction  S y stem  and V entricu lar F ibrilla tion
Aim 1 found that the proximal conduction system has a more rapid activation rate 
than the VM after 1-2 minutes of VF. Even though there is mounting evidence that the 
conduction system may be a driver of long-duration fibrillation, it is unclear whether this 
system can be used as a target for low-energy treatment of VF. The conduction system 
is a promising potential target for terminating VF for two primary reasons. First, it has 
been implicated in the maintenance of VF, and therefore by pacing this system we may 
prevent potentially short-lasting, self-terminating VF from progressing into sustained VF. 
Second, the conduction system structure is electrically connected to the VM at many sites. 
By pacing the conduction system it may be possible to consistently capture large regions of 
cardiac tissue to stop VF. To determine whether the conduction system may be a target for 
pacing during VF, we have to determine whether this system can be paced during VF. The 
conduction system may be activated as soon as it comes out of refractory. If this is the case, 
pacing the system will not have an effect during VF. Our preliminary data suggest that 
the conduction system can be paced during VF. The setup was similar to what is described 
in Chapter 5, except that the His bundle was paced at 90% of its average cycle length, 
and a second plaque was placed on the VM to determine whether the pacing reached the 
distal regions of the conduction system. Fig. 8.1 shows an example in which the His bundle 
was paced during VF, and the pacing began to capture the distal VM, which resulted in 
termination of VF.
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Fig. 8.1: His bund le  paced du ring  V F , resu lting  in te rm in a tio n  of th e  a rrh y th ­
mia. An ECG, an electrogram from the His bundle, and an electrogram from the distal 
Purkinje fibers are shown. The His bundle was paced at 90% of its cycle length. During 
early pacing the distal Purkinje fibers and ventricular myocardium are not being captured. 
However, at the end of the pacing train, of approximately 20 pulses, the His bundle is 
being captured. Furthermore, the pacing pulses at the His bundle are conducting to and 
capturing the distal ventricular myocardium. VF no longer was sustained immediately after 
the pacing.
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8.1 .2  S tru ctu re  o f F ibrosis and Its E ffect on C on d u ction
This aim found that during chronic AF, conduction slows in the transverse direction, 
which may be due to the structure of fibrosis. A major limitation is that histology was 
obtained only from a 4um-thick sample of histology 500um from the epicaridal surface. 
Therefore, the fibrosis structure was known only on that single plane, and it is not clear what 
the structure was through the LA wall. An extension of this study would be to visualize and 
quantify the fibrosis structure transmurally through the LA wall. This three-dimensional 
structure of fibrosis could be made by sectioning the tissue from epicardium to endocardium, 
and then reconstructing these sections. Fig. 8.2 shows an example of the three-dimensional 
structure of fibrosis.
Another limitation of this study that could be studied more is that it is unclear whether 
the conduction slowing is due to the fibrosis, or whether it is due to electrical remodeling 
of gap junction due to AF. A potential way to examine whether this transverse conduction 
slowing is due to electrical or structural remodeling is to repeat these studies in an animal 
model that has fibrosis but does not have electrical remodeling. Utah State University 
has such a model, in which goats have been genetically modified to have more atrial 
fibrosis. These animals can be more easily induced into AF, as compared to controls, 
but the mechanism is unclear. A potential mechanism is that structural remodeling alone 
is sufficient to increase the likelihood of AF.
The clinical expansion and implications of this aim are that the architecture of fibrosis 
may be more important than the overall fibrosis level. There may be patients with 
substantial levels of diffuse fibrosis who never develop AF because of the architecture of 
their fibrosis. Of course, there may also be a subset of patients with substantial amounts 
of obstructive fibrosis (risky substrate) but whose hearts lack a trigger for premature atrial 
contractions so they do not develop AF. A possible future study would be to determine 
whether there are differences in fibrosis architecture from patients who respond well to 
antiarrhythmic drugs or ablation therapy versus those who do not. Quantifying fibrosis on 
an individual patient basis could lead to patient-specific treatments based on the patient's 
fibrosis architecture.
8 .1 .3  F ibrosis E ffect on A tria l F ibrilla tion  C ond uction
Aim 2 examined how fibrosis may increase the likelihood of AF initiation, and aim 
3 examined the role of fibrosis in sustaining AF. This study found that regions of high- 
frequency activation tend to occur on the border of fibrosis. The stablility of high-frequency 
activation sites suggest that fibrosis acts as an anchor to driving sites during AF. However,
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Fig. 8.2: R eco nstru c tio n  of th ree-d im ensional collagen bands from  LA tissue 
of an  A F dog. A) Masson trichrome staining shows normal cardiomyocytes and nuclei 
in red and the extracellular collagen stains in blue. The epicardium is on the top and the 
endocardium is on the bottom. B) Blue stained tissue is shown. The 16 sequential sections 
are aligned and stacked. A large intramural collagen band is shown with a white arrow. C) 
Rotated image of the three-dimensional stack is shown to demonstrate the three-dimensional 
structure of collagen bands. The white arrow shows the same collagen band from B) but 
shows that the collagen band has depth through the entire stack. We anticipate that large 
collagenous sheaths such as the one marked with the arrow in Panels B and C may be 
consistent sites of block or conduction slowing.
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it is unclear why these sites are more prone to this activity. Specifically, it is unclear 
whether these driving sites are rotors, or whether they are just regions of multiple wavelets. 
An example of the possible mechanisms of fibrosis is shown in Fig. 8.3. Future work for 
this study would be to do more high-density mapping of regions of stable high dominant 
frequency, with the goal of mapping cardiac waves during fibrillation. This mapping could 
be done with either a higher density mapping catheter, or in an isolated perfused setup 
with voltage-sensitive dyes.
Another expansion to Aim 3 is more clinical and is to determine whether ablation of 
fibrosis sites can result in long-term freedom from AF. If the fibrosis is ablated, there may 
no longer be the anchor sites available to sustain the arrhythmia. Furthermore, the ablation 
sites could be preplanned after computing a pixel by pixel T1 map from MRI. Preliminary 
studies utilizing the canines in aim 3 showed that ablation of fibrosis had promising results 
with all of the fibrotic target ablation animals not having recurrence after 1 month, and 
with random ablation being successful in only one third of animals. Furthermore, three 
out of four of the fibrosis-targeted ablation group could not be induced into AF with burst 
pacing from three locations. Further studies would need to be done to determine whether 
T1-Mapping MRI can be used to find ablation targets for humans, which could result in 
cardiac substrate-guided patient-specific ablation.
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Fig. 8.3: Schem atic of in itia tio n  of a ro to r due to  v o rtex  shedding. A1 and  A2)
Cardiac wave shown in black is approaching an inexcitable cardiac tissue shown in blue. 
B1) Cardiac wave interacts with inexcitable cardiac tissue and begins to bypass the tissue. 
C1) When cardiac wave bypass tissue a source sink mismatch forms at the boundary of 
the object. This causes a convex wave shape at the boundary of the inexcitable object 
where conduction slows. D1) If the curvature of the wave is large enough, the wave can 
start to rotate around an inexcitable center known as a singularity point. This rotational 
conduction around an inexcitable core is known as a rotor. B2) The broad cardiac wave 
conducts into the fibrotic region and is broken into many smaller wavelets. C2) The many 
wavelets then conduct out of the fibrotic region. D2) The many wavelets then interact with 
other cardiac wavelets to promote multiple wavelet reentry.
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